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"Music does not influence research work, but both are nourished by the same sort of 
longing, and they complement each other in the release they offer."  
                                                                                                  Albert Einstein 
 
"What Artistic and Scientific Experience Have in Common - Where the world ceases to 
be the scene of our personal hopes and wishes, where we face it as free beings 
admiring, asking, and observing, there we enter the realm of Art and Science. If what is 
seen and experienced is portrayed in the language of logic, we are engaged in science. 
If it is communicated through forms whose connections are not accessible to the 
conscious mind but are recognized intuitively as meaningful, then we are engaged in 
art. Common to both is the loving devotion to that which transcends personal 
concerns and volition."  
                                                                                           Albert Einstein 
iv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I wish to dedicate this PhD Thesis to my grandmother Marianna Kowalczyk (1933-
2012), and my two cousins Adrian Federowicz (1994-2013) and Mateusz Kowalczyk 
(1991-2013). 
 
 
v 
 
Acknowledgments 
“The journey of our lives is not just about the destinations we have reached. Our 
wisdom, education and personal growth will come from the people we meet, the paths 
we choose to follow and the lessons we have learned along the way.” Unknown 
During my long journey which is called PhD, I have met many valuable people whom I 
would like to thank.  
Firstly, I wish to thank my supervisors, Dr G. Richard Stephenson, for giving me the 
opportunity to carry out my project in Norwich. You were supportive and helpful. I 
would also like to thank Prof. Pierre-Yves Renard for our collaboration, great support 
and for the opportunity to work in Rouen. Thanks to Prof Anthony Romieu for help and 
advice during my stay in Rouen. I would also like to thank my secondary supervisor 
Prof. Andy Cammidge. Thanks as well to my examiners Dr Chris Richards from 
University of East Anglia and Dr Simon Lewis from University of Bath. 
 I am very grateful to Dr Kenneth Hamilton for his help especially when I started my 
PhD and all the way through and for correcting my English.  
I would like to thank all the members of the Stephenson’s group, past, present and 
future. Many thanks to people with whom I worked in the lab 3.16 and 3.13 for 
creating such amazing atmosphere and all the people from 3rd floor. In particular, I 
wish to thanks: Ketan (for lots of fires and cool times with a bit of respect), Francesca, 
Oliver (for being you crazy self), Dominika, Luis, Doyle, James T. (for making me laugh), 
Johanna, Hemin, Sonia, Daniel, Ian, Cesar, Ryan, James H., Edmond, Dr Yohan, Dr 
Jamal, Dr. Julien Doulcet (for support and precise help) and many others.  It is actually 
difficult to name you all. But definitely, thanks a lot to all of you, guys.  
Thanks as well to all the technical staff of the department, in particular: Peter Mayes, 
Liz Suveg and Colin Mcdonald for the NMR. 
I wish to thank all my friends from Norwich, in particular: Dr Fabiola Gomez- Lopez 
(Fabiki) for huge support and great heart, Sarah Delf (small lion) for being more than 
labmate and our real trips, Iskander (Scandal) for long discussion about life and 
“scandals”. 
vi 
 
My housemates who have made me feel at home during staying in Norwich. In 
particular, big thanks to: Gabriela Bianchi (Brazilian beauty) for huge support and 
teaching me the management of life and being for me whenever I need, Dr Kim Findlay 
Cooper (Kimi) for nice advice and crazy times, Cristina Macarov for crazy kindness and 
support. Definitely, thanks a lot to all of you, guys. You are all unique. 
As well, I wish to thank my teacher and in the same time cool friend without whom I 
would have never reach this place; Dr Fabrice Bisaro you are one of the best person 
whom I met during this “trip”. Cheers for helping me to understand and appreciate the 
organic chemistry with the Bob Dylan songs in the background and as well for your 
support in critical situations. 
I wish to thank all my friends from Poland without whom I would have ever come to 
Norwich. In particular, many thanks to Piotr Socha (Pitus) for beautiful smile, nice 
advices, and making me laugh; Iwona Nowak (Iwoncia) for great support and being 
sensitive, Katarzyna Bielawska (Kate B) for the best times with Gutek, Boguslaw 
Kowalczyk (Bobo) for great support and, Daniel Bernacki (Berni) for advices, Gabriela 
Rybak (Gaba) for support and being crazy. Although we don’t meet that often but I 
always know that you are there for me. You are all very special to me. 
 
Special thanks to Dr Konrad Kowalski, who encourage me to come to Norwich to work 
with Richard. That was a very good move and I owe you a lot. 
 
I wish to thank Antoni Socha and Zofia Kalkowska for all support and advices especially 
during critical situations. You are like family to me. 
 
Finally, I wish to thank the families Glowacki and Kowalczyk for their love and support 
at all levels. In particular, many thanks to my mother Irena Stanislawa Glowacka, my 
father Ryszard Andrzej Glowacki, my brother Daniel Bartosz Glowacki. Finally I would 
like to thank my handsome blue eyed Simon James Hawkes for love, support during 
the last part of my PhD and not only. Without you I will never be at this place. 
 
 
 
vii 
 
 
ABSTRACT: The synthesis of diene ligands with H-bonding capabilities for bioimaging 
applications 
Investigations of the synthesis of novel bioprobes (Scheme A), potentially useful in 
bioreactions and sugar sensing, are described. A preliminary study is reported that 
aims to validate the feasibility of tricarbonyl iron complexes and their derivatives in 
applications as a constituent part of IR/fluorescent bioprobes. Infrared spectroscopy 
has significant potential in studying these carbonylmetal-based bioprobes, as the M-
CO signals fall in a window in the water background spectrum at about 2000 cm–1 
where absorptions of most of organic functional groups are absent. Their narrow 
vibrational stretching modes provide information about the iron complex and its 
environment. 
 
Scheme A 
In the first project, novel tricarbonyliron complexes were synthesised by N-acylation 
with various amines. This procedure allowed direct access to novel amide products. 
(Scheme B). 
 
Scheme B 
Work towards the development of reactions for the preparation of 9-
aminomethylanthracene is described. An improved preparation of this fluorophore in 
good yield from readily available precursors (Scheme C) was developed. 
 
 
Scheme C 
viii 
 
Furthermore, the synthesis of bioprobes suitable for sugar analytes using 9-
aminomethylanthracene derivatives containing boronic acids were also investigated. 
The synthesis of bioprobes with self-immolative linkers that also contain both 
fluorophores and tricarbonyliron complexes and a study of their enzymatic cleavage 
reactions is also described. The reaction of an electrophilic cyclohexadienyliron(1+) 
complex with 7-amino-4-methylcoumarin gave a new fluorescent compound, Scheme 
D. The methodology was then applied to the preparation of a novel series of 
fluorescent compounds which are valuable precursors in prodrug applications. 
 
 
Scheme D 
Finally, a study was made of the reaction of  PABA derivatives with different protecting 
groups to incorporate the carbonyl group followed by attempted reactions with these 
new fluorescent compounds to give fully-functional target molecules, but this was 
unsuccessful (Scheme E). 
 
Scheme E 
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1.1 About bioprobes in general 
The history of bioprobes began with the development of enzyme-coated electrodes by 
Leland C. Clark, in 1962.1 From that point on, research in the fields of biology, 
chemistry, medicine, and agriculture have come together to discover and develop 
more sophisticated systems, consisting of biosensing devices for applications which 
extend even tomilitary uses for bioterrorism detection and prevention. There are many 
different definitions and terminologies used depending on the field of application, but 
biosensors are known variously as: immunosensors, optrodes, chemical canaries, 
resonant mirrors, glucometers, biochips, and biocomputers.2 A generally cited 
classification is the one accepted by IUPAC: “an electrochemical biosensor is a self-
contained integrated device, which is capable of providing specific quantitative or 
semi-quantitative analytical information using a biological recognition element 
(biochemical receptor) which is retained in direct spatial contact with an 
electrochemical transduction element”.3 
Bioprobes must include a mode to read out the information from the molecular 
recognition event. Typically, bioprobes have three parts (Figure 1): a binding site for an 
analyte molecule; a signal transduction portion of the molecule; and a responsive 
portion of the molecule which provides a read-out of the information. This design is 
restricted by the selectivity of the receptor where parallel analytes can compete for 
binding in the receptor. This methodology requires a time consuming process of design 
and synthesis of an optimized receptor for each analyte.4 
 
 
Figure 1 Representation of bioprobe. 
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Biosensors can be applied to many biotechnological uses, for example, in blood 
glucose sensing, expressing abundant market potential.  Moreover, biosensors have 
great potential for commercialization in other application areas, but unfortunately 
commercial acceptance has been slow because of several technological challenges, 
such as complexity of the real samples, the need for reduction and simplification of the 
technology, selectivity and stability of the recognizing element.5 
 
1.1.1  Methods for bioprobes applications 
More advanced biosensors can enable remote and automated environmental 
monitoring. The biorecognition elements used include enzymes, whole cell receptors, 
DNA, or antibodies. They are linked with a transducer, such as: an electrochemical, 
optical, piezoelectric, or thermal device, which changes the biorecognition event into a 
quantifiable signal. Fluorophores or enzymes are often used to increase and generate 
detectible signals. The transduced signal is recorded as a digital output, normally on a 
computer facilitated by dedicated software. The biosensor is also responsible for 
detecting the analytes of interest and converting a biorecognition event into a digital 
output. The main purpose in building effective biosensors is to create technology 
which is user-friendly, sensitive, precise, reliable, and inexpensive.  
 
1.1.2 Approaches for the read-out of information 
The most well-known methods for signal transduction and read-out of information use 
spectroscopic methods such as UV, fluorescence spectroscopy and electrochemistry.  
In a UV experiment, the binding of a guest molecule in the receptor changes the 
spectroscopic properties of a chromophore and so the spectrum of the molecule 
changes. This kind of spectrum then can be measured in the presence and the absence 
of the analyte, and comparing the results can give the basis for analytical 
measurements, and calibration curves can be defined.6  
Fluorescence spectroscopy can be used in a similar manner to UV/visible methods, but 
has the important advantages of greater sensitivity.7 
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The molecular design of probes constructed to use fluorescence spectroscopy is often 
problematical. Figure 1 shows a fluorophore (responding component) which is 
covalently linked to the molecular receptor to separate the design of the binding 
component and the read-out component. Signal transduction, in both UV/visible and 
fluorescence-based systems, occurs between full and empty π / π* orbitals (or n / π* 
orbitals). Modifications in the molecule to optimize signal transduction vary the 
spectroscopic and fluorescence properties of the molecule. Even though there are 
some disadvantages to both of these spectroscopic techniques, they are very popular 
and have many successful applications in research. Advanced designs such as those 
employing fluorescence quenching have been devised to provide large changes in the 
spectroscopic responses upon binding of the analyte.8  
Electrochemistry is also used as a read-out method.9 The experiment involves the 
measurement of changes in redox potentials to identify the binding of the guest 
analyte. One positive aspect of utilizing redox chemistry is that many subtle molecular 
factors can impact the electrochemical outputs of the electrophore. Therefore, an 
array of signal transduction strategies can be used. Organometallic derivatives can 
offer intense and precise electrochemical responses, and thus it is advantageous to 
introduce an organometallic structure as the read-out method of the molecular sensor. 
Ferrocene10 can be chosen as a good example because it has high levels of chemical 
stability with a wide selection of synthetic procedures for derivatisation. Ferrocene 
also has suitable characteristic electrochemical responses that can be used in sensor 
applications.10 For example, the binding of lithium and sodium ions in an azacrown has 
been studied by such an electrochemical approach.11 
Although infra-red spectroscopy is not very widely used in molecular sensors, it can 
show surprisingly many advantages. In the study of biological systems, one of the 
problems to overcome is the background from water which makes large sections of 
the IR spectrum unclear, and so not useful in a spectroscopy read-out strategy. It is 
therefore important to run a background spectrum before the sample spectrum. The 
most visible features of the background spectrum are strong IR peaks around 3800, 
2400, 1600 cm-1.  The appearance of these peaks is due to O-H stretch of water and 
asymmetric stretch of carbon dioxide followed by H-O-H of water, respectively.  In IR 
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spectra, the water bands are made up of many sharp peaks which are the vibrational 
transitions between different rotational states of water. When a high resolution 
instrument is used, the CO2 band shows similar rotational splitting, but the lines are 
closer together.12  Rotational splitting only occurs in the gas phase. Within the 
spectrometer cavity, air contains water and carbon dioxide. To overcome 
observational problems arising from this, purging the spectrometer has been used, 
involving the passing of a steady stream of nitrogen through the spectrometer to 
eliminate the H2O and CO2 bands. Despite all this, organometallic chemistry again 
shows the best answer to this problem. In designing a bioprobe, it is important to 
achieve a good signal transduction between the receptor site and the responding 
group, which are less likely to suffer from interference when vibrational spectroscopy 
provides the read-out process. The key benefits of IR are: 1) minimal background 
absorbances from biological functional groups in the window in the water background 
system; 2) this technique can function on a very fast timescale, so it is possible to 
resolve details of quickly changing events.5  
To summarise, in order to build good bioprobes, many factors have to be considered, 
such as high sensitivity in the spectroscopic responses is fundamental. With greater 
sensitivity, a larger array of biological matters can be distinguished, as method 
depends on the capability to recognise changing signals from the read-out system in 
the presence of the background spectra of the biological sample. It needs to be 
mentioned that low competition from background spectroscopic transitions is crucial. 
This ensures that when the signal transduction component that conveys information to 
the responding group changes, or when the structures of the host molecules in the 
host-guest chemistry of the receptor create change, there are corresponding changes 
in the spectroscopic responses of the system. The IR-based techniques show that it is 
possible to cover all requirements and they show great promise as a read-out method 
for biological applications. 
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1.1.3  Advantages of IR-based read-out method based on organometallic 
chemistry 
There is a region (1900-2100 cm-1) in the IR spectrum where organic functional groups 
do not show vibrational bands, except some very weak overtone bands of bending 
modes of organic functional groups.12 The vibrational stretching mode of carbon 
monoxide (centred on 2143 cm-1) is shifted to lower wavenumbers in carbonylmetal 
transition metal complexes. Many metal complexes with carbonyl ligands display 
intense vibrational stretching modes in this window in the background spectrum.5 In 
cases when the complex is connected to a receptor function by a transduction 
component (Figure 2), a suitable design for bioprobe using IR as a read-out technique 
can be established. When designing a bioprobe using IR as a read-out technique, it is 
worth noting that many carbonylmetal complexes show intense vibrational stretching 
modes in the window in the background spectrum, so they are suitable to be 
connected to a receptor function by a transduction component (Figure 2). 
 
 
Figure 2 Representation of the complex connected to a reception by transduction component 
Furthermore, in the case of the carbonylmetal complexes, the complicated 
vibration/rotation band structure of carbon monoxide gas is portrayed as single 
intense vibrational mode. The CO stretching of this mode when attached to the 
complex normally appears in the 1800- 2100 cm-1 region.5 
The explanation for the shift of the vibrational frequency of free CO into the 1800-
2100 cm-1 region in the metal complexes will be now described. A sigma bond (σ) is 
formed between the carbon of the CO molecule and the metal arising from the overlap 
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of symmetrical metal orbital and the sp hybrid orbital on carbon (which in the case of 
free CO holds a non-bonded pair of electrons at carbon). This is called a σ donor 
interaction which is from the CO carbon lone pair into an empty metal orbital.  
The ligands can possess empty antibonding orbitals which have the correct orientation 
to receive electrons back from the metal to form pi bonds, created from the overlap of 
a π* orbital of the CO triple bond with a suitable symmetry (antisymmetric) metal-
centred atomic orbital (an interaction between the carbonyl ligand and the metal). 
This can produce a flow of electron density from metal to the ligand which fulfils a π-
acceptor function as the metal complex forms.12,13 
 
Figure 3 Representation of the σ and π back bond between iron and carbon monoxide. 
These properties of the σ-donation and π-acceptance gives a convenient model to 
recognise the consequences of complexation on the strength of the CO bond, and 
consequently on the shifts in the vibrational frequency of its stretching mode [υ(CO)]. 
It is necessary to explain why the cationic carbonyl-metal complexes show υ(CO) at 
higher wavenumbers than neutral complexes, and correspondingly why neutral 
complexes will have υ(CO) at higher wavenumbers than anionic complexes. It is 
needed to take into account that anionic complexes possess greater electron density 
on the metal than a neutral structure, so π-acceptor properties of ligands provide a 
means for charge delocalization. Greater transfer of electron density from the CO π-
bonding system into the orbital which includes the π* antibonding orbital of the 
carbonyl ligand, make the triple bond weaker and lowers the vibrational frequency of 
the stretching mode. 
In analogous way, the cationic case can be explained. The lower electron density at the 
metal results in a smaller tendency to transfer electron density to a π* antibonding 
orbital, which avoids making the bond weaker, so the peak for stretching mode 
appears at higher wavenumbers. If the carbonyl ligand is exchanged for a phosphine 
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ligand, the vibrational frequency of any remaining carbonyl ligands will be shifted to 
lower wavenumbers as the phosphines are weaker π-acceptors than carbon 
monoxide.12  
 
 
 
Figure 4 Representation of IR spectra for metal with ligands (adapted from reference 5). 
When a metal is connected to several carbonyl ligands, vibrational coupling will 
produce a more complicated spectrum. Figure 4a is the representation of the IR 
spectrum as a single sharp band for an isolated M(CO) group. When two carbonyl 
groups are attached to the metal in an M(CO)2 structure (Figure 4b) this always gives 
two distinct vibrationally coupled signals, and consequently more information can be 
read from it. The symmetric vibrational mode of the M(CO)2 corresponds to the higher 
energy vibrational band, and the antisymmetric mode corresponds to a lower energy 
vibrational band. The distance between these two bands [(υsym(CO) and υasym(CO)]  is 
important because it depends on the efficiency of  vibrational coupling. The position of 
the bands also plays a significant role, as the location of the centre point between the 
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two band maxima is strongly influenced by the charge on the metal, but the vibrational 
coupling is most affected by the changes in the geometry of the complex.14 It is 
noteworthy that already it is possible can read more information from M(CO)2 than 
from a M(CO) group, so it is clear that when the three carbonyl groups are attached to 
the metal even more data is obtained.5  
In Figure 4c, the IR spectrum for M(CO)3 is presented. There is as before a symmetric 
stretching mode which shows the highest wavenumber vibrational band. However, 
there are now two opportunities for antisymmetric stretching modes and often they 
have the same energy for the vibrational transition – i.e. they are degenerate. In the 
first instance, Figure 4c, the signals from these therefore appear at the same place in 
the IR spectrum which shows a smaller υsym(CO) band followed at lower frequency by a 
single υasym(CO) band of nearly twice the intensity. In second case, Figure 4d, the 
υasym(CO) bands can sometimes be partially resolved, for example if in non-polar 
solvents such as cyclohexane. This involves a second vibrational coupling and so 
provides an additional source of information in the read-out process. Considering 
bioprobe applications, it is worth notice that the overlapping υasym(CO) bands are also 
of value because loss of degeneracy and the degree of separation of the two bands are 
consequences of changes in the nature of the complex, which can be assessed by 
comparing the degree of broadening of the symmetric and antisymmetric signals.15  
The IR based technique using organometallic bioprobes with carbonyl ligand shows 
promising and unusual features, especially considering the absorption frequencies of 
υ(CO) signals (sharp and narrow) can be adjusted by changing other ligands in the 
complexes. These structures are able to behave in a differential way to a variety of 
charge/structural effects in the complex. Another great advantage of this method is 
that the signals of several organometallic complexes can be determined individually in 
a single spectroscopic experiment. It is also possible to choose to have vibrational 
bands that do not overlap, which can be very useful in the case of biological systems, 
where many competing influences on the output of the sensor have to be addressed.5  
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1.1.4 The selectivity of responses in IR-based read-out methods 
It has been shown that changing from non-polar solvents both shifts and broadens 
signals. It can be considered as due to the increased effect of dipole-dipole interaction 
between the vibrating dipole of the read-out group and dipoles of the solvent 
molecules, rather than to changes in charge distribution within the structure induced 
by the greater solvation of charged functionality by more polar solvents. Both cases 
are possible and substantial because they cause changes to vibrational spectra from 
the influence of different solvation environments.16,17,18 
 
1.1.4.1 How solvent affects the IR spectrum 
Stephenson and Creaser et al.19 showed how to analyse the environment sensitivity of 
IR-active metal complexes with carbonyl ligands. They used the Bellamy plots20 of 
υsym(CO) against υasym(CO) vibrational modes and found that the solvents of different 
polarities give spectra in which the positions of the centres of vibrational bands are 
shifted substantially relative to one another (Figure 5a). It is worth notice that it 
correlates to a linear plot in which the responses to each solvent are spread out along 
a diagonal between hexane and DMA (Figure 5b). The calculation of the diagonal 
separation (δ) of the extreme points on the plot, corresponding to polar solvents such 
as dimethylformamide (DMF) and dimethyacetamide (DMA) and non-polar solvents 
such as hexane and cyclohexane allowed the degree of differentiation of environments 
shown by each complex to be assessed. 
The parameter (δ) was defined (Eq. 1) as: 
 δ = {[υsym (hexane)- υsym (DMA)]
2 +[ υasym (hexane)- υasym (DMA)]
2}1/2 (Eq. 1) 
where the vibrational signals for measurements in hexane and DMA lie at the 
extremes of the Bellamy plot. 
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Figure 5a IR spectra influenced by different solvents, reproduced from reference 5. 
 
 
Figure 5b Bellamy plots of symmetric and antisymmetric stretching modes of tricarbonyl(1-methoxy-1,3-
cyclohexadiene)iron(0): 1, hexane; 2, cyclohexane; 3, toluene; 4, dichloromethane; 5, diethyl ether; 6, 
tetrahydrofuran; 7, acetonitrile; 8, ethyl acetate; 9, acetone; 10, 1-octanol; 11, dimethylformamide; 12, 
dimethylacetamide; 13, acetic anhydride (reproduced from reference 5). 
 
The purpose of this investigation was related to addressing biological applications, as 
the variation of environment-induced shifts in the IR spectra offers a good read-out 
tool. In figure 5b, it can be seen that hydrophilic and hydrophobic environments 
correspond to the ends of the diagonals in the Bellamy plots. Moreover, specific issues 
that could possibly affect the relative positions of vibrational bands in various 
environments will provide a more significant to answer specific biological needs. 
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1.1.4.2 How the IR spectrum responds to changes at different pHs 
It has been proved that both the symmetric and antisymmetric modes of the 
carbonylmetal absorption respond to changes in pH.21 The complex 1 (Scheme 1) is a 
suitable example to show these changes. The υsym(CO) bands gives the simplest one, as 
the case of υasym(CO), which possess an overlapping pair of antisymmetric modes, is 
more complicated. The position of the υsym(CO) band of 1 and 2 in a pH range between 
3 and 8.6 is represented by filled circles (read against the scale on the left hand vertical 
axis) in Figure 6. 
 
 
Scheme 1 Example of the carbonylmetal in response to changes in pH which can be observed by IR. 
The pH effect was also studied on derivatives of 1 in which one CO ligand was 
exchanged for PPh3. It is shown in Figure 6 that this change caused the shift of the 
position of the vibrational bands (Figure 7) and also influences the pKa of the acid 
(Fe(CO)2PPh3 complexes are less effective anion stabilizers than their Fe(CO)3 
counterparts, because PPh3 is a weaker π–acceptor than CO). The data for υasym(CO) of 
the phosphine complex is represented by white circles also shown in Figure 6 (read 
against the right-hand axis). These spectra in Figure 6 can give even more information 
when they are compared with previous ones in Figure 5b where different 
solvents/solvent mixtures gave shifts of the whole band envelope.  
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Figure 6 Plot of IR spectra at different pH values (adapted from reference 5) 
 
 
Figure 7 Representation of IR spectra affected by pH values (adapted from reference 5). 
 
1.1.4.3 How the IR spectrum is affected by π–stacking interactions between organic 
structures 
Bioprobes can be based on π-stacking; an effect which is important because of 
interactions with aromatic side-chains in proteins and between adjacent bases in 
nucleic acids, and an example has been described by Stephenson et al.22 What makes 
the arene complex perfect for this case is that the aromatic ring is still flat after η6-
complexation, and the empty antibonding orbitals of the M-C bonding interactions lie 
in the region above the complexed arene, on the side opposite to the metal. These are 
envisaged to be suitably placed to form charge transfer interactions with electron rich 
aromatic rings. The result of π-stacking is that the vibrational bands of 
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tricarbonylchromium complexes are moved to lower numbers, as seen in benzene 
when compared with cyclohexane. The results shown in Figure 8 can be explained as 
follows: in the overlapping vibrational bands for spectra measured in mixtures with 
dimethoxybenzene in cyclohexane, the positions of the higher wavenumber υsym(CO) 
and υasym(CO) bands stay constant and reduce in intensity, while a new pair of υsym(CO) 
and υasym(CO) bands appear at lower wavenumbers, and grow in intensity as the 
influence of the π-stacking increases. It can be noticed that there is broadening of the 
new pair of υsym(CO) and υasym(CO) absorptions as they shift more, an effect that can 
also be affected by gradual addition of a more polar solvent to non-polar 
(cyclohexane). 5 This shows that the arene complexes of Cr(CO)3 are prospective 
probes with π-stacking effects. 
 
 
Figure 8 FT-IR spectra of (benzene)Cr(CO)3 5 in cyclohexane in the presence of 1,2-dimethoxybenzene (trace a: 39 mM, trace b: 
79 mM, trace c: 392 mM, trace d: 785 mM, trace e: 1.57 M, trace f: 3.92 M) (adapted from reference 5). 
 
1.1.5 How to use organometallic bioprobes with proteins 
Stephenson et al.23,24 showed that it is possible to attach carbonylmetal bioprobes to 
the surfaces of proteins. They used the electrophilic 
tricarbonyl(cyclohexadienyl)iron(1+) salts 3 to react with nucleophilic groups on the 
protein, for instance lysine NH2 groups (Scheme 2). This reaction of the cation with the 
protein α-chymotrypsin was examined by IR. The bands at 2051 and  
1980 cm-1 of salt 3 gradually decreased in intensity as higher frequency bands 
appeared at about 2058 and 1993 cm-1, which are due to formation of compound 4 
which is in equilibrium with 5.   
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Scheme 2 Use of organometallic reagent 3 to react with proteins. 
 
These results can be explained as the addition of the tricarbonyliron complex to 
surface lysine groups forming ammonium ions by alkylation of the NH2 groups. An 
increase in the concentration of the enzyme results in the appearance of the new 
signals. The experiment was performed at four different concentrations of α-
chymotrypsin (1.96, 2.52, 3.32, and 4.82 mM).24  
 
1.1.6 IR-based bioprobes 
There are two distinct ways which are used to develop the organometallic bioprobe 
structures. The organometallic part can be connected directly to a biological 
macromolecular structure or to a small molecule which cooperates with a biological 
receptor system. In studies on oestrogens, Jaouen25 described a method in which 
steroidal compounds are derivatized at different positions while seeking to maintain 
biological activity. This research offered the basis for the development of the 
CarbonylMetalloImmunoAssay26,27 (CMIA) method by using metal carbonyl complexes 
as tracers, organic solvents (ethyl acetate, isopropyl ether) to separate the free and 
bound fractions, and FT-IR spectroscopy for quantification. Good representatives of 
this method are 628,29 and 730. The way these two compounds work is different, as 6 is 
believed to bind competitively to the receptor and 7 is able to make a covalent 
connection by forming a metal stabilized electrophile by loss of OH from propargylic 
position. 
Another example is the cyclopentadienylrhenium complex 831 which has been shown 
by modelling to be suitable to bind the hormone binding domain of the oestradiol 
receptor. Compounds 9 and 1032 represent derivatives of zeranol and the natural 
mycotoxin zearalenone and have also been found to be very useful in a system for the 
biological recognition of these structures. The compound 1133 (a carbonylmanganese 
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complex) has been found to be suitable as an organometallic tracer34 chemical 
(derived from the herbicide atrazine). Derivative 1235 is particularly interesting because 
the IR experiments for these compound shows non-overlapping IR bands, so it is 
possible to perform both measurements in a single spectroscopic experiment. 
Derivative 1336 proved effective in binding studies with avidin which is the binding 
protein produced in the oviducts of birds, reptiles and amphibians.  
In designing of the target bioprobes, it is needed to exploit changes in spectroscopic 
responses upon binding to the target or upon the cleavage of a bond. Whereas the 
competition assay work targets the determination of binding affinities by measuring 
attached and removable material. In all cases, it is essential to employ highly efficient 
spectrometers and to ensure that the organometallic compounds display biological 
activity. This will allow a precise screening of the biological activity to be performed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
Figure 9 Examples of organometallic bioprobes. 
The wide range of examples mentioned above indicates the prospective significance of 
organometallic carbonylmetal complexes as bioprobes. In our research group, and in 
collaboration, we are aiming to establish this approach in sugar sensors based on 
boronic acids, and prodrugs based on peptide “bond cleavage”. Almost all of the 
current methods utilise fluorescence for reporting the event of binding or cleavage. 
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There will be detailed descriptions about the structure and synthesis of the target 
organometallic carbonyliron bioprobes in the Results and Discussion, Chapters 2 and 3. 
The purpose of this work is to make the high information-content responses of IR-
based systems available for the first time in sugar and enzyme-sensing. As a novel 
development it can lead the way for many new applications. 
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1.2. Introduction to iron carbonyls and diene-Fe(CO)3 complexes 
Many metals form complexes which are of great utility for synthetic purposes, 
including palladium, chromium, magnesium and rhodium. The focus of this project is 
on organoiron complexes, specifically iron carbonyl complexes which are of special 
interest due to their high stability, with an iron(0) centre capable of coordinating 
complex organic ligands - the basis for organoiron chemistry. The most stable and well-
known compounds in air are iron(II) complexes. These are readily oxidized to iron(III). 
Iron(0) can coordinate five or six ligands with trigonal bipyramidal and octahedral 
geometries. Iron(II) complexes ([Ar]4s03d6) bind six ligands with octahedral geometry 
and for iron(III) ([Ar]4s03d5)  the coordination number is three to eight with octahedral 
geometry.1 
1.2.1. Preparation of iron tricarbonyl complexes 
The most common procedure for the preparation of tricarbonyliron-diene complexes is 
based on the complexation of dienes by direct reaction with carbonyliron compounds. 
The main reagents used are iron pentacarbonyl [Fe(CO)5] 14, diironnonacarbonyl 
[Fe2(CO)9] 15, and triiron dodecacarbonyl [Fe3(CO)12] 16. The first of these 14 a yellow 
liquid, was independently described in 1891 by Monde2 and Bertholet3, and was 
prepared by a direct reaction between finely divided iron and carbon monoxide. The 
second reagent (small gold flakes) was prepared by photolysis of [Fe(CO)5] in acetic 
acid using a medium pressure mercury lamp. The last reagent, triiron dodecacarbonyl 
[Fe3(CO)12]  16 (dark green solid), has been prepared by the thermal decomposition of 
[Fe2(CO)9] 15, Figure 10. 
 
Figure 10 The most common reagents used for preparation of tricarbonyliron complexes. 
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1.2.2. Synthesis of tricarbonyliron complexes 
The synthesis of tricarbonyliron complexes was pioneered by Reihlen and his co-
workers, although he appears not to have fully appreciated the importance of this 
innovative discovery in organometallic chemistry. In 1930, Reihlen’s group prepared 
(ɳ4-buta-1,3-diene)tricarbonyliron 18 by reaction of buta-1,3-diene 17 with iron 
pentacarbonyl 14, Scheme 3.4 
 
Scheme 3 Synthetic route towards preparation of 18. 
At the time, this report made no impact as no further papers were published for 
twenty-eight years in this research area. However, a U.S. patent5 was published in 
1946, in which Reihlen’s method was used for synthesis of the previously described 
compound 18. The product was found to be an effective antiknock reagent but 
unfortunately was unstable - a severe limitation was the need to protect hydrocarbon 
fuels which contained it from light and oxygen. Hallam and Pauson developed 
Reihlen’s method by refluxing 1,3-cyclohexadiene 19 with pentacarbonyliron to obtain  
(ɳ4-cyclohexa-1,3-diene)tricarbonyliron 21.6 
 
Scheme 4 Synthetic route developed by Hallam and Pauson to obtain 21. 
It is important to note that in the case of unconjugated (1,4)-cyclohexadienes such as 
20, the complexation occurs through an isomerisation mechanism originally reported 
by Arnet and Pettit in 1961.7 A great number of substituted  
cyclohexa-1,4-dienes are now readily available thanks to the convenient Birch 
reduction of corresponding benzene derivatives which gave access to a broad range of  
(ɳ4-1,3-cyclohexadiene)tricarbonyliron complexes.8 
There are now many experimental methods which have been explored for 
complexation of dienes, as it known that the thermal reaction of FexCOy (x=1 or 2, Y=5 
or 9, respectively) requires a temperature around 135-140 °C for the isomerisation of 
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1,4 dienes to proceed. The drawback here is the presence of side reactions, especially 
with reactive diene systems. There is an continuous challenge to find milder conditions 
to give diene complexes with high selectivity. A huge range of substituents and 
functional groups are now known to be compatible with the coordination of  
1,3-diene ligands to the metal.1  
One of the most curious methods to obtain tricarbonyliron complexes, and one which 
had a large input in our own creative procedures (see Chapter 3, 3.2 Results and 
Discussions for Project 2) to prepare tricarbonyliron complex, was performed in the 
absence of solvent by gentle heating of a mixture of the diene and a preformed 
mixture of Fe2(CO)9 and silica gel, which has advantages during work up.  There is still a 
need to improve the yields for complexation reactions because they are often quite 
moderate (20-50 %). An important factor is that, in order to obtain high yields, a large 
excess of the iron carbonyl reagent is necessary, which leads to a hazardous work up 
due to the building up of pyrophoric iron and the presence of Fe(CO)5 which is highly 
toxic. The answer to that was found by using a tricarbonyliron transfer reagent. 
 
1.2.2.1. Tricarbonyliron transfer reagents 
The first (ɳ4-1-oxabuta-1,3-diene)tricarbonyliron complexes 23 were reported in 1964 
by Weiss et al.,9 and were employed by Lewis10 as transfer reagents in 1972. The 
reagent was prepared by reaction of benzylideneacetone 22 and diironnonacarbonyl 
15 as shown in Scheme 5. 
 
Scheme 5 Synthetic route towards preparation of 23. 
The (bda)Fe(CO)3 23 transfer reagent is a suitable source of the tricarbonyliron moiety 
and was used in the complexation of 8,8-diphenylheptafulvene 24 to yield its 
tricarbonyliron derivative 25. A limitation is that this transfer reagent only works in 
reactions with conjugated dienes.11 
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Scheme 6 Synthetic route for preparation of tricarbonyliron derivative 25. 
Subsequently, Grevels in 1984 synthesised the bis(ɳ2-cis-cyclooctene)tricarbonyliron 
complex 27 which has advantages over Weiss’s reagent since the reaction conditions 
do not require high temperatures to transfer the tricarbonyliron fragment to 1,3-
dienes.12 Scheme 7 shows the preparation of  Grevel’s reagent by photolytic reaction 
of pentacarbonyliron 14 and cis-cyclooctene 26. 
 
Scheme 7 Photolytic reaction of 15 and 26 to afford 27. 
This transfer reagent 27 was used to react with cis-cycloocta-1,5-diene 28 which 
produced two compounds (ɳ4-cycloocta-1,3-diene)tricarbonyliron 29 and  (ɳ4-
cycloocta-1,5-diene)tricarbonyliron 30 as a consequence of double-bond migration. 
 
 
Scheme 8 An application of 27 as a transfer reagent to obtain 29 and 30. 
Another type of transfer reagent was first prepared by Otsuka13 and Lewis14 many 
years ago but in recent times it has been taken up by Knölker et al. in an extensive 
development of this area.15,16,17,18 He studied the scope and limitation for their 
synthesis and we were inspired in our own research by his chemistry. 
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The most effective transfer reagent was prepared by imine condensation of trans-
cinnamaldehyde 31 with p-anisidine 32 to produce 1-(4-methoxyphenyl)-4-phenyl 
followed by sonication with diironnonacarbonyl 15 (Scheme 9).18 
 
Scheme 9 Synthetic route used for preparation of 34. 
The reaction of this complex with 1,3-cyclohexadiene 19 at a suitably high temperature 
causes transfer of the metal fragment and provides the tricarbonyliron-1,3-
cyclohexadiene complex 21 in very good yield. As well as the complexation of 
conjugated diene, the reaction can be performed in catalytic matter by reaction of 
pentacarbonyliron 14 or diironnonacarbonyl 15 in the presence of the azabuta-1,3-
diene 33. (Scheme 10) 
 
Scheme 10 Synthetic route used for preparation of 21. 
When comparing the currently reported transfer reagents, the best one is Knölker’s 
compound 34.18 The huge benefit of using his compounds compared to others is that 
when reacting free ligands of type 33 with diirononacarbonyl, a sub-stoichiometric 
quantity of the free azadiene ligand may be used in synthesis of cyclobuta-1,4-
dienyliron tricarbonyl derivatives such as 21,  and it is possible to recover compound 
33 during the work-up of the reaction. 
1.2.3. Applications of tricarbonyliron complexes 
The synthetic application of the tricarbonyliron complexes is well established in 
organic synthesis. It is used as a stereochemical control group, a catalyst to isomerize 
double bonds, a protecting group, and an activating group, or as in this project, for the 
preparation of advanced biosensors. An outline of some of these will be discussed 
further. 
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1.2.3.1. As a stereochemical control group 
The application of the iron tricarbonyl moiety as a stereochemical controller is one of 
the most important synthetic tools. 
Scheme 11 shows an example of such control, which was reported by Pearson and 
Srinivasan.19 Reduction with sodium borohydride of tropone-tricarbonyliron complex 
35 formed a single diastereomer 36. When a ketone located alpha to a tricarbonyliron 
diene is reduced, the reaction is stereochemically controlled. This effect was explained 
by addition of hydride anti to the tricarbonyliron moiety.19  
 
 
Scheme 11 Example of stereochemical control using tricarbonyliron group. 
 
1.2.3.2. As a protecting group 
Hallam and Pauson’s observations in 1958 on dienes attached to the tricarbonyliron 
complex, suggest that the iron group could be potentially used as a protecting group.20 
For instance, it can survive reactions such as hydroboration, osmylation, 
hydrogenation, or epoxidation, which are characteristic for the modification of carbon-
carbon double bonds. The perfect example of this is exemplified in Scheme 12. The 
ergosterol benzoate complex 37 goes through these previously mentioned reactions, 
selectively at the 22,23-double bond, and hydrogenation of this bond is  illustrated  
below. When Fe(CO)3 is attached to the diene system none of these reactions occur on 
the ring double bonds.  
 
Scheme 12 Hydrogenation step to obtain 38. 
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1.2.3.3. As an activating group 
The tricarbonyliron moiety can be used in the formation of new carbon-carbon bonds 
as it acts as an electron acceptor and opens the possibility for nucleophilic addition to 
the diene carbon atoms. The nucleophilic addition of 2-lithio-2-methylpropionitrile 
(LiCMe2CN) to (ɳ
4-cyclohexa-1,3-diene)tricarbonyliron 21 and then decomplexation 
gives four products (39, 40, 41, 42) in which compound 39 can be isolated when the 
reaction mixture is permitted to come to room temperature (Scheme 13).21 
 
Scheme 13 Decomplexation step of 21.  
 
1.2.3.4. Stabilising capacity of the tricarbonyliron unit 
An example of another role in which the tricarbonyliron fragment shows increased 
stability by coordination is cyclohexa-2,4-dien-1-one, a tautomer of phenol.  
Cyclohexa-2,4-dien-1-one is the less stable tautomer in the uncomplexed form, 
however, when the tricarbonyliron fragment is introduced, the compound 43 is stable 
enough to be used in further synthesis. Scheme 14 shows the limitation in reactivity of 
the complex with selected nucleophiles. When reduction occurred to form compound 
44, the endo hydroxyl complex is favoured as the attack is anti to the metal. Similarly, 
treatment with zinc ethyl bromoacetate resulted in a complex 45 which could undergo 
dehydration to produce derivative 46, followed by hydride abstraction, to obtain the 
highly electrophilic tricarbonyliron cation 47. This substituted (ɳ5-cyclohexadienyl)-
tricarbonyliron cation 47 can react with a vast array of nucleophiles.22 
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Scheme 14 An example of stabilising role of the tricarbonyliron fragment 
 
1.2.4. Cationic forms of tricarbonyliron complexes 
A significant revolution in the organometallic chemistry of iron complexes arose in 
1960 with the discovery of the tetrafluoroborate salt of (ɳ5-cyclohexa-1,3-
dienyl)tricarbonyliron 48.23 This highly electrophilic cation was prepared by hydride 
abstraction from complex 21 with triphenylcarbenium tetrafluoroborate (Scheme 15). 
It has been proved that iron is bonded to five sp2 carbon atoms in the cationic complex 
and they are planar except for the sixth carbon, which in the cyclohexadienyl ring is sp3 
hydribised and lies above (48a) or below 48b the plane, Figure 11.24 Wilkinson et al. 
showed by 1H-NMR studies that for the (ɳ5-cyclohexadienyl)tricarbonyliron 
tetrafluoroborate complex, the correct conformation is 48b.25 
 
 
Scheme 15 Synthetic route towards preparation of salt 48. 
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Figure 11 Representation of the conformation of salt 48 
It is no surprise that these cationic complexes opened many gates in organic synthesis 
due to their strongly electrophilic nature. There was much discussion regarding how 
nucleophiles could possibly attack the cationic complex (for instance, anti or syn attack 
on the ring, attack at the metal). Most evidence to date suggests that in irreversible 
reactions nucleophilic attack takes place on the ring at the face opposite to the metal, 
because the products have an exo configuration.26  
The hydride abstraction reaction for mono- and di- substituted diene complexes is 
regioselective and the product formeddepends on the nature of the substituent 
(electronic effect) and also on steric effects as the counterion, such as the 
triphenylmethyl anion, is generally a very bulky group. In substituted cyclohexadiene 
complexes, there are two methylene groups which can be removed. The electron 
donating groups preferentially give almost entirely compound 50 and electron-
withdrawing groups give complex 51, but in each case with traces of the other 
compounds are found, (Scheme 16).27 
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Scheme 16 Hydride abstraction of 49 affording 50 or 51 depends on R substituent. 
It is worth noting that it is not possible to perform the hydride abstraction process with 
cyclohexadiene complexes 52 when a substituent is at the carbon-5 position (anti to 
the metal). This means that after a first addition of nucleophile to a dienyl complex, 
second addition is not possible, as shown in Scheme 17.22 
  
 
Scheme 17 Representation of hydride abstraction process. 
There are a few papers which describe alternative methods to overcome steric 
hindrance in hydride abstraction, such as oxidation of the neutral  1,2-dimethoxydienyl 
iron tricarbonyl complex 54 with thallium(III) tris(trifluoroacetate) or activated DDQ-
HBF4 at -78°C. Stephenson and his group used thallium(III) oxidation to prepare (±)-
carvone 56 and (±)-sylvecarvone 57.28 
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Scheme 18 Synthesis of (±)-carvone and (±)-sylvecarvone 
An alternative preparation of ɳ5-cyclohexadienyl salts is shown in Scheme 19, involving 
the reaction of suitable 1- or 2-substituted methoxydienyl or hydroxyl tricarbonyliron 
complexes under acidic conditions.29 
 
 
Scheme 19 Preparation of cation 48 under acidic conditions 
Stephenson et al.30 have explored the formation of complexes in acid conditions. 
These diene diols were primarily used for tricarbonyliron complexation. In Scheme 20, 
it is shown that depending on the electronic nature of substituent R, cation 63 or 66 is 
obtained by reaction of 1,2-cis dihydrodiol complexes 60, 61, 62 with 
hexafluorophosphoric acid in acetic anhydride. With a trifluoromethyl substituent, 
compound 68 is formed as the salt, but in the case of methoxy and chloro substituents 
predominantly 102 and 104 complexes result in a ratio 2:1, and 7:2 respectively.  
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Scheme 20 The preparation of monosubstitued cations 
 
1.2.5. Reactions of cations 
As the cyclohexadienyl-tricarbonyliron complexes are very reactive electrophiles, their 
reactions with nucleophiles have been well studied, and high regio- and stereo- 
selectivities have been observed in this type of reaction. Birch et al.31 demonstrated 
the reaction of ɳ5-methoxy iron cation 69 with nucleophiles and showed that the 
neutral iron complex 70 can behave differently upon demethylation and 
dehydrogenation, giving p-substituted anisole 71 or under acidic hydrolysis the 4-
substitued cyclohex-2-enone 72.31 
 
 
Scheme 21 The superimposed lateral control of reactivity. 
 
There has been a great deal of research on this type of reaction, specifically in the 
synthesis of natural products but not exclusively, as it is a very useful tool to carry out 
C-C, C-X (X=N, O, S, etc.) bond formation under mild conditions.32 
These types of salts easily undergo reactions with typical nucleophiles, for example 
amines, enamines33, hydroxide, alkoxyanions34, enolizable ketones, thiocyanate, 
selenocyanate, halide ions, nitrite ions, azide and dithiocarbamates. It is also known 
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that tricarbonyliron cations react with organocuprates, dialkylzinc, dialkylcadmium, 
and lithium alkyls in alkylation reactions.35,36,37,38 
Adejoro et al.39 described the reaction of cations 73 and 74 with pyridine and its 
derivatives to give new tricarbonyliron pyridino(1,4-ɳ-2-methoxycyclohexa-1,3-diene) 
complex derivatives (Scheme 22). The reactions were carried out at room temperature 
in acetonitrile; twelve new products were isolated although yields were not reported. 
 
Scheme 22 Preparation of iron complexes with pyridine and its derivatives 
Pearson’s group have presented a regio- and stereo- specific method of reaction  
at the methylated dienyl terminus with the potassium enolate  
of methyl 2-oxocyclopentanecarboxylate and tricarbonyl(4-methoxy-1-
methylcyclohexadienylium)iron hexafluorophosphate 77 to give two diastereoisomers 
78 and 79, which were transformed into 12,13-epoxy-4-methoxytrichothecenes of 
potential biological interest. This methodology can be applied to the preparation of 
trichothecene derivatives such as (±)-trichodermol, (±)-trichodiene, (±)-12,13-
epoxytrichothec-9-ene.40,41 
 
Scheme 23. Synthesis of aphidicolin and trichtocene dye. 
McCague and Potter42 reported a new approach to produce potential anticancer drug 
82 which is an analogue of tamoxifen (tamadron) by reaction of 2-methoxy-substituted 
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cyclohexadieneiron complex 81 with low-order organocopper complexes (Scheme 
24).42 
 
Scheme 24 Synthesis of tamadron 82. 
Carbazoles,43 which are found in certain groups of alkaloids, can show potent neuronal 
cell protection and display free radical scavenging activity. In 2000, Knolker et al.44 
demonstrated the first enantioselective total synthesis of the carbazole alkaloid 
carquinostatin A. An enantiopure arylamine was used for nucleophilic trapping of 
cyclohexadienyl complex 83, and then oxidative cyclization afforded the 
tricarbonyliron complex 85. Simple decomplexation by trimethylamine-N-oxide, 
followed by aromatisation using 10% palladium on activated carbon, gave carbazole 86 
which can undergo simple functional group manipulations to obtain the carbazole 
alkaloid carquinostatin (90, Scheme 25). 
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Scheme 25 Synthesis of alkaloid carquinostatin. 
Another interesting example of the use of tricarbonyliron salts was shown by 
Stephenson et al.45 His group prepared the organometalcarbonyl probe 93 by reaction 
of cyclohexadienyl-tricarbonyliron complex 69 with flavanone 91, Scheme 26. 
 
 
Scheme 26 Synthesis of the organometalcarbonyl probe 93. 
This research shows that the probe can be used to explore the mode of action of nod 
gene induction in Rhizobium leguminosarum by attaching the probe to protein binding 
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sites. When a tricarbonylmetal complex is bound to target sites, the vibrational modes 
of its complex undergo environment-induced shifts (see Sections 1.4.1.1-3). These 
intense vibrational bands of metal carbonyl complexes have also been employed in the 
CMIA (carbonylmetalloimunoassay) method which exploits the low detection limits of 
the vibrational modes by FT-IR spectroscopy (see Section 1.5). 
Birch46 used cyclohexadienyl tricarbonyliron complex 94 to prepare (−)-gabaculine 97,  
a naturally occurring amino acid which is potentially useful in treatment of Parkinson’s 
disease, schizophrenia and epilepsy. The synthesis included the nucleophilic addition 
(anti to the metal) of tert-butyl carbamate to tricarbonyliron cation 94, to give the 
neutral complex 95. After decomplexation by reaction with trimethylamine N-oxide, 
followed by hydroxide ion promoted ester hydrolysis, the last step is a simple acid 
catalysed hydrolysis of the protected (−)-gabaculine 98 to afford the target compound 
97.46 
 
 
Scheme 27 Synthetic route for preparation of (−)-gabaculine 98. 
 
1.2.6. Decomplexation of tricarbonyliron complexes 
To remove the tricarbonyliron fragment it is common to use one of a variety of 
different oxidizing reagents, resulting in liberation of ligand without changing its 
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structure. In 1963, Shvo and Hazum47 used trimethylamine-N-oxide (Me3NO) for 
demetallation and since then, it has been widely used. Other oxidants including 
iron(III) chloride, copper(II) chloride, pyridinium chlorochromate, Pb(OAc)4, 
H2O2/NaOH, MnO2 and ceric ammonium nitrate also remove tricarbonyliron 
complexes, as shown by the example in Scheme 28.22  
 
 
Scheme 28 Example of decomplexation step. 
The tricarbonyliron complexes conveyed novel reactivity and selectivity providing 
unique opportunities to design various probes and natural products. The preparation 
of novel tricarbonyl iron complexes and development of already known examples of 
these reagents will be described in Chapters 2 and 3 Results and Discussion. 
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1.3. Fluorescence  
Fluorescence (a physical process) is observed as an emission of light by a molecule 
which has absorbed light of specific wavelength and returned to its ground state by a 
radiative transition. The absorption and emission of light can be described as being 
caused by the movement of electrons between different energy levels within the 
molecule. The fluorescence processes were schematically illustrated by the Polish 
physicist Alexander Jabłoński in 1933.1 
 
 
Figure 12. General demonstration of a Jabloński diagram adapted from 
http://molecular.magnet.fsu.edu/primer/java/jablonski/jabintro/index.html. 
This diagram can clearly describe the different energy levels that a single electron can 
occupy within an atom or molecule. In the middle of the diagram, in Figure 12 are 
shown singlet states. S0 corresponds to a singlet ground state, and S1 and S2 to first and 
second singlet excited states, respectively. The excited triplet state, T1 is shown on the 
right side. All states have closely separated vibrational and rotational energy levels. A 
fluorophore can be excited from the lowest vibrational energy level of the ground 
state (S0 = 0) to a higher orbital in the second excited state (S2 = 3 for instance). 
Similarly absorption can happen from the second vibrational level (S0 = 1) of the 
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ground state to the highest vibrational level in the next excited state (S1 = 5). 
Straightaway after excitation by a photon, there are numerous processes which can 
occur. The molecule may quickly relax to the lowest vibrational energy level of the first 
excited state (S1 = 0, Figure 1). This process is named internal conversion or vibrational 
relaxation (loss of energy in the absence of light emission).2 It is a nonradiative process 
and generally takes place in a picosecond or less. Because a significant number of 
vibrational cycles can occur during the lifetime of excited states, molecules virtually 
always undergo complete vibrational relaxation during their excited lifetimes. 
Alternatively, before relaxation to the ground state S0 =0, an excited electron can stay 
in the lowest excited singlet state for periods in the order of nanoseconds. 
Fluorescence is the process of relaxation from long-lived state to the ground state, the 
energy being dissipated with the emission of light. Many fluorophores are able to 
repeat the excitation and emission sequence many times before the exceedingly 
reactive excited state of the molecule is photobleached (a chemical reaction then 
occurs, and fluorescence can no longer take place). It is possible to observe other 
outcomes which compete with the fluorescence emission route. The excited 
fluorophore can collide with another molecule which results in transfer energy as a 
non-radiative process, for instance as heat or by a quenching mechanism. Another 
possibility that can be observed is called intersystem crossing3 (IT) to the lowest 
excited triplet (T1), when the electron will change spin orientation. This alternative 
process is quite rare, but it results in release of a photon through phosphorescence or 
conversion to the singlet ground state which is called delayed fluorescence. This is an 
example of a so-called forbidden route.  Such forbidden transitions are slower 
processes, with rate constants for triplet emission many orders of magnitude lower 
than those for fluorescence. The small chance of intersystem crossing is due to the fact 
that it is crucial for molecules to undergo spin conversion to yield unpaired electrons, 
which is not a favourable process. The essential significance of the triplet state is the 
high chemical reactivity characteristics of molecules in this state, which often results in 
photobleaching and the creation of destructive free radicals.1  
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1.3.1. Characterisation of the fluorescence 
A few factors should be taken into consideration in the discussion of fluorescent 
species, for instance absorption (excitation) and emission spectra, quantum yield, 
absorption coefficient, fluorescence lifetime, or fluorescence quenching. All of these 
depend on the configuration of electronic energy states within the molecule. The 
interactions of fluorophores with their surroundings cause perturbations in the 
electronic configuration, and, as a consequence fluorescence can be a very sensitive 
tool to detect these perturbations, and thus the fluorophore’s environment. This is one 
of the reasons why fluorescence is so widely used in analysis. As a consequence, 
fluorescent measurements are not just able to differentiate between individual species 
of fluorophores but can additionally provide the information about their surroundings.  
 
1.3.1.1. Fluorescence absorption and emission spectra (Stokes Shift) 
The most important characteristic properties of a fluorophore are the absorption and 
emission spectra. As a consequence of the Boltzmann statistical distribution,4 which 
indicates that at room temperature in any electronic state, the population distribution 
will be biased towards the lowest vibrational mode of that state and as a result the 
absorption spectrum will be observed which is caused by broadening from transitions 
between the lowest energy level in the ground state and different vibrational levels in 
the excited states. Alternatively, for reflected emission spectra, the probabilities of 
transition between the lowest energy level in the excited state and different 
vibrational levels in the ground states are taken into account. The Stokes Shift5 defines 
the separation between the maxima for the wavelengths of excitation and emission, 
Figure 13.1  
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Figure 13 Representation of the Stokes shift. 
 
1.3.1.2. Fluorescence lifetime 
First of all, a system which contains a single fluorescent type that is excited by light will 
be considered. The fluorescence lifetime describes the average time when a molecule 
can occupy the excited state before returning to the ground state. The number of 
molecules that stay in the higher energy band will drop exponentially with time. The 
measured intensity of the fluorescence emission is described by equation  
I (t) = I0 exp (-t/ τ) 
Where: 
τ = 1/(kR+kNR) 
In the above, t is time1, τ is the fluorescence lifetime, I0 is the initial fluorescence at 
t=0, and k are the rates for each decay pathway (radiative and nonradiative). More 
importantly, the lifetime, τ is independent of the initial intensity of the emitted light. 
This can be utilized for making non-intensity based measurements in chemical 
sensing.1 
 
1.3.1.3. Quantum yield 
By definition, the quantum yield describes the number of emitted photons 
comparative to the number of absorbed photons. It is an indication of how effective 
spontaneous emission is when competing with nonradiative decay paths.1  
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ɳ = kR/ (kR + kNR) 
 
1.3.1.4. Absorption coefficient 
The absorption coefficient is defined by the Beer-Lambert Law, which shows the 
modification in intensity when light goes through an atomiser or solution of the 
absorbing species. It indicates the number of photons absorbed as a fraction of those 
which are encountering the fluorophore.1 
 
I = I0 exp – (ɛbC) 
where: 
ɛ - molar absorption coefficient [mol-1 cm-1] 
b – length of atomiser or solution cell 
C – concentration of the absorbing species  
 
1.3.1.5. Fluorescence quenching 
There are many processes which can cause the reduction in fluorescence intensity, 
some one of them are gathered in a term named quenching, which gathers different 
phenomena. Most of these processes take place during the excited state lifetimes. 
They include: molecular rearrangements, energy transfer, collisional quenching, charge 
transfer, electron transfer reactions or photochemistry, and also the formation of 
complexes in the ground state. Quenching experiments are suitable to define the 
availability of the quencher to a fluorophore and one of the reactants. There are two 
types of quenching: collisional (dynamic) quenching and static (complex formation) 
quenching which will be considered. Both involve an interface between fluorophore 
and quencher.1,6 
Collisional quenching is observed when the excited fluorophore diffuses to an atom or 
molecule which is causing nonradiative returns to the ground state. The best known 
quenchers included O2, I
−, Cs+ and acrylamide. The Stern-Volmer equation describes 
the collisional quenching, and shows that the decrease in intensity is due to ratio of 
the fluorescence in the absence of quenching to that in the presence of quencher.1  
 I0/I = 1 + KSV [Q] 
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I0 and I are the observed fluorescence with and without quencher, [Q] is the quencher 
concentration and KSV is the Stern-Volmer quenching constant. The value of KSV is given 
by kqτ0 where kq is the bimolecular quenching rate constant and τ0 is the excited state 
lifetime in the absence of quencher. The plot of I0/I versus [Q] will show the linear 
dependence of quenching and is known as a Stern-Volmer plot.  
 
Static quenching proceeds by the formation of a stable complex between fluorophore 
and another molecule and when the excited state of the complex is nonradiative then 
the fluorophore has been statically quenched.1 Gregorio Weber7 was the first to 
describe such cases of quenching via complex formation. The dependence of the 
fluorescence as a function of the quencher concentration is represented by the 
equation: 
I0/I = 1 + Ka [Q] 
Where Ka is the association constant of the complex. 
Noteworthly, the lifetime of the sample is not reduced since fluorophores which are 
not forming complexes are able to emit after excitation and will have normal excited 
state properties. 
The intensity of the fluorescence for samples is decreased because the quencher is 
basically reducing the number of fluorophores which can emit.1  
 
1.3.2. Types of fluorophores 
There are numerous useful types of fluorophores which play very important roles in 
chemistry and also in biology. By definition, fluorophores are fluorescent moiety which 
can possess contrasting chemical structures, including small organic, organometallic or 
inorganic molecules, proteins and even semiconductor beads. All the fluorophores 
possess specific spectral properties. These are directly related to the possible excited 
states which are due to energies involved when electrons of fluorophores make 
transitions between states. The fluorophores can be connected via covalent or 
noncovalent linkages with a sample to be analysed, giving the conjugates or complexes 
which can show fluorescence from short to very long wavelengths. The current rising 
interest in the development of new fluorophores is due to the extreme importance 
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their application to biological investigations. Precisely, fluorophores proved to be very 
suitable when applied in the case of organic fluorescent markers for labelling of amino 
acids, peptides, proteins, DNA and other biomolecules.1 The most common organic 
fluorophores will be now discussed. 
 
1.3.3. Organic fluorophores with emission spectra up to 500 nm 
1.3.3.1. Coumarin 
Coumarins are nowadays an important group of organic compounds that are used as 
drugs,8 additives to food and cosmetics,9 optical brightening agents,10 and dispersed 
fluorescent and laser dyes.11 The derivatives of coumarin usually occur as secondary 
metabolites present in seeds, root, and leaves of many plant species. Their function is 
far from clear, although suggestions include waste products, plant growth regulators, 
fungistats and bacteriostats.12 It is therefore of utmost importance that the synthesis 
of coumarin and its derivatives should be achieved by a simple and effective method. 
The structure of coumarin is shown in Figure 14; the positions 3, 4, 5, 6, 7, 8 are 
potentially sites for substitution. Substituents introduced on positions 3 and 7 have a 
relatively stronger electronic effect on the optical properties of the resultant 
molecules than do substituents at other positions. An important point is that when 
substituents are attached at different positions they will cause different fluorescence 
properties of the host fluorophores, but there is still much discussion about exactly 
how this occurs, and it is difficult to predict the outcomes rationally. 
 
 
Figure 14 Structure of coumarin.  
One quite unusual route was published by Pechmann13 and co-workers, where a 
catalytic approach contributes to the development of clean and green chemical 
process. This type of reaction is very useful for synthesis of 4-substitued coumarins. It 
is a simple condensation of resorcinol with ethyl acetoacetate in the presence of BiCl3. 
49 
 
 
Scheme 29 Synthesis of 4-substitued coumarins. 
 The advantage of this reaction is the use of BiCl3 as a catalyst which is inexpensive and 
relatively nontoxic, and almost insensitive to small amounts of water avoiding the 
need for dry conditions. During this kind of reaction, normally acidic catalysts(sulphuric 
acid, aluminium chloride, trifluoroacetic acid, etc.) are used in excess.  
As was mentioned before, coumarins are very useful tools for fluorescent detection. 
Specifically BrMOZPhC 103 (4-bromomethylcoumarin-7-phenyl[6,7-b](6,9)oxazine)14 
and BrMOZC15 104 are valuable probes for this reason, but they also can be used to 
determine carboxylic acids by HPLC (Figure 15).15  
 
 
Figure 15 Examples of coumarins used as fluorescent tools. 
Another advantage of using coumarin derivatives is that they can be used in ion 
detection by incorporation of the coumarin chromophore into a larger indicator 
framework. The first reported ion monitoring coumarin probe is benzothiazolyl-
coumarin BTC 105 (Figure 16). This compound is one of the most widely used and is 
characteristic of a generation of low affinity calcium probes. The APTRA-BTC 106 
analogue of BTC dye is more useful to analyse the mixtures of Zn2+ and Cd2+.16 
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Figure16 Ion monitoring coumarin probes. 
These dyes are long-lasting enough to reduce “background” fluorescence of cellular 
components, tissues and biological fluids. Additionally, a significant fluorescence 
Stokes shift makes it possible to avoid the overlap of excitation and emission peaks, so 
improving sensitivity. Fluorescein and rhodamine present large excitation coefficients 
when compared to coumarin based ion indicators. However, coumarin dyes exhibit a 
large fluorescence quantum yield which is important in biological applications to 
permit ion detection at low indicator concentrations, thus allowing coumarins to be 
introduced to cells either by microinjection or as membrane permeable derivatives 
without causing death cell. 
 
1.3.3.2. Anthracene based fluorophores 
Anthracene based fluorophores possess noteworthy biological activities. They are 
made up of three planar fused aromatic rings, (Figure 17).  
 
 
Figure 17 Examples of anthracene based fluorophores. 
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It is possible to place the anthracene derivatives into the category of fluorescent dye 
photosensitizers. They are capable of light-reliant chemical reactions that result in 
damage to biological systems. Anthracenes are good photosensitizers because of their 
low polarizability, strong fluorescence, good absorption in the near UV region, and a 
long-lived excited triplet state. Certain anthracene derivatives are also known to be 
active against specific types of cancers.17 Specifically, anthracene-based drugs such as 
Pseudourea (bis-(2-thio(2,2′-(9,10-Anthrylenedimethylene) dihydrochloride) 
dihydrate)18 were tested in clinical trials which showed that anthracene itself is 
effective  against specific skin cancer.19 
The planar, linear, three-ring system of the anthracene nucleus has the potential for 
significant overlap with the DNA base pairs. The versatile chemistry of the anthracene 
nucleus provides a convenient route to prepare a number of closely related 
derivatives.20 Additional advantages of the anthracene derivatives are that they have 
moderate absorption cross-sections in the near-UV region, and good fluorescence 
quantum yields, which are beneficial for example to monitor ligand binding to DNA by 
spectroscopic methods.21  
In 2014, José Berná and co-workers22 reported the synthesis of 9-aminoanthracene 
which is a part of a [2]rotaxane.22 This design expected to develop a change in the 
fluorescence of the anthracenyl group of the [2]rotaxane by the competitive binding of 
an analyte by the hydrazodicarboxamide moiety in which initially resides in a 
macrocyclic tetralactam ring functionalized with strong electron-withdrawing groups. 
Another advantage is that the removal of this analyte (by an ion exchange reaction or 
by oxidation of the hydrazo group) will reset the system to its original state.22 
More details of choosing this type of fluorophore will be discussed in Chapters 1.4 and 
2: boronic acid based bioprobes and Results and Discussion for project number 1. 
 
1.3.4. Organic Fluorophores with Emission Beyond 500 nm 
1.3.4.1. Rhodamines  
Rhodamine dyes are probably the oldest synthetic fluorophores used for dyeing of 
fabrics, or as fluorescent markers in structural microscopic studies, and they show 
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good applications in laser dyes. Their derivatives are strongly fluorescent and possess 
high molar absorptivities in the visible region. This class of fluorophore can have 
different photophysical properties, depending on the substituent R1, R2, R3, R4, Y or 
ion X- (Cl-, Br-, ClO4-) which is shown on Figure 18.
23 
 
Figure 18 Rhodamine based fluorophore. 
 
There are many rhodamine derivatives used in bioanalysis (covalent or noncovalent 
labels), but the most modern are Rhodamine 800 and Texas Red, (Figure 19).21  
 
 
Figure 19 Rhodamine derivatives. 
Other xanthene fluorophores such as Rhodamine 110 has been used in studies of 
enzymatic activity. Raines and co-workers24 described the synthesis of latent 
fluorophore 115 which was covalently attached to a cationic protein (an RNase, a 
member of the thiol containing variants of bovine pancreatic ribonuclease). Scheme 30 
shows a synthetic route for the preparation of the fluorogenic label 115. It starts from 
Boc protection of Rhodamine 110 (111), then a coupling reaction using DPPA, DIEA in 
dry THF to yield urea 113. Deprotection via iminium salt 114 by using TFA and then 
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another coupling reaction gives the desired latent fluorophore 115. Compound 115 is 
called a latent fluorophore since its fluorescence is quenched through the formation of 
the cyclic lactone. Yet, when this compound is submitted to esterases enzymes, the 
acetate moiety is cleaved, and an intramolecular cascade reaction restores the initial 
fluorescence by formation of the aniline and the subsequent lactone opening. 
 
 
54 
 
 
Scheme 30 Synthetic route for the preparation of the probe 115. 
To increase water solubility and facilitate conjugation of protein with rhodamine 
derivatives, Burgess et al.25 synthesised compound 116 by introducing several 
carboxylic acid functionalities (Figure 20).  This probe also contains an aryl bromide 
group which can be used for linking other moieties to the fluorescent dye.  
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Figure 20 Water soluble rhodamine probe. 
 
1.3.4.2. Fluorescin 
Another class of fluorophore which is commercially available and used for labelling 
proteins, peptides, amino acids is the fluorescein group. The simplest way to 
synthesise fluorescein involves a Friedel-Crafts type of reaction shown 
in Scheme 31.26,27 
 
 
Scheme 31 Synthesis of fluorescein via Friedel-Crafts type reaction. 
Fluoresceins have high molar absorptivities and quantum yields, and good solubility in 
water. Furthermore, fluorescein has an excitation maximum at 494 nm which lies close 
to the emission line of the argon laser (488 nm); for this reason they are significant 
fluorophores for applications in laser scanning microscopy and flow cytometry. One of 
the most widespread fluorophores used in interactions with proteins is fluorescein 
isothiocyanate (FITC) 120 which is shown on Figure 21.28,29 
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Figure 21 Fluorescein isothiocyanate (FITC). 
This fluorophore was for instance used by Kilar and co-workers30 who used it for 
marking the iron-free human serum transferrin (a glycoprotein binding two ferric ions 
and responsible for delivery to cells through receptor-mediated endocytosis). This 
process was observed by using different dye-protein ratios, followed by capillary 
electrophoresis. This is a very useful technique as the labelled protein can be used as a 
receptor-mediated endocytosis marker and allows the study of the action of 
transferrin with FITC.  
An excellent example reported by Giralt and Fernandez-Carneado31 of solid phase 
fluorescent labelling of proline peptides in the N terminals with 5(6)-
carboxyfluorescein, is shown in Scheme 32. This technique can be applied to solid-
phase combinatorial synthesis of natural products, polyamides and peptide nucleic 
acids, where fluorescent labelling for cell biology is very much needed.  
 
 
 
Scheme 32 Preparation of fluorescent labelling on solid phase. 
A good example of the successful synthesis, photophysical characterization and 
bioanalytical applications of new fluorescent amino acids is shown in Figure 22. The 
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compounds 123a and 123b have a big advantage over their analogues 123c based on 
fluorescein because of significantly better photostability and their pH-independent 
quantum yields.32 
 
 
Figure 22 New fluorescent amino acids.  
However, sometimes these types of fluorophores can also possess some 
disadvantages, such as a quite high percentage of photobleaching,33,34,35 pH-sensitive 
fluorescence,36,37 and an expansive fluorescence emission spectrum.38 The last 
problem causes limitation of their utility in multicolour applications. They also have a 
tendency to self-quench on conjugation to biopolymers, mainly at high levels of 
substitution.39 
 
1.3.4.3. Cyanines 
One of the reasons the cyanine dyes are interesting molecules is their capability to 
impart light sensitivity to silver halide emulsions in an area of the spectrum at which 
the silver halide is not usually sensitive. They have found many technical uses since the 
discovery that they can be used as photographic sensitizers40, nonlinear optical 
materials or more lately as fluorescent probes for bimolecular labelling41,42 where in 
this last field, cyanines have found applications in genetic analysis, DNA sequencing,43 
and in vivo imaging.44  
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Typically these dyes contain two nitrogen centres, where one has a positive charge and 
is conjugated with a chain of an odd number of carbon atoms to the other nitrogen. It 
can be considered as a ‘push-pull’ polyene which can form the skeleton of the 
polymethine dyes, which have the streptopolymethine unit as their chromophore. 
They can be classified as cationic streptopolymethine-cyanine and hemicyanine dyes 
124, anionic streptopolymethine-merooxonol dyes 125, neutral streptopolymethine-
merocyanine dyes 126, and zwitterionic squaraine-based cyanine dyes 127, as shown 
in Figure 23.45  
 
 
Figure 23 Examples of cyanines dyes. 
A common way of preparation of hemicyanines includes the condensation of a 2/4-
methyl quaternary salt of the base with a substituted benzaldehyde in presence of a 
base as shown in Scheme 33. 
 
Scheme 33 Preparation of hemicyanines. 
 
1.3.4.4. BODIPY 
4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene, or boron-dipyrromethene (BODIPY) 131, 
which is presented in Figure 24, belongs to a group of fluorescent dyes which were first 
synthesized by Treibs and Kreuzer in 1968.46 They can be considered as rigidified 
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cyanine dyes. They show interesting properties, such as high stability, sharp 
fluorescence peaks, tunable emission and high quantum yields. The BODIPYs increased 
in prominence after the publication of a patent in 1988 by Molecular Probes®.47 
 
Figure 24 Basic structure of BODIPYs. 
The synthesis of BODIPY can be performed in two ways. To get a symmetrical BODIPY, 
condensation of two identical pyrrolic units and a carbonyl compound (aldehyde or 
acyl chloride) is performed in presence of a strong acid [hydrobromic acid (HBr) or 
trifluoroacetic acid (TFA), see Scheme 34]. Three reaction conditions gave a 
dipyrromethane which is substituted by the structure previously linked to the carbonyl 
reagent at the central position (meso position). The dipyrromethane undergoes 
aromatization with chloranil or DDQ to form a dipyrromethene (or dipyrrin), which is 
followed by complexation with a difluoroboryl derivative in a base-catalyzed reaction 
with trifluoroboryl etherate (BF3.OEt2) and triethylamine (TEA) resulting in the 
expected BODIPY.  
Analogously, to obtain non-meso-substituted BODIPYs, it is essential to use two 
different pyrrolic units but one of them needs to have a carboxyaldehyde group at C2 
position of the pyrrolic ring. The reaction is performed in the presence of phosphoryl 
chloride to achieve the dipyrrin, which is subsequently converted into BODIPY as was 
described for previous example. 
This class of fluorophores has been found to be useful in applications in biochemistry, 
biophysics and biotechnology for protein labelling. There are many examples in the 
literature, but only a few will be discussed. 
BOBIPY derivatives with a succinimidyl ester group were first described in 1988 by 
Molecular Probes®.47 The reaction involved the coupling of an ester-substituted 
pyrrole with pyrrole carboxyaldehyde dyes to achieve a dipyrromethene, then 
complexation produces the BODIPY connected to the ethyl ester. The reaction of this 
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product with an aqueous solution of potassium carbonate released the carboxyl group 
that was then coupled with N-hydroxysuccinimide (Scheme 34). Currently, many 
succinimidyl ester BODIPY derivatives with different spectral characteristics are 
commercially available. 
 
 
Scheme 34 Synthetic route towards the preparation of BODIPYs. 
These succinimidyl ester BODIPY dyes are used, for example, in the labelling of casein 
(a simple protein which serves as a substrate to several endoproteases) or the 
surfactant protein B (which prevents the alveoli from collapsing). 
The synthesis of a BODIPY with an aminooxy reactive group was reported in 2011.48 
This fluorophore, shown in Figure 25, was synthesised for making quorum sensing 
chemicals (i.e., 3-oxododecanoyl homoserine lactone) attached to a proteic 
transcriptional modulator which is present in some bacteria. This can allow 
bioorthogonal labelling of this protein to be performed.  
 
 
Figure 25 BODIPY with aminooxy reactive group. 
Not all synthesised BODIPYs are successful in conjugation. Scheme 35 shows the 
preparation of a BODIPY dye with a free MTS group. The synthesis includes the 
reaction of the commercial BODIPY with 3-aminopropyl methanethiosulfonate 
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hydrobromide, in the presence of diisopropylethylamine (DIPEA) to get the desired 
BODIPY derivative. The conjugation of this BODIPY with the muscle nicotinic 
acetylcholine receptor, however, was not successful, despite the fact that this had 
been achieved with other MTS fluorophores.49 
 
 
Scheme 35 Unsuccessful route for preparation of BODIPY dye. 
 
1.3.5. Fluorescent bioprobes 
Fluorescent bioprobes are broadly used in many fields as they possess a unique 
capability to improve the analytical sensitivity. Additionally, they make possible 
temporal and spatial sampling with a greater proficiency. The main attention in this 
section will be a focus on fluorescent bioprobes which are designed with cleavable 
active bond as a linker. In the past few years, the design and development of such 
probes has received immense attention particularly in the context of the specific 
determination of analytes with high hydrolytic reactivity (from metal ions to enzyme 
activity).50 Moreover, they allow the monitoring of many biological processes in situ 
and in real time. Many spectroscopic techniques can be used to allow the accurate 
observation of fluorescent bioprobes with the cleavable active bond providing 
selectivity for the precise detection of specific analytes. The most famous technique is 
to use photoinduced electron transfer, photoinduced proton transfer, or fluorescence 
resonance energy transfer.51 All these probes can be summarized as “turn on”, latent 
fluorescent or pro-fluorescent probes, as introduced by R. T. Raines in 2005.52 
In project number 2, the target is to synthesise a bioprobe with a peptide cleavage 
bond as the linker. As an introduction to this topic, the main classes of cleavable types 
of bond will now be described. 
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1.3.5.1. Fluorescent bioprobes with a cleavable phosphoester bond 
The phosphate and polyphosphate esters have significant roles in cells as enzyme 
substrates or secondary messengers. Specifically, the metabolism of polyphosphate 
esters has a big input in the activities of cells. Bioprobes with a cleavable phosphoester 
bond have been developed to detect the activity of phosphatases and other enzymes 
(ATPases and DNA/RNA polymerases).53 The main factor which needs to be taken into 
account is the choice of a fluorophore which is suitable for the design of bioprobes 
with this type of cleavable bond. The most commonly used fluorophores possess 
hydroxyl groups (fluorescein, 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one 
DDAO, 7-hydroxy-4-methyl-coumarin) which are derivatised as phosphate esters. 
 An interesting example of a sensitive fluorogenic phosphatase substrate 142 
(derivative of fluorescein) is shown in Scheme 36. Before the reaction with alkaline 
phosphatase, dye 142 is colourless and non-fluorescent. Afterwards, this compound is 
hydrolysed in two steps to fluorescein 144, with a strong fluorescence, the cleavage of 
the two phosphate bonds being accompanied with the intramolecular lactone ring 
opening, restoring the conjugation between the two parts of the fluorescein moiety. 
The turn on probe displays significant fluorescence enhancement.54 
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Scheme 36 Example of fluorescent bioprobe with cleavable phosphoester bond. 
Another phosphatase substrate (145, Scheme 37) has been applied to localise the 
endogenous alkaline phosphatase in tissues and cultured cells with high-resolution.55 
 
Scheme 37 Phosphatase substrate probe used for detection of alkaline phosphatase. 
The substrate 145 has weakly blue-fluorescent properties but after the enzymatic 
cleavage provides an intensely photostable yellow-green fluorescent product 146 
which is a consequence of the recovered hydroxyl which takes part in intramolecular 
hydrogen bonding and enhances fluorescence through the ESIPT56 phenomenon 
(intramolecular proton transfer in the excited state).57 
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1.3.5.2. Fluorescent bioprobes with amide cleavable bonds 
In the development of monitoring enzyme activity, peptide substrates containing a pair 
of fluorescent donor and acceptor groups are important because of the ability of a 
peptidase to cleave selectively peptide bond.58 
Bioprobes with amide cleavable bonds are important because of their interaction with 
enzymes, specifically the peptidases and proteases, which play significant roles in 
protein activation, cell regulation and signalling, as well as in the generation of amino 
acids for protein synthesis. These bioprobes most commonly are based on 7-amino-4-
methylcoumarin (AMC) to detect enzymatic activity in cells, homogenates and 
solutions.59 Additionally, rhodamine, which is a visible light-excitable dye, is widely 
used in designs that usually comprise two identical amino acids or peptides attached 
to single fluorophore, as is shown in Scheme 38. The hydrolysis of bisamide derivatives 
147 of Rho 110 by a peptidase occurs in two stages. 
 
 
Scheme 38 Representation of hydrolysis of bisamide to afford Rho110. 
 
The enzymatic activity starts with non-fluorescent bisamide 147 which is converted 
into the monoamide 148 which is fluorescent. Additionally, the hydrolysis of its second 
amide 148 by the peptidase releases even more fluorescent Rho 110. The fluorophore 
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149 can be retained within the cell and this fluorescence can be excited by visible light 
at 495 nm.60 Further important designs and coumarin-based probes with a cleavable 
amide bond, will be discussed in the results and discussion section for project 2.  
 
1.3.5.3. Fluorescent probes with lactamase-cleavable active bonds 
The clinical importance of the precise detection of β-lactamases activity in biological 
samples has led to the development of bioprobes that respond to the presence of 
antibiotics resistant bacteria strains through development of beta-lactamase activity. 
These types of bacteria belong to the families which cleave penicillins and 
cephalosporin with high catalytic efficiency and so are resistant to β-lactam antibiotics. 
Dyes 150, 151, 152 presented in Scheme 39 have been established to detect β-
lactamase activity with high sensitivity.61 
 
 
 
Scheme 39 The detection mechanism for β-lactamases activity employs as a first step the hydrolysis of 
150 which gives rise to the release of the fluorophore 152 with enhanced fluorescent signals through a 
domino 1-6 elimination process.
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The mechanism of β-lactamase activity is presented in Scheme 39. The hydrolysis of 
152 will promote the release of fluorophore 154 with fluorescent signals through a 1-6 
elimination process, which is only possible once the beta-lactam ring has been cleaved.  
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1.3.5.4. Fluorescent bioprobe with cleavable bond by metal ions 
The challenge to design and synthesise bioprobes for detection of metal ions required 
a wide investigation as they resemble and have similar reaction properties to common 
spectroscopic probes. The answers to the problem rely on novel probes based on 
fluorophores with selectively hydrolysable groups. A bioprobe for the detection of Cu2+ 
was reported by Czarnik et al.62 and is shown in Scheme 40. The probe 155 is non-
fluorescent, since the gamma lactam ring breaks the conjugation on the rhodamine 
scaffold, and was based on the hydrolysis mechanism in which the addition of Cu2+ 
results in N,O chelation by hydrazide species followed by redox hydrolysis with release 
of fluorophore 158.  
 
 
Scheme 40 Example of fluorescent bioprobe with cleavable bond by Cu
2+
. 
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1.3.5.5. Fluorescent bioprobes with bonds which are cleavable by reactive 
oxygen species 
The bioprobes based on the detection of reactive oxygen species are important 
mediators for the pathological conditions of many diseases. The most common 
reactive oxygen species are hydrogen peroxide, superoxide, hydroxyl radical or singlet 
oxygen.63 
The molecule 159, designed for singlet oxygen (1O2) detection, is shown in Scheme 41. 
This probe has highly selective and sensitive chemiluminescence. The precise 
methodology for operation of the probe is through the incorporation of an electron-
rich tetrathiafulvalene dye into the luminophore of anthracene which is sensitive to 
1O2. During reaction with hydrogen peroxide or hypochlorite, superoxide, hydroxyl 
radical, or 1O2, the probe displays chemiluminescence (CL) outputs.
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Scheme 41 Example of chemiluminescent bioprobe for singlet oxygen detection. 
Importantly, it is a highly sensitive process for reaction with 1O2 in comparison with 
other reactive oxygen dyes. As a consequence of this effect, the probe is widely used 
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for 1O2 detection in many chemical and biological systems as 
1O2 can be easily 
differentiated from other reactive oxygen species mentioned above.64 
Another good example of a novel fluorescent probe 162 for detecting, in this case, the 
superoxide ion, was reported by Maeda’s group.65 Scheme 42 shows the mechanism 
by which this works, which involves the reaction of the non-fluorescent substrate 162 
with O2
–• (nucleophile) followed by cleavage of the sulfonic ester bonds to release the 
product 163. Two equivalents of O2
–• are needed to liberate the desired compound 
163. 
 
 
 
Scheme 42 Example of fluorescent probe for detecting of the superoxide ion. 
 
Representative examples of variety fluorescent probes with cleavable bonds for the 
detection of analytes have been discussed to outline a field which is under 
investigation in organic and bioanalytical chemistry. The future research in the design 
of fluorescence bioprobes will seek to establish more precise analytical properties in 
the sense of the selectivity and sensitivity, which can improve the understanding of 
mechanism of biomolecular interactions or in vivo processes. 
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1.4. Bioprobes based on boron-diol interactions 
Boron-diol interactions are most significant when considering human health,1 plant 
growth2 and additionally quorum-sensing among certain bacteria.3 Boron is one of the 
ten most common elements in sea water and saccharides are one of the most 
significant classes of biomass on the planet.4 
Currently; under investigation is the development of synthetic saccharide receptors 
which are based on the covalent interactions between boron and sugars. These 
interactions are reversible in aqueous solution.5 In this chapter, the current 
understanding of these processes will be reviewed, to provide a historical perspective 
on their discovery, and to classify these interactions by carbohydrate types. This 
information is crucial to the design and synthesis of the bioprobe for project number 1, 
containing boronic acid as a molecular recognition tool. The nature of the mechanism 
for the reversible binding between boron acids and diols has been widely exploited in 
sensor design. Furthermore, the use of boronic acid derivatives with carbohydrate 
recognition properties could provide procedures for the selective detection of specific 
sugars in future applications in early-stage diagnostics. The aim of this project is to 
design a boron-based bioprobe targeting the cell-surface sugars that will be able to 
recognize particular characteristic antigenic determinants for the identification of 
diseases, thus enabling earlier diagnosis and treatment. In this chapter, the 
fundamental research of boron-carbohydrate interactions will be described. However, 
discussion of how this translates into the design of synthetic carbohydrate receptors 
will also be included. 
 
1.4.1. Boron-saccharide interactions 
Due to the unique strong interaction between boronic acids and diols through 
reversible ester formation, there has been a great deal of interest in using boronic 
acids as the recognition moiety for the development of sensors for sugars. Their well- 
documented ability to form complexes with diols rapidly and reversibly in basic 
aqueous media gives them a very significant role in this field. Sugars which have 
prearranged cis-diols can form stronger complexes with boronic acids and are 
convenient as an interface for artificial sugar receptors. The interactions between 
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sugars and boronic acids can be combined with the use of hydrogen bonding 
interactions for sugar sensing in aqueous systems. This can be explained as more the 
strongly associated covalent structures that arise when boronic acids are connected 
with polyhydroxylic saccharides, allowing them to be selectively recognised by 
reactions at diols unit. It has been known for over forty years that the boron atom in a 
boronic acid becomes more acidic when bound to a saccharide. The 1,2- and 1,3-cis 
diols interact with saccharides to form five or six membered rings, respectively.6 In 
1913, Böeseken7 reported the increase in acidity of boronic acids in the presence of 
glucose, but  almost half a century passed before the group of Lorand and Edwards 
quantified the affinity of boric and phenylboronic acids with diols (for example 
catechol), and sugars (e.g. fructose, glucose).8 
Boronic acids can be considered as electron deficient Lewis acids, and thus electron-
pair acceptors (Lewis bases are electron pair-donors). A good example of interactions 
between the Lewis acid boron trifluoride 165 and the Lewis base triethylamine 166 is 
shown in Scheme 43. The covalent bond between them is formed by the electrons 
from the Lewis base. These types of bonds are called coordination or dative bonds.9 
 
 
Scheme 43 Interaction between Lewis acid and base. 
The geometry of boronic acids is planar trigonal as they have an sp2 hybridized boron 
atom and an empty p orbital to receive electrons, explaining how they can easily react 
in a Lewis acid manner with anions. Another example of this interaction, shown in 
Scheme 44, is with hydroxide anion.8,9  
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Scheme 44 Equilibrium between Lewis base and acid. 
The equilibrium between diols and boronic acid is shown in Scheme 45. This process 
illustrates the unique Lewis acid feature of boronic acids and esters. The binding 
interaction by the esterification of 170 to form 172, causes a decrease in the Lewis 
acidity which involves a reduction of the pKa. The formation of the anionic form of the 
boronic species 173 is made by complexation of boronic acids. The derivative 173 is in 
equilibrium with dye 170 boronate ester 172 has a trigonal structure. This ester 172, 
with pKa ~ 6.2, is able to convert into structure 173 as shownin Scheme 35, and the 
pKa of the conversion from acid 170 to dye 171 is different from ester 172 to dye 173 
(pKa ~ 8.5) due to the increase in acidity when diols bind to the boronic acids. The 
geometry of the anionic adducts is tetrahedral with a sp3-hybridized boron atom which 
is electron rich. These changes produce a significant effect on the properties of these 
compounds, so the pKa of 8.8 is reserved mostly for a phenylboronic acid itself, but in 
the case of the adduct (boronic group + sugar), the pKa typically will reach about 6.8 
for its glucose ester and 4.5 for fructose esters. The boronate esters with low pKa are 
explained by the higher affinity for specific diols to bind to phenylboronic acid (PBA), 
thus D-fructose binds to PBA much better than D-glucose.9,10,11 
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Scheme 45 The binding interaction between boronic acids and diols. 
 
1.4.2. Bioprobes based on the complexes of boronic acids with diols 
In the 1950’s, the high affinity of boronic acids for sugars was first described. Structural 
studies of saccharide-boronic acid complexes could not be presented until much later 
when NMR techniques became available. From the point of view of carbohydrate 
bioprobes development, it is important to know the structural features in aqueous 
conditions. The most common models for sugars are glucose and fructose, and mono 
or diboronic acids. Additionally, some researchers have reported much work on 
conformational and structural investigations which were established by the 
determination of C-H and H-H coupling constants. These allowed to differentiate 
different adducts depending on the size of the ring and conformation of the sugar in 
the cyclic ester.12,13,14,15 The question then arose: in which form does the complex exist 
between glucose and phenylboronic acid? The first answer for that question was 
reported by Eggert and Norrid in 1995.16 They studied ester formation between the 
boronic acid and D-glucose using 13C and 1H NMR spectroscopy in neutral non-aqueous 
and basic conditions. The results showed that the first binding site was position (1,2) of 
the furanose form of the D-glucose in both neutral non-aqueous and alkaline 
conditions. The boronic acid dye 174 was then formed by binding to the (3,5) positions 
of the furanose form of D-glucose under neutral non-aqueous conditions, (Scheme 46). 
Binding to positions (5,6) was observed for the diboronic acid probe 175. However, the 
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boronic acid 176 was bound to positions (3,5,6) in a tris coordinated manner under 
basic conditions, as shown in Figure 26.16 
 
 
Scheme 46 Examples of sugar-boronic acid interactions. 
Another answer about the form of these complexes was obtained by Norrid in 1996. 
His group reported structural studies of the fructose complex with phenylboronic acid. 
The boronic acid and fructose (ratio 1:1) under alkaline conditions was shown to form 
a 2,3,6 tridentate complex as the major product (Figure 26). Furthermore the fructose 
was in furanose form in all cases and observed only traces of 2,3 exo and endo isomers 
were observed.15 
 
Figure 26 Example of fructose forms. 
At the ratios 2:1 and 4:1 boronic acid/fructose, they observed four new complexes 
which are a consequence of binding to positions (2,3) and (4,5) in the fructopyranose 
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form with two boronic acids. These four compounds, which are diastereomers (endo 
and exo) are shown in Figure 27. 
 
 
Figure 27 The structures of diastereomers. 
The observations that the first boronic acid is bound to 2,3 position of D-fructose and 
the second boronic acid is bound to 4,5-position of the D-fructose was confirmed by 
Draffin et al.17 who reported the crystal structure of the fructopyranose complex with 
the phenylboronic acid.17  
Another important sugar discussed in the literature is sorbitol. This sugar forms a 
trivalent complex with a boronic acid, confirmed by the studies of the reaction 
between D-sorbitol 185 and (S,S)-2-(N,N-dimethyl-1-aminoethyl)ferrocene boronic acid 
184 by Norrid’s group (Scheme 47).18 Sorbitol, as well as fructose, has the ability to 
bind to boronic acid in a tridentate manner a factor in the higher affinity of these 
mentioned sugars for boronic acids, compared to glucose or mannose. 
 
 
Scheme 47 Formation of trivalent complex between sorbitol and a boronic acid derivative. 
Some of the furanose and pyranose forms of sugars typically exploited in the biosensor 
methodology are presented in Table 1. 
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Table 1 Furanose and pyranose forms of sugar exploited in the biosensor methodology 
 
 
1.4.2.1. The events which can influence the binding event 
Several factors which can affect the binding effect need to be considered when 
designing boronic acid-based bioprobes. The most noteworthy factors are pH, pKa of 
the boronic acid, the nature and concentration of the buffer, the dihedral angle of the 
diol, and temperature.9  
 
1.4.2.1.1. The pH and pKa of boronic acids 
The pH is influenced by the affinities of boronic acids towards diols. The higher the pH, 
the higher the binding constants between boronic acid and diol. Hence, for example, 
boronic acids with lower pKas have higher affinities at neutral pH.19,20,21  Studies of 
relationship between pKa, pH and binding constant were pioneered by Wang et al.11 
This group used a three component competitive method to show the importance of 
pKa and pH on the binding event. In their study, they compared the binding affinities 
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between a series of 25 arylboronic acids derivatives with varying diols at different pH. 
The outcome showed that the pKa of monosubstituted boronic acids can be predicted 
based on the substituent effect (σ values) using a Hammet plot. Interestingly, this 
suggests that the previous view that boronic acids with lower pKas have greater 
binding affinities at neutral pH is not necessarily correct. In fact, the optimal pH for 
binding is related to both the pKas of the boronic acid and the diol and it is not 
necessarily higher than the pKa of the boronic acid. Typically, before this publication, it 
was believed that higher pH favours the binding between boronic acid and a diol. The 
pH would need to be above the pKa of the boronic acid to see meaningful binding. On 
this basis, the more acidic boronic acids binding more tightly with diols will be 
observed. When Wang’s group described the binding constants at varying pH values of 
various substituted phenylboronic acids with glucose, fructose and catechol It was 
shown that the trend of the boronic acid pKa is not essentially correct in the ranking of 
binding constants among different boronic acids with a diol at physiological pH. 
Although 2,5-difluorophenylboronic acid has a higher apparent pKa (7.6) than 3,4,6-
trifluorophenylboronic acid (6.8) it can bind more effectively with glucose at pH 7.5, 
contrary to prediction.11 
The pH of the solution plays an important role as well. The binding constant between 
2,5-difluorophenylboronic acid and fructose is larger than that of 3-chloro-4-
fluorophenylboronic acid at pH 7.5, but lower at pH 8.5. So it was needed to consider 
the pH of the solution in which the binding constants were measured to understand 
the relative binding constants of various boronic acids with a particular diol. 
Interestingly, the predicted optimal pH is 9.8 for the binding between 2,5-
difluorophenylboronic acid and glucose but the highest binding constant was detected 
at pH 7.5. As this outcome shows, the pKas of boronic acids and diols were not the 
only the major factor to influence the binding constants and optimal pH, and the 
nature of the buffer and steric factors, need to be taken into account, as they affect 
the binding constants.11,22 
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1.4.2.1.2. The pKa of the boronic esters and the stability of the boronic-
acid-diol complex 
The pKa values of boronic esters are lower than those of the corresponding boronic 
acids, and different diols have various affinities for a given boronic acid. The binding 
constant is generally associated with the apparent pKa value of the boronic ester, 
except for sugars engaged strongly in trivalent binding such as sorbitol.11 The higher 
binding constant should be observed for lower pKa of the boronic ester and any 
influence on the increase of the boron Lewis acidity would be expected to improve the 
binding constant. Theoretically, there are two features (steric and electronic effects) 
which can cause the change in pKa values from boronic acid to boronic esters, and the 
electronic factors are probably not the dominant factor. The steric (geometric) factor 
can help to understand the relative affinities among different diols. Specifically, their 
capability to force the boron to go from trigonal to the tetrahedral form is due to the 
boronic ester pKa and the diol-boronic acid binding constants. 
During the consideration of the issue of the conversion from trigonal to tetrahedral 
form, it should be noted that there is only a small distance between the two diol 
oxygens. The consequence of this is to have a smaller O-B-O bond angle in the ester 
which is similar to the sp3 form 109° and moves away from the 120° needed for the 
boron to stay in the triganol form. This is why diols with small and constrained binding 
angles are able to bind to boronic acids with higher affinities.9 
 
1.4.2.1.3. Buffer effects 
Another significant factor in establishing boronic acid based receptors is the buffer. 
One of the common buffers in psychological conditions at pH 7.4 is phosphate. As the 
boronic acid is a Lewis acid and the phosphate a Lewis base, it can be expected that it 
will affect the complexation state of the boron atom, and potentially it is possible to 
interact with other Lewis bases such as water and sugars.9 
 
1.4.3. The bioprobes based on fluorescent boronic acid reporter 
The significant part of fluorescent bioprobes is the fluorescent reporter 
 which can cause changes in fluorescence upon binding. In the literature  
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there are many examples of work towards the development of these types of 
reporters based on boronic acids.6,14,23,24 The binding between a boronic acid and diols 
works an on-off or off-on system to produce visible fluorescence changes. This will 
now be discussed with selected examples from the literature on fluorescent reporter 
compounds and their valuable properties. 
 
1.4.3.1. Photoinduced Electron Transfer (PET) types of bioprobes 
A significant tool to distinguish fluorescence intensity is the photoinduced electron 
transfer (PET) mechanism. The PET sensors possess three major parts; a fluorophore, a 
linker, and an acceptor. The fluorescent probes based on boronic acids for saccharide 
detection have to provide a strong fluorescence intensity to aid accurate detection. 
Additionally, the pH in the presence of sugar must be shifted to a lower pH range as 
the sensor can then detect sugars more sensitively at specific pH. This interaction is 
due to the increase in the Lewis acidity of the boronate adducts.9 
Yoon and Czarnik, reported the first fluorescence PET bioprobe for sugars which are 
established on fluorophore-containing boronic acids. Their results showed that 2-
anthracenylboronic acid 187 (Figure 28) could be used to detect saccharides but 
unfortunately the changes in fluorescence were minor.25  
 
 
Figure 28 Structure of PET bioprobe. 
Afterwards, Suenega et al. studied eight aromatic boronic acids, among which, 
acids188 and 189 (Figure 29) are the most appropriate for sugar detection.26 
 
 
Figure 29 Example of boronic acids dyes used for sugar detection. 
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These first reported systems suffer from the disadvantage that they can only perform 
precise binding with saccharides at high pH, which is required to make a boronate 
anion, and this is problematic to attempts to address applications in biological systems. 
The solution to the problem was found by Wulff who incorporated an amine adjacent 
to the boronic acids. This forced the creation of tetrahedral sp3 boron at or near 
neutral pH and it is illustrated by the equilibrium between 190 and 191 (Scheme 48). 
This equilibrium involves the deprotonation of an ammonium ion, after which the lone 
pair on the nitrogen associates itself with the empty p orbital on the boron.27 The 
results of these investigations showed that complex 191 reacts with saccharides at 
neutral pH and additionally that this process is analogous to the interconversion of 171 
and 173 as shown in Scheme 45. The pKa is raised from 9 to 12 by the boron-nitrogen 
interaction, as the Lewis acidity of the boronic acid is decreased. This interaction also 
lowers the pKa of the ammonium ion, which changes from 9 to 5. All these changes 
can be observed by 11B NMR. The peak for boron in compound 190 (trigonal) appears 
around 28-30 ppm and in the case of compound 191, the peak lies around 9-10 ppm. It 
is the tetrahedral form of the boron atom that causes the chemical shift downfield 
from the trigonal planar geometry.28 
 
Scheme 48 The equilibrium of 190 and 191. 
Another advantage of incorporation of an amine core is that the fluorescence intensity 
is controlled by its properties. Consequently, these types of system are working as 
off/on receptors. The ‘off’ state occurs when sugar is not bound to the compound and 
the ‘free’ amine can decrease of the fluorescence by PET quenching. In the case of the 
‘on’ system, the sugar is added and the boron becomes more Lewis acidic and makes a 
strong bond to the amine. In this way, the cyclic esters conveniently adopt the 
tetrahedral form and possess a higher affinity. The lone pair on the nitrogen is no 
longer available as the nitrogen is bound to boron, and the fluorescence cannot now 
be quenched, which causes the strong fluorescence emission. Scheme 49 presents the 
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equilibrium between these two “off-on” systems; in the “off” state, the equilibrium is 
moved to the left hand side however in the “on” state the equilibrium is more in 
favour of the right hand side.27 
 
 
Scheme 49 The equilibrium between two “off-on” systems. 
 
The first PET system for sugars was reported by James and Shinkai et al.,14 and such a 
dye 194 displays a selectivity for D-fructose as shown in Figure 30. 
 
 
 
Figure 30 Structure of the first PET system for sugars. 
An interesting and noteworthy development and reinvestigation of the mechanism of 
the changing fluorescence intensity of the Shinkai system 194 has been reported by 
Springsteen’s group. The initially-proposed mechanism described that the changes in 
the intensity of the fluorescence are due to B-N bond formation (lone pair on nitrogen 
is masked). W. Ni et al.28 performed studies that suggest a more sophisticated 
mechanism for the complexation of boronic acid 194 with diols. The new proposal 
includes solvolysis which leads to protonation of the amine nitrogen, but for this to 
occur, the reactions need to be performed in a protic solvent such as water. The 
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protonation of the nitrogen atom stops the photoinduced electron transfer, resulting 
in reduced quenching of the anthracene fluorescence. The suggested mechanism 
describes the various forms of boronic-acid and boronic acid-diol structures, which are 
shown in Scheme 50.28 
  
 
Scheme 50 The new proposal of equilibrium which includes solvolysis. 
 
To determine precisely the proposed mechanism, they examined the effect of changes 
in the pH profile of the reporter system in the presence and absence of a sugar, and 
also studied the maximal fluorescence intensity for changes caused by different sugars. 
The effect of sugars capable of trivalent binding to boronic acid was tested and then 
the B-N bond strength was taken into account. In detail, when the pH is below the first 
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pKa of boronic acid, the amino group can exist in the protonated form 194a. The 
research shows that the first pKa is the deprotonation of amine which is due the B-N 
bond formation. A significant decrease of fluorescence is observed when compound 
194b is formed, in spite of formation of the B-N bond. These results suggest that the 
creation of B-N bond itself is not enough to completely “tie up” the lone pair electrons 
to stop the PET process. Increasing pH will give 194c which no longer has a B-N bond 
(the hydroxide displaces the amino group).  
During the addition of the diol, there are two possibilities, neither of which has been 
experimentally confirmed or disqualified. In the first case (the “B-N bond mechanism”)  
which was proposed by Shinkai and co-workers14, the pKa1 of the ester 195a 
corresponds to the deprotonation of the amino group and the formation of the B-N 
bond in 195b. The pKa2 leads to 195c due to the replacement of the B-N bond by B-O 
bond. In the second case (referred to as a “hydrolysis mechanism”), which is shown in 
the bottom of Scheme 50, the pKa1 corresponds to the formation of 195d due to 
addition of the hydroxide to the boron and pKa2 now corresponds to the loss of the 
proton from the ammonium ion to form 195c. The main difference between these two 
cases is that under neutral conditions, addition of diol will give 195b in B-N bond 
mechanism or 195d in the hydrolysis mechanism.  
The pH profile of the free boronic acid 195a shows a significant fluorescence intensity 
decrease. These reductions are not influenced by hydroxide ion association with / 
dissociation from boron, but instead by deprotonation/protonation at the nitrogen. 
The reason that this is consistent with the hydrolysis mechanism is that the B-N bond 
formation can give the ester at the same pH profile as the free acid itself and if the 
boronate ester 195b adopts a tetrahedral structure this will support small binding 
angles (the investigations by using different sugars also give to those results). The pKa 
values of the boronic esters of different sugars have different values which could lead 
to the conclusion that the B-N bond strength would also be different for 195b. 
Additionally, this is supposed to sequentially influence the quenching efficiency by the 
lone pair electrons and consequently the maximal fluorescent intensity for a particular 
ester.28 
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In reality, all saccharides offer the same maximal fluorescence intensity, which is not 
correct for the B-N bond mechanism. However, it fits with the hydrolysis mechanism 
because the fluorescent species 195d has the same structural properties independent 
of the choice of the sugar. However, if hydrolysis mechanism is correct it will not be 
expected to observe a difference in the magnitude of the maximal fluorescence 
recovery. Furthermore, considering that the B-N bond formation is responsible for the 
loss of fluorescence intensity for sugars which are bonded in the trivalent way to a 
boronic acid, this should not be able to prompt the changes in the fluorescence 
intensity. In the cases of sorbitol and fructose (binding in a trivalent fashion), the same 
changes in the intensity of fluorescence were observed. This example is now correct 
for the B-N bond mechanism, and not consistent with the hydrolysis mechanism. 
Finally, the strength of B-N bond was calculated (3 kcal mol−1) which is too small to “tie 
up” the lone pair of electrons to avoid the PET effect.28  
The outcome of the investigations shows that the changes in the fluorescent intensity 
which are occurring when a sugar binds to the boronic acid derivatives are due to a 
hydrolysis mechanism which gives derivative 195d. However, the form of the sensor 
without sugar can be present as 194b but after addition of sugar (because of the 
lowered value of pKa of the boron), the first equilibrium is described by the reaction of 
the boron with a water molecule to give 195d. The protonated form is also stabilised 
by the presence of the anionic form of boron which is next to the amine. The effect of 
masking of the lone pair electrons, which eliminates the PET quenching of the 
anthracene fluorescence and results in a rise of the fluorescence intensity, is due to 
tranformation of the weak B-N bond form in 194b into the amine-protonated form 
195d. The compound 195d represents the on-state of the system and 194b 
corresponds to the off-state.28 In conclusion, the hydrolysis mechanism is right for the 
pH profile studies of the boronic acid and its sugar and, as well, the estimation of B-N 
bond strength confirms this. 
An interesting example of a design of a fluorescent bioprobe has been reported by 
Wang et al.29 This group have developed biosensor 196, suitable for binding D-
glucarate based on the cooperative action of boronic acid and guanidium groups. D-
glucarate 197 is an important biologically active carbohydrate, and is present in human 
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serum, vegetables and fruits, and additionally it can act as a chemopreventive agent in 
certain cancers. The bioprobe’s use of the guanidium ion allowed the recognition of 
the carboxylate groups of glucarate. The outcome shows that glucarate can bind more 
strongly than glucuronic acid 198. This process demonstrates that both carboxylates of 
glucarate are involved in the binding, through an anionic interaction with the 
guanidium group. The intensity of the fluorescence for the bioprobe solution is raised 
by 4-5 fold following the addition of glucarate (Figure 31).29 
 
 
Figure 31 Biosensor suitable for binding with D-glucarate and D-glucuronic acid. 
Another noteworthy example of an anthracene-based PET bioprobe 200 (Scheme 51) 
was developed by Spingsteen et al.30 Their sensor for boronates used the 
diethanolamine recognition site 199 which acts on the same basis but the opposite 
way round to sugar sensors. It was proved that the high binding affinity of boronic and 
boric acids dyes with diethanolamine in the boronate formation process is due the 
manner of incorporation of diethanolamine. The lone pair on nitrogen is donated to 
the boron atom to form the five membered rings (boronate is stabilized). In the 
absence of boronic acid and boric acid, weak fluorescence was detected, but in its 
presence, the fluorescence intensity was increased by 16 fold at saturated 
concentrations.30 
 
Scheme 51 An example of an anthracene-based PET bioprobe 200. 
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Another example worth notice is research on the same system by James et al.31 This 
group have found that the sensor 199 does not bind with phenylboronic acid 201 in 
methanol but instead chloroform was used to form a stable complex between 199 and 
phenylboronic acid 201. The increase in fluorescence intensity was observed in 
fluorescence titrations of 199 (Scheme 52) employing rising concentrations of 
phenylboronic acid. The resulting cyclic boronate ester (complex 202) has a strong B-N 
bond and this causes the changes in the fluorescence intensity.  
The fluorescence titration of complex 202 with various diols resulted in the 
 reduction of the fluorescence intensity. The selectivity order  
is: 204 > 208 > 207 > 206 > 205. Scheme 42 presents the changes in intensity which are 
due to reaction of 199 and phenylboronic acid 201 in chloroform to form a fluorescent 
complex 202. This complex is unstable upon the addition of diols to produce complex 
203 and reform 199 (which has low fluorescence because of PET). This type of 
methodology helps to evaluate the relative stability of adducts of general form 203.31 
 
Scheme 52 Reaction of 199 and phenylboronic acid affording fluorescent complex 203. 
A good example of a ratiometric sensor (where fluorescence changes are observed in 
two different wavelengths) was published in 2001 by James and co-workers. His group 
synthesised the monoboronic acid 209a as a fluorescent reporter.32 They confirmed 
the expectations based on the fundamental binding affinity of monoboronic acids; D-
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fructose showed the expected higher binding affinities with 209a than did D-galactose 
and D-glucose (Scheme 53).  
 
 
Scheme 53 Structures of boronic acid based dyes 209a-c. 
The same group subsequently discussed new outcomes for 209a when compared to 
compounds 209b and 209c, which were used as controls.33 
 
1.4.4. Internal Charge Transfer (ICT) in bioprobes 
Another process which can cause changes in spectral properties during the interaction 
between boronic acid and saccharides is called Internal Charge Transfer (ICT). This 
process is very sensitive to small changes which can affect the spectral shifts and 
changes in the intensity. The ICT structure has two parts in the same chromophore, an 
electron donor group and an electron acceptor group. These types of bioprobes have 
the sp2-hybridized boron atom of the boronic acid which acts as an electron acceptor 
because of the empty p-orbital on boron. This can be connected directly to the 
chromophore to form a conjugated system with the aromatic moiety, and the inclusion 
in the same molecule of a donor group can cause excited-state charge transfer. It is 
noteworthy that the change from sp2 to sp3 hybridization will lead to a boron atom 
which no longer has an empty p orbital and this will stop the ICT route. The lowering in 
the pKa value (2-3 units) can be observed following the conversion of a phenylboronic 
acid analogue into its ester with saccharides. The changes of the boron atom from the 
neutral sp2 form to the anionic sp3 occur when boronic ester is formed and this can 
happen at physiological pH, so by the addition of a sugar to the boronic ester it can be 
possible to cause changes in the ICT effects.6,34 
An example chosen to illustrate this is the simple bioprobe using a donor-acceptor dye 
based on the diphenyloxazole 210 which was reported by DiCesare and his co-workers. 
They presented the comparison of the dye 210 with sensor 211, showing that the high 
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fluorescence intensity and spectral changes are due to the formation of the anionic 
form of the boronic acid as the pH increases (Figure 32).35 
 
Figure 32 Structures of donor-acceptor bioprobes.  
 
This group has also described the chalcone-analogue fluorescent probes 212 and 213 
which are shown in Figure 33.36 
 
 
Figure 33 Chalcone based fluorescent probes. 
 
In bioprobes 210 and 211 the boronic acid group was directly involved in the ICT, and 
the blue shift observed in those two probes was huge in comparison with the systems 
212 and 213. Additionally, dyes 212 and 213 showed a high affinity to D-fructose. 
 
1.4.5. Bioprobes for glucose binding 
Monitoring glucose concentrations is widely understood to be a major challenge in the 
management of diabetes. Enzyme-based determination methods requiring multiple 
and often frequent collection of blood samples are the most common way in which 
blood sugar concentration is determined, with glucose oxidase and hexokinase being 
the most common enzymes utilised in the method. When testing blood sugar levels, it 
is common for blood sample to be applied to a test-strip paper where the chemical 
monitoring system is contained. The test strip is then inserted into the meter where a 
reading is given. Some problems from this type of procedure occur due to the fact that 
the monitoring is not continuous, and the shell-life of the test kits is limited by the lack 
of stability of the enzymes themselves. Chemical bioprobes can offer the answer to 
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these problems, by the advantage of higher stability and relatively easy manufacturing. 
To establish a viable design for a chemical bioprobe-based continuous monitoring 
device, one needs to develop glucose sensors that show high selectivity and 
appropriate affinity. It is not only the monitoring of glucose concentrations during 
treatment of diabetes that needs to be taken into account. Other analytical methods 
that rely on the selective recognition of D-glucose could possibly have significant 
applications. In humans the breakdown of glucose transport has also been correlated 
with diseases such as renal glycosuria37, cystic fibrosis38, and even human cancer39. 
Fluorescence is one of the techniques used to monitor the blood glucose levels. 
Typically, mono-boronic acid derivatives have been used to develop glucose bioprobes, 
but with limited success. Fortunately, Shinkai discovered that di-boronic acids 
derivatives, in particular the 9,10-bis-(aminomethyl)anthracene skeleton 214, are 
suitable as glucose binding agents with a high enough affinity to make an effective 
sensor. The bioprobe is another example of the use of photoinduced electron transfer 
(PET) (Figure 34).40  
 
 
Figure 34 Bioprobe for glucose based on photoinduced electron transfer. 
 
The results show that sensor 214 is selective for glucose because it forms a 1:1 
complex between the two boronic acids and the 1,2 and 4,6-hydroxyls of glucose. 
Additionally, glucose binds to the boronic acids in a pyranose form and the sensor 
displays a clear order of selectivity for monosaccharides: D-glucose > D-allose > D- 
fructose ~ D-galactose.40  
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Furthermore, this selectivity applies to all diboronic saccharides, but bioprobes of type 
215 were the first of a series of compounds used for the ditopic recognition of 
monosaccharides based on a PET sensor system, Figure 35.41 
 
 
Figure 35 An example of bioprobe 215 based on a PET system. 
When compared to the Shinkai 194 system, however, the two boronic acids of 216, 
Figure 36 are not as well arranged to cooperatively capture D-gluocose.41 
 
 
Figure 36 The structure of the bioprobe 216 which shows poor arrangement of boronic acids to bind 
 D-glucose.  
An interesting example of a more flexible structure was described by Shinkai’s group42 
which reported a photoactive azo-dye based diboronic acid 217a, with switchable 
selectivity for D-glucose. The outcomes of their research indicate that by irradiation of 
diacid cis-217b with visible light it is possible for binding to occur for glucose and allose 
with very high selectivity (Scheme 54).42 
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Scheme 54 Representation of photoactive azo-dye based diboronic acid. 
 
The bioprobe 218 combines low pKa values and water solubility and also showed 
selectivity for glucose. Norrid’s group established that glucose binds to the compound 
as the α–D-glucofuranose 1,2:3,5-bisboronate complex at physiological pH.43 
 
 
Figure 37 Structure of bioprobe 218. 
 
Wang’s group44 also investigated glucose sensitive diboronic acid fluorescent sensors. 
Three different diboronic acids were synthesised. As the outcome of their research, 
the bioprobe 219 was found to bind with better affinity (300 fold increases) and 
selectivity (1400-fold) for glucose over fructose in comparison with phenylboronic acid. 
Additionally, based on the structure of 219, the phenyl ring with two acetamides 
connected to it in an ortho relationship gives the best (proper) orientation for 
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diboronic acid for binding with glucose, with the distance between the boron atoms 
matching perfectly the required separation. Unfortunately, the compounds 220, 221 
did exhibit sufficient selectivity and affinity for glucose at the required levels. It has 
been reported by Ansyln45 that boronic acid 201 can be used in competitive assays 
with a separate reporter component. It is necessary that the receptor and reporter 
associate under sample conditions. After an initial measurement, selective dissociation 
of the complex between receptor and reporter can be quantified by addition of 
suitable analytes. As the result, the measurement of this response is observed when 
the reporter dissociates from the receptor.45 The most commercially useful reagents 
for a competitive assay are Alizarin Red S 222 (ARS) and phenylboronic acid 201, see 
Figure 38. 
 
 
 
Figure 38 Bioprobes with high affinity for glucose. 
Another good example of a D-glucose fluorescent bioprobe that uses ARS 222 was 
reported by James et al.31 The results show that upon addition of the boronic acid 201, 
a new absorbance at 464 nm appears. However, another new absorbance at 530 nm is 
monitored when the experiments is investigated during addition of D-glucose and D-
fructose to the solution containing ARS 222 and the sensor. There are some significant 
changes observed in absorbance and fluorescence which are due to release of free ARS 
as the saccharides compete for the boronic acid in solution (Scheme 55).31 
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Scheme 55 Representation of the competitive assay with Alizarin Red S 222 and phenyl boronic acid 
.201. 
The discussion turns now to an enantioselective and chemoselective fluorescent 
sensor 225 (Figure 39) for sugar acids and alcohols. The fluorescent bioprobe is well 
suited for use as an in vivo probe, for example mapping the spatial and temporal 
distribution of the biological analytes.46,47,48 
 
 
Figure 39 Structure of enantioselective and chemoselective bioprobe 225. 
These fluorescent boronic acid-based probes which have been reported to be perfect 
sensors for tartaric acid, D-glucuronic acid and D-glucaric acid (shown with D-sorbitol 
in Figure 40).46,47,48 
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Figure 40 Structures of D-glucaric acid, D-(-)-tartaric acid, L-(+)-tartaric acid, D-sorbitol. 
 
The chiral bioprobe 226 was designed by James et al.49 in order to analyze chiral 
molecules such as sugars, sugar acids and sugar alcohols. In this work, anthracene is 
used as a suitable fluorophore for read out as a rigid linker and the chiral centres are 
built-up in close proximity to the binding site of the receptor. This group also 
synthesised the chiral monoboronic acid receptor 227 which is shown in Figure 41.49  
 
 
Figure 41 Structures of chiral bioprobes. 
 
1.4.6. Boron-cell surface interactions 
The development of synthetic carbohydrate receptors is a very important tool as they 
may serve as diagnostics to monitor changes on cell surfaces associated with disease 
progression in, for example, cancer, or they could be useful as drug-targeting agents to 
deliver chemotherapeutic agents to specific cell types. A few examples of boron-cell 
surface interactions will be described. 
An excellent example is provided by work performed by Hageman’s group which 
demonstrated the targeting of cell-surface structures with fluorescent dansyl 
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boronates to associate with Bacillus subtillis.50 Additionally, they showed that the 
diboronate dyes can detect the agglutination of erythrocytes. Later on, Gallop 
advanced a technique using boronates to transfer lipophilic dyes and probes into cells. 
This method is called “boradaption”.51 There is commercial interest in preparation of 
artificial transporters for the extraction of sugars (glucose, fructose or lactose).52 In 
2006, a significant development appeared for the use of lipophilic boronic acids as 
membrane transport agents for hydrophilic molecules (sialic acid and their 
derivatives).53 The Kataoka’s group54 reported polymeric boronates, which were used 
to target cell surface sialic acids to produce biological and analytical responses. The 
outcome of their research showed that these boronates can cause the induction of 
lymphocytes in the way that the natural lectins behave.54 The technique for the precise 
determination of cell surface sialic acid levels has been reported by Miyahara and co-
workers. They established that the use of a self-assembled monolayer on a gold 
electrode helps to apply the coating of boronates.55,56 The research in this area and 
development and applications of boron-carbohydrate interactions continues to expand 
into 21st century. Much knowledge has been obtained, specifically from the 
development of boronate based glucose receptors for application in sugar monitoring 
in diabetics. Nowadays, an increasing number of research groups are dedicated to the 
development of boron based receptors for complex oligosaccharides. These types of 
receptors are very significant in applications as diagnostics for cancer and drug 
targeting. Unfortunately, application of these interactions to target oligosaccharides 
still has limitations as not many boron-based oligosaccharide receptors have so far 
been developed. The answer to this challenge is to combine boron-carbohydrate 
interactions with several additional non-covalent interactions, H-bonding, 
hydrophobic, and, as in our work, to increase the information read-out from the 
spectroscopic study of the potentially many interconverting adducts that can form 
between the sensor and its target, in cell surface applications.9  
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CHAPTER 2: 
Results and Discussion Project 1 
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2.1. Aim of the project 1 
In both of the projects comprising this work, the aim was to prepare bioprobes with 
not just fluorescent features but also with an IR-responding group and so, by 
comparing the outputs from both reporting methods, it was hoped to demonstrate the 
high information-content responses of IR-based systems. 
Several research groups have described work on anthracene-based fluorescence 
reporters (See Chapter 1.4.3.1). Photoinduced electron transfer (PET) is a valuable tool 
in the design of the fluorescent bioprobes. As previously discussed, PET dyes are 
generally construct from a fluorophore and a receptor connected by a short spacer. 
When a guest binds to the receptor, changes occur in the oxidation/reduction 
potential of the receptor which can disturb the PET process and lead to changes in 
fluorescence. 
The design of bioprobe (Figure 42) with successful anthracene based fluorophore was 
inspired by work of James and Shinkai et al.1  The boronic acid dye 194 (Figure 30) 
showed a great binding affinity to D-fructose in 33.3% methanol-water at pH 7.77 
(phosphate buffer). Based on this research, the design of bioprobe 228, Figure 42 to 
prove the accuracy of the proposed IR-read out method by comparison with the well-
established PET approach was investigated. In target molecule 228, Figure 42 the 
amine group is important because of two roles in the system: 1) boronic acids in the 
presence of a neighbouring amine show increased binding of saccharides to boronic 
acids at neutral pH; 2) the lone pair on the amine controls the intensity of 
fluorescence. 
 
 
Figure 42 Structure of the target molecule 228. 
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The advantages of the target compound are; it contains an anthracene portion as a 
fluorescence reporter group, and an organometallic tricarbonyliron portion as an IR 
reporter group. These features allow us to use two analytical techniques, fluorescence 
spectroscopy and IR spectroscopy, to detect the saccharide binding. The IR method will 
allow observation of the hydrogen bonding interactions, because although the sugar 
uses two of its OH groups to bind to the boronic acid, there will remain other OH 
groups on the sugar which can form hydrogen bonds with an amide group which was 
intended to be placed on the 1,3-cyclohexadiene ligand of the iron complex (228b, 
Figure 43). The expectation is that different sugars will show different hydrogen 
bonding interactions, because they have different patterns of OH groups as their 
substituents, and so could be distinguishable by examination of details of the IR 
response for both the positions of the bands and their vibrational couplings. The 
binding event will show a response in both the fluorescence and IR reporter groups, 
and so establish that the changes in the IR spectrum are indeed a consequence of the 
binding of the sugar by the receptor. By the plotting of a correspondence graph 
between these two outputs, a firm footing of the ability of the IR technique to read out 
the details of the sugar binding is to be achieved. In future work it could be possible to 
optimise the reporting protocol to improve the selectivity of response. 
 
 
Figure 43 Representation of the hydrogen bonding interaction in the design molecule. 
 
2.1.1. The Photoinduced Electron Transfer (PET) effect on the target 
bioprobe 
The target molecule 228 will possess a tertiary amine attached to the boronic acid 
receptor site. As mentioned above, the fluorescence intensity is controlled by an 
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amine, so the lone pair of nitrogen can interact with the anthracene molecule and 
block access to the fluorescence route. Scheme 56 shows simply this effect of nitrogen 
lone pair donation to the anthracene molecule upon absorption of a photon, which is 
the basis of bioprobe design.  
 
 
 
 
Scheme 56 Representation of equilibrium for off and on state in target bioprobe. 
Fluorescence is best described by a Jablonski diagram as shown in Chapter 1.3 in Figure 
12. To restate this briefly, the fluorescence emission is the consequence of the return 
of an excited electron to its ground state, and PET stops this process by transferring 
electrons into the ground state of the molecule (for example, the anthracene moiety in 
the sensor). This result in the complete occupation of the ground state orbital, and 
thus blocks the return of the excited electron to its ground state. In general, when 
photoinduced electron transfer of the nitrogen lone pair to an anthracene molecule 
occurs, the fluorescence is quenched. Interestingly, in the case of target bioprobes, if 
the sugar successfully binds to the boronic acid 228b, the amine should become more 
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strongly bound to the boron centre which should now be in the form of a cyclic ester 
228c which has a higher affinity and is more easily adapted into the tetrahedral form. 
As a consequence, the boron-bound amine is unable to quench the fluorescence since 
the nitrogen lone pair is no longer available and hence a strong fluorescence is 
observed, “on-state”, Scheme 56. Although, as discussed in detail in Section 1.4, the 
results from pH profile studies of the free boronic acid and sugar (Scheme 50) showed 
that the hydrolysis mechanism provides a better explanation for observed changes in 
PET quenching, compared to the B-N mechanism, until now it has been hard to prove 
which mechanism is right. In developing the designs for the organoiron analogues of 
the boronic acid fluorescent reporter dyes the ortho-substituted example shown in 
Figure 43 could operate by either the hydrolysis mechanism or the B-N mechanism 
(Scheme 50), but for the alternative meta-substitution pattern in the arylboronate, 
only the hydrolysis mechanism should be applicable. The position of B(OH)2 in the 
target molecule will be modified due to some difficulties in the synthesis of target 
molecule 228. However, while in principle, the ortho-substitution should best allow the 
B-N bond mechanism to operate, the comparison of ortho- and meta- substitution 
patterns can be of value as a potential way to distinguish between the two mechanistic 
alternatives, so it was felt that the meta series was also a worthwhile goal.  
 
 
2.1.2. Hydrogen bonding interaction observed by IR upon binding 
As mentioned above, the target molecule is made from three important parts. The IR 
responding part was designed to be able to form hydrogen bonding interactions. On 
successful binding of saccharide to boronic acid derivative, this interaction will be 
observed between hydroxyl groups on the saccharide and the amide group attached to 
1,3-cyclohexadiene (Figure 44). As the amide group is in conjugation with the diene 
system, after binding, the hydrogen bonding interactions should affect the electron 
density in the π-system. This should be observable by the IR method because this is 
sensitive to the degree of back-donation of electron density into the CO antibonding 
orbital (See Chapter 1.1.3, Figure 3). 
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Figure 44 Representation of hydrogen bonding interaction between hydroxyl group on the saccharide 
and the amide group attached to 1,3-cyclohexadiene. 
 
2.2. Results and discussion 
The retrosynthethic route towards the preparation of target molecule 228 is 
shown in Scheme 57. 
 
Scheme 57 Retrosynthetic route towards the preparation of desired bioprobe 228. 
There are two pathways which will be investigated to build the target structure; both 
pathways will involve the preparation of 9-aminomethylanthracene 107 and novel 
tricarbonyliron complexes. Pathway A includes reductive amination of 2-
formylphenylboronic acid 256a, followed by nucleophilic substitution of derivative 229 
to give the target bioprobe 228. In pathway B, the first step will involve the 
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nucleophilic substitution of tricarbonyliron salt with 9-aminomethylanthracene 107, 
then the N-alkylation of 230 to obtain desired compound 228. This project requires the 
development of a synthetic route to novel iron complexes (as IR reporting groups) 
bearing both a 9-aminomethyl anthracene as a fluorescence reporting group and a 
boronic acid derivative to bind with sugars.  
2.2.1. The choice and synthesis of IR reporting group 
The applications of transition metals are a major interest in research in organic 
chemistry. Nowadays, handling air and moisture sensitive organometallic compounds 
for use in synthetic procedures is a straightforward process and this has led to major 
advances in the field of organometallic chemistry. As described in Chapter 1.2, 
organoiron complexes are well established in synthetic chemistry and possess 
excellent spectroscopic properties. Those advantages lead us to select the 
tricarbonyliron group as the organometalcarbonyl system for the intended 
applications. It was decided to explore the viability of forming iron tricarbonyl 
complexes of 235 and its derivatives. In course of doing so, commercially available 
Fe2(CO)9 was used, which is more reactive and less toxic than Fe(CO)5. Additionally it is 
easier to handle a solid as opposed to a liquid. More details for iron complexation will 
be discussed in Results and Discussion for project 2 as the comparison of these two 
reagents and more details of the scope and limitations for iron complexation reactions 
was investigated in the course of project 2. 
Preparation of the starting materials followed the procedure of Graden and co-
workers,2 who described in 2004 the synthesis of carboxylic acid iron complex 235.   
Synthesis of the Wittig salt 232 started from the commercially available methyl-4-
bromocrotonate 231 by addition of triphenylphosphine in dry toluene. The reaction 
was stirred at room temperature for 2 days and the desired (3-methoxycarbonylallyl)-
triphenylphosphonium bromide 232 was obtained in 96% yield (Scheme 58).3 
 
 
Scheme 58 Synthesis of Wittig salt 232. 
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Cyclohexa-1,3-dienecarboxylic acid methyl ester 233 was synthesised by treatment of 
the phosphonium bromide 232 with acrolein and sodium bicarbonate. The reaction 
was stirred for 3 days at room temperature before being quenched to obtain the 
expected compound 233 in good yield (52%) (Scheme 59).3 
 
 
Scheme 59 Preparation of Cyclohexa-1,3-dienecarboxylic acid methyl ester 233. 
The last two steps route (Scheme 60) started with  the hydrolysis of cyclohexa-1,3-
dienecarboxylic acid methyl ester 233 with methanolic sodium hydroxide to produce 
the cyclohexa-1,3-dienecarboxylic acid 234 in 59 % yield, followed by iron 
complexation of acid derivative 234 by heating for 5 hours at reflux in the presence of 
diironnonacarbonyl in dry THF. The 1H NMR and 13C NMR spectra of the product 235 
were in agreement with data reported in the literature.2 The tricarbonyl(cyclohexa-1,3-
dienecarboxylic acid)iron 235 was synthesised in good yield (59%) and was used as the 
starting material for the parallel synthesis of the target amides (Scheme 60). 
 
 
Scheme 60 Synthetic route to produced precursor 235. 
There are two potential ways to create the novel amide-bearing complexes - by an 
acylation reaction or by peptide coupling. As an acylation reaction was successful, it 
was decided to continue in this way. Nowadays, the procedures for amide synthesis 
have become highly developed because of the introduction of new peptide coupling 
reagents in organic synthesis. But still, the simple two step acylation reactions 
(activation of carboxylic acid followed by reaction with amines) have not been 
discarded in this chemistry.  The key intermediate for this type of reaction is an acid 
chloride, which can be used for transformation into many other functional groups as 
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well as amides: for instance, anhydrides, esters and ketones. Additionally, this type of 
reaction can be used as a protecting strategy in significant synthetic methods which 
involve several steps, leading to many bioactive compounds (vitamins, agrochemicals, 
xanthenes, also conjugational peptide synthesis).4  
Scheme 61 shows an example of an N-acylation reaction, where in the first step the 
carboxylic acid is activated by changing it into the acid chloride and subsequent 
reaction with the amine.  
 
 
Scheme 61 Representation of N-acylation reaction. 
The acylation reaction is a crucial step in the synthesis of the novel tricarbonyliron 
complexes. The synthesis of tricarbonyl iron complexes which possess a range of 
different amide groups was developed. The intention is that the amide carbonyl group 
in conjugation with the diene complex will be suitable for the proposed hydrogen 
bonding interactions (see Figure 44) that should provide the basis for the differential 
read-out in the IR of the presence of different sugars. 
As a first step, tricarbonyl(cyclohexa-1,3-dieneacyl chloride)iron 240 was made by 
reaction of tricarbonyl(cyclohexa-1,3-dienecarboxylic acid)iron 239 with oxalyl chloride 
in dry DCM in the presence of a catalytic amount of DMF to form the acyl chloride 240 
in situ. In a series of reactions, various types of amines were added to a solution of this 
key intermediate 240 in dry DCM at room temperature, in the presence of 
triethylamine. The reaction mixture was stirred at room temperature for 3 hours 
before being quenched. Under these reaction conditions the desired novel 
tricarbonyliron complexes with different amides group 241a-f were obtained in good 
yields (Scheme 62, Table 2). Analysis by IR showed vibrations at around 1974 and 2050 
cm−1 for the Fe(CO)3 moiety and at about 1722 cm
−1 for the amide carbonyl group.  The 
use of longer reaction times was also examined but offered no improvement in yields. 
These reaction conditions failed for compounds 241g-j.  
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Scheme 62 The preparation of novel tricarbonyliron complexes and their salts. 
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Table 2 Isolated yields for different substituents under reaction conditions described in Scheme 62. 
 
 
All the synthesised tricarbonyl complexes 241a-f are new apart from the compound 
241c. In 2006, J. Eriksson and co-workers synthesised 241c by polymer-amide cleavage, 
as shown in Scheme 63. Different types of active esters 239a-c were reacted in dry THF 
at room temperature. The reaction was followed by HPLC using N,N-
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dimethylbenzamide as a standard. The best results were obtained by using the ester 
239a which gave 241c in 96 % yield. The 1H NMR, 13C NMR and IR spectrum of the 
product 241c obtained by our method agreed with data reported in the literature.5 
 
 
Scheme 63. The synthesis of tricarbonyliron 241c by polymer-amide cleavage. 
However, in order to optimise the reaction conditions for compounds 241g-j, the 
influence of the supporting base and solvent on the course of the reaction was 
specifically studied. The addition of pyrrole, 2-pyrrolidinone, δ-valerolactam, and 
succinimide to solutions of tricarbonyl(cyclohexa-1,3-dieneacyl chloride)iron 240 in dry 
THF in the presence of sodium hydride was successful for only one compound. An 
excellent 95% yield was obtained to give derivative 241j when the reaction was stirred 
for three hours at room temperature, but no yield was observed for the rest of the 
substrates using these same conditions (Table 3, Scheme 63). These compounds seem 
to be unstable under the reaction conditions and decompose upon extended reaction 
time. Changing the solvent to diethyl ether failed to improve results. 
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Scheme 63 Modification of the reaction conditions to obtain tricarbonyl iron complexes 241g-j. 
 
Table 3 Isolated yields for different substituents under reaction conditions described in Scheme 63. 
 
 
 
2.2.1.1. Preparation of tricarbonyliron salts 
The synthesis of the tricarbonyl ɳ5-cyclohexadienyl iron salts 242a-j was approached by 
hydride abstraction with trityl cations (triphenylcarbenium hexafluorophosphate or 
triphenylcarbenium tetrafluoroborate) in dry DCM as shown in Scheme 65.2,6  The 
work-up of the reaction mixture involves the addition of diethyl ether, which causes 
the precipitation of tricarbonyliron salts. Unfortunately these reaction conditions did 
not work consistently for all the novel complexes, even when the counterion was 
changed from PF6
- to BF4
-. The best result was obtained for compound 242c (Table 4, 
Scheme 65), but for the rest of the examples the salt could not be precipitated. As an 
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alternative, it was decided to investigate whether those salts can be used with 
nucleophiles in situ without isolation of the salts. The IR measurements after hydride 
abstraction show the peaks ~2118 cm
-1 and ~2063 cm
-1 that indicate the salts are 
formed in the solution but cannot be precipitated. The un-isolated tricarbonyliron salts 
can still be potentially useful in future syntheses, for example with different types of 
nucleophiles. 
 
 
Scheme 65. The preparation of novel tricarbonyliron salts. 
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Table 4 Isolated yields for different substituents under reaction conditions described in Scheme 65. 
 
2.2.2. Choice and synthesis of the sugar sensor 
It is important to understand clearly the role of the boronic acid moiety of the target 
molecule, and how it functions. In the introduction (Section 1.4), the importance of 
boronic acids specifically in carbohydrate bioprobe systems was discussed. They have 
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unique properties as strong organic Lewis acids. It is also significant that boronic acids 
can be described as “green” compounds because of their low toxicity and their 
ultimate degradation into boric acid which is environmentally friendly.7 
Additionally, boronic acids are not always very convenient in purification and 
characterization, but their ester derivatives are often more easily handled, since the 
two hydroxyl groups are protected. In addition, conversion of the hydroxyl groups into 
other functional groups (halides) can give increased reactivity necessary for several 
synthetic applications. All of the boronic acids which were used in this research were 
commercially available but it was still necessary to perform some protection reactions 
of these compounds. The representative Scheme 66 describes the synthesis of boronic 
esters from boronic acids and alcohols or diols. The reaction is in equilibrium and the 
formation of the ester is favoured when this product is not soluble in the reaction 
solvent.7  
 
Scheme 66 Equilibrium and the formation of the esters. 
Within this project 2,2-dimethyl-1,3-propanediol 244 in dry toluene was used for 
protection and the reaction mixture was stirred overnight at room temperature before 
being quenched. The corresponding esters are listed in Scheme 67 and were obtained 
in good yields.  
 
 
Scheme 67 Synthetic route for protection of boronic acids. 
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2.2.3. Choice and the synthesis of fluorescent reporting group 
The choice of the 9-aminomethylanthracene 107 fluorophore is based on its 
advantageous use in the synthesis of known bioprobes. This type of fluorophore is 
commercially available but is very expensive (2 g costs $1250, at 
Betapharmascientific®) so it was important to find a short and easy way to prepare it. 
Following a literature search,8 an attractive way to prepare the required fluorophore 
107 was identified. The first step involved bromination of 9-anthracenemethanol 248 
by phosphorous tribromide in dry toluene to yield (88 %) the bromomethyl product 
249 as yellow crystals. Subsequent preparation of 9-azidomethylanthracene 250, was 
achieved in 78 % yield by reaction of 9-bromomethylanthracene 107 in presence of 
sodium azide in DMSO. The final step is called the Staudinger reaction9 and is the 
conversion of an azido group into an amino group. 9-Azidomethylanthracene 250 was 
reduced by using triphenylphosphine in water with hydrolysis to produce 9-
aminomethylanthracene 107 in good yield (69%) (Scheme 68).  
 
 
Scheme 68 Synthetic route to prepare desired fluorophore 107. 
Although, the literature example is very precise and easy to follow, it was decided to 
investigate a shorter way to prepare this fluorophore just by simple reductive 
amination. In the synthesis, the number of steps were reduced from three to just one 
to give the desired compound 107 in good yield by this reductive amination approach. 
Reductive amination of aldehydes and ketones is a well-known method of preparation 
of secondary amines. In this type of reaction, the amine 252 will react with the 
carbonyl group to produce an imine 253 (reversible), which involves the loss of one 
molecule of water. The equilibrium between the formed imine 253 and aldehyde or 
ketone 251 can be moved toward imine formation by removal of the water. It is 
possible to isolate and reduce the imine 253 (an intermediate) with a suitable reducing 
agent: this is called indirect reductive amination (Scheme 69).10 
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Scheme 69 Representation of reductive amination. 
It is also possible to perform both steps in one pot, with the imine formation and 
reduction occurring in sequence, which is known as direct reductive amination. In this 
case, the initial equilibrium can be driven by the irreversible reduction step. These 
methods use reducing agents which are more reactive towards imines than ketones, 
for example sodium cyanoborohydride (NaBH3CN) and sodium triacetoxyborohydride 
[NaBH(OCOCH3)3]. Another interesting and significant transformation of the imine 
intermediate is catalytic hydrogenation. The disadvantage of this method, however, is 
that the hydrogenation conditions for the reaction are not suitable for many other 
reducible functional groups, for instance nitro, cyano, double, triple bond. To avoid 
those extra reductions, sodium cyanoborohydride is preferable.10 
The shortened synthesis of the fluorophore was started from the reaction of 9-
anthracenecarboxaldehyde 255 with ammonium chloride and sodium borohydride as 
shown in Scheme 70. In order to optimise the reaction conditions, the influence of the 
solvent, reducing agent and source of ammonia on the course of the reaction was 
specifically studied, by changing each parameter in turn while keeping the others 
constant. The best solvent under these conditions was found to be dichloroethane, 
Table 5. 
 
 
Scheme 70 Reductive amination of 255 to afford 107 by using various solvents. 
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Table 5 Yields and corresponding solvents applied to Scheme 70. 
 
 
Next, a comparison of different sources of ammonia for this reaction was explored 
(Scheme 71). Reaction with either ammonia in methanol (liquid), or ammonium 
chloride (powder), surprisingly showed that ammonium chloride powder gave slightly 
better results as we obtained the required compound in excellent yield 80% (Table 6). 
 
 
Scheme 71 Reductive amination of 255 to afford 107 by using various sources of ammonia. 
Table 6 Yields and corresponding ammonia sources applied to Scheme 71. 
 
 
Finally, the effect of different reducing agents was shown. Reactions and yields with 
different reducing agents; NaBH4, NaBH(OAc)3, and NaBH3CN in dry DCE are shown in 
Scheme 72,Table 7, respectively. 
 
 
Scheme 72 Reductive amination of 255 to afford 107 by using different reducing agents. 
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Table 7 Yields and corresponding reducing agents applied to Scheme 72. 
 
As a conclusion concerning the reductive amination step, the best conditions were 
achieved by using NH4Cl as a source of ammonia and NaBH4 as the reducing agent in 
dry DCE. 
 
2.2.4. Synthesis of the main part of the target molecule (pathway A) 
Boronic acids 256 or 256a are commercially available and were chosen for an initial 
examination of the reductive amination following the known procedure from a 
previous PhD thesis11 in which the reaction was performed in the ortho series, using a 
boronic acid prepared for the project. The meta and ortho derivatives of 
formylphenylboronic acid (256, 256a) were reacted individually with 9-
aminomethylanthracene 107 in the presence of sodium borohydride but unfortunately 
failed to give the desired compound 257 or 257a, Scheme 73.  
 
 
Scheme 73 Unsuccessful attempt to produce molecule 257. 
It was decided to reverse the functional groups on the two substrates and then apply 
the same conditions as previously for the reductive amination step. Surprisingly, this 
reaction also failed to give the desired building block 229 for the target molecule 228, 
but instead 9-aminomethylanthracene 107 was isolated, Scheme 74. The formation of 
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107 was confirmed by IR, 1H-NMR and 13C-NMR. The reaction was repeated several 
times to make sure that this product did not arise from cross-contamination. 
 
 
Scheme 74 Unpredictable synthesis of fluorophore 107. 
The next attempt was to use protected boronic acid derivatives under the same 
conditions (Scheme 75), unfortunately with no success. 
 
 
Scheme 75 Unsuccessful route to achieve molecule 229. 
 
In the light of this observation, the use of the chloro analogue was considered instead. 
The previously prepared 3-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)aniline 245 and the 
commercially available 9-(chloromethyl)anthracene 258 were arbitrarily chosen for 
this study (Scheme 76). The reaction was carried out using pyridine as a solvent but 
unfortunately it failed to achieve the expected compound 259.12 
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Scheme 76 Unsuccessful route towards 259. 
Facing these unsuccessful efforts to prepare the target molecule by pathway A, it was 
decided to move on to the pathway B which is shown in Scheme 56. 
2.2.5. Reaction of tricarbonyliron salt with nucleophile (pathway B) 
First, following literature conditions,13,14 it was attempted to prepare compound 
(±)-260 by reaction of 9-aminomethylanthracene 107 and tricarbonyl[5-(morpholine-4-
carbonyl)cyclohexa-2,4-dien-1-ylium]iron hexafluorophosphate 242c in dry CH3CN and 
then in DCM. Unfortunately both reactions failed to provide the desired compound  
(±)-260. The new (±)-tricarbonyl{5-[(anthracen-9-ylmethyl)amino]cyclohexa-1,3-dien-1-
yl)(morpholino)methanone}iron complex (±)-260 was isolated in low yield (5%) by 
using dry THF as a solvent and stirring for 3 hours at room temperature. A series of 
experiments was then undertaken to attempt to optimise the yield of this 
transformation; starting by varying the choice of the supporting base (Table 8, Scheme 
77). When triethylamine was used, the yield was marginally improved to 8%. It is 
noteworthy that changing the supporting base to dimethylaminomethyl-polystyrene 
(DMAM-Ps) gave the best yield (15%) for this reaction. The use of longer reaction 
 times at room temperature, and reflux were also compared but did not improve yield. 
These results suggest the reaction between 9-aminomethylanthracene  
molecule and tricarbonyl{5-(morpholine-4-carbonyl)cyclohexa-2,4-dien-1-ylium}iron  
hexafluorophosphate 242c with DMAM-Ps should be considered for future 
investigations.  
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Scheme 77 Synthetic route towards compund (±)-260 under different reaction conditions. 
 
Table 8 Yields and corresponding supporting base and solvents applied to Scheme 77. 
 
 
2.2.6. Preparation of target molecule (±)-228 and modified target molecules 
(±)-228d and (±)-267 
The synthesis of the ideal target molecule with the ortho-substituted boronic acid was 
attempted via a second nucleophilic addition reaction with molecule (±)-260, by 
addition at room temperature of commercially available 2-bromomethylphenylboronic 
acid 261 followed by treatment with potassium carbonate in dry acetonitrile (CH3CN) 
to give bioprobe (±)-228 (Scheme 78). This reaction failed to proceed and no product 
was obtained. The supporting base was varied by using potassium bicarbonate in dry 
THF but this reaction also failed. 
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Scheme 78 Synthetic route towards preparation of ideal target molecule (±)-228. 
 
Table 9 Reaction conditions applied to Scheme 78. 
 
 
Additionally the preparation of modified target molecule with a meta-substitued 
boronic acid was attempted, varying the conditions of the reaction by changing the 
boronic substrates, base and solvents. The reactions were carried out at room 
temperature and also at reflux. Unfortunately, none of these modifications allowed for 
isolation of the desired product (±)-228d, (Table 10, Scheme 79). 
 
Scheme 79 Synthetic route towards preparation of modified target molecule (±)-228d. 
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Table 10 Reaction conditions with different substrates applied to Scheme 79. 
 
 
Faced with this setback, alternative methods of synthesising the changed target 
molecule (±)-267 were examined. It was decided to prepare the molecule following the 
synthetic route presented in Scheme 80. Based on the literature,15 in the first step the 
(R)-2-phenyl-2-(anthracen-9-ylmethylamino)-ethanol 265 was synthesised by reductive 
amination in 55% yield. This time, the reductive amination of (R)-2-amino-2-phenyl-
ethanol 264 was performed in a mixture of DCM/MeOH (3/1) in the presence of 
sodium borohydride. Next, an approach that required the conversion of 
tricarbonyl(cyclohexa-1,3-dieneacyl chloride)iron 240 in dry DCM by using 
triethylamine (Et3N) or pyridine as a base, which could possibly lead to the novel 
compound 266, was investigated. Subsequently a simple N-alkylation with 2-(2-
bromomethylphenyl)-1,3,2-dioxaborinane 246 would yield the diastereoisomers 267a 
and 267b. Unfortunately, this strategy proved unsuccessful. 
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Scheme 80 New synthetic routes to achieve (±)-267a-b. 
A last route for this part of project was finally considered. The previously developed 
conditions were applied to the reductive amination step, as follows; 
9-anthracenecarboxaldehyde 255 was reacted with (R)-2-amino-2-phenyl-ethanol 264, 
by treatment with sodium borohydride in dry DCE, to produce the (R)-2-phenyl-2-
(anthracen-9-ylmethylamino)-ethanol 265 in an improved yield (74 %), compared with 
the literature example. The next step involved reaction of (R)-2-phenyl-2-(anthracen-9-
ylmethylamino)-ethanol 265 with 2-(2-bromomethylphenyl)-1,3,2-dioxaborinane 246 
in dry acetonitrile (CH3CN) by using potassium carbonate. The reaction mixture was 
refluxed for 8 hours before being worked up. The desired compound 268 was 
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synthesised in 25% yield. Following that, the addition of tricarbonyl(cyclohexa-1,3-
dieneacyl chloride)iron 240 in the presence of a Et3N or pyridine in dry DCM (Scheme 
81) was attempted. These reactions led only to complex mixtures of products. 
 
 
 
Scheme 81 Unproductive modification of synthetic route to achieve 267a-b. 
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2.3. Conclusions 
Although the target molecule was not synthesised, even after several attempts, and it 
was not possible to directly prove, by spectroscopic evaluation, the bioprobe approach 
that formed the motivation for this project, the desired target is just one step away 
from the point in the synthesis currently reached. In the course of the work described 
in this section, the novel tricarbonyliron complexes 241a-b, 241d-f were synthesised. 
These new complexes have potential utility for synthetic elaboration and have 
accumulated important information about the scope and limitations of the use of 
tricarbonyliron chemistry to address highly functionalised target structures. Some 
further investigations with the electrophilic cations 242a-f, 242j are still needed to 
explore their reactivity with nucleophiles by the ‘in situ’ approach. To summarise the 
outcomes reported in this section of the thesis, development of a new way to prepare 
the expensive fluorophore, 9-aminomethylanthracene 107 was achieved, which has an 
important role in the field. Subsequently, the synthesis of the main part of the target 
molecule was attained with interesting outcomes which can possibly guide future work 
to investigate these types of reactions. Results (both successful and unsuccessful) 
presented in this thesis provide crucial information needed to devise alternative 
approaches to achieve the synthesis of the first examples of this novel class of sensor 
structures. 
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CHAPTER 3: 
Results and Discussion Project 2 
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3.1. Aim of the project 2 
This project describes collaboration with Prof. Pierre-Yves Renard and Pr. Anthony 
Romieu in University of Rouen, whereby I spent six months working under their 
supervision. It involved the preparation of a molecular bioprobe associating two 
modalities: fluorescence and infra-red, which will work as an enzyme assay to visualize 
enzyme activities. As described in Section 1.3, the last decade has seen a high level of 
interest in the synthesis of pro-fluorescent compounds to use in this type of bioprobe 
to advance the discovery and optimization of industrial enzymes which have become 
of increasing importance because of the impact they make in economically viable, 
mild, environmentally-friendly production processes. Furthermore, the progress of 
research with these types of bioprobes opens the way for advances in drug discovery 
efforts, medical diagnostics and in the technologies for cellular and tissue imaging.1 
The most uncomplicated and feasible bioprobes rely on a synthetic molecule that 
releases a coloured or fluorescent product during reaction or make a noticeable 
change in solution, for instance a precipitation. As well, such reactions use different 
types of techniques which respond indirectly to consumption of substrate or product 
formation. The indicator techniques can be used simply as a pH-meter, but also many 
bioprobes are based on NMR, IR or fluorescence.2  
This project is based on bioprobes which are constructed with a cleavable active bond 
as a linker. These types of bioprobes typically contain three potential parts: a signalling 
moiety, a labelling or recognition moiety (which allows specific recognition of the 
targeted analyte and/or a specific reaction) and, in most of the cases, a suitable linker 
or spacer (which connects the two functional moieties). This project was designed by 
proposing a self-immolative cleavable linker to connect a recognition unit to a 
signalling unit which has been the most prevalent and provides the inspiration for 
many spectroscopic probes, through unveiling of the signalling unit once the self-
immolative cleavable linker has been cleaved. The Figure 45 represents the general 
mechanism for this type of bioprobe.2,3,4 
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Figure 45 Representation of mechanism for pro-fluorescent bioprobe. 
When the fluorophore is connected to a quencher with a cleavable active bond it emits 
only a weak fluorescence because of intramolecular self-quenching or fails to 
fluororesce at all. Afterwards, when an analyte is added and the linker in the probe is 
cleaved, the fluorophore is released and so is separated from the quencher, with the 
return of a fluorescent response. In the past few years, this design of bioprobe and the 
mechanism of operation has opened a novel alternative route to the specific 
determination of analytes with high hydrolytic reactivity and has permitted many 
biological processes to be monitored in situ and in real-time.5 
The project is based on the synthesis and proof of model dye 268 (Figure 46) with 
novel fluorescent / IR reactive probes with cleavable active bonds aiming at the 
detection of a model protease. As in project 1, this target molecule will contain the 
conventional fluorophore (the aminocoumarin) and the IR-active tricarbonyliron 
complex, to convey the read-out information which can be validated by comparison of 
IR and fluorescence responses. 7-Aminocoumarins with electron-withdrawing groups 
at the aniline moiety generally display a high quenching of their fluorescence. Cleavage 
of the amide bond by a model protease (namely penicilin G acylase) will lead, through 
a 1-6 elimination process, to the release of the 7-aminocoumarin, and thus, to the 
release of the fluorescence, as well as the modification of the IR responsive Fe(CO)3 
moiety, which should also display a significant modification on the IR signal (vide infra). 
 
 
Figure 46 Representation (left) and structure (right) of target bioprobe 268. 
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Pro-fluorescent bioprobes (or fluorogenic probes) are molecules in which a physical 
property of the fluorophore or IR-active group is changed upon interaction with an 
analyte (enzyme, metal cation, and reactive oxygen species) so displaying important 
information. As an example, for fluorophores, there will be changes in the 
fluorescence spectrum and/or an increase in the fluorescence quantum yield at a 
particular wavelength, and/or a change in some other fluorescent properties of the 
molecule. In some cases, the fluorogenic probes unveiled intense fluorescence only by 
a user-designated chemical reaction, so they present a unique selectivity and limited 
interferences related to the probe’s concentration, excitation intensity, and emission 
sensitivity.4 These properties have made them very advantageous in many fields 
because they have ability to improve analytical sensitivity and can provide greater 
temporal and spatial sampling capabilities. Principally it is shown in the literature that 
bioprobes are valuable tools in challenging biomedical applications such as in vivo 
fluorescence imaging, or in the enzyme-linked immunosorbent assay (ELISA), high 
throughput screening of enzyme inhibitors, detection of DNA and RNA, and evaluation 
of cell viability.6 
In this concept, the target is the detection of a model protease, penicillin acylase 
(PGA), where the biocatalyzed transformation will be combined with a domino 
reaction.  As shown in Scheme 82, the mechanism will include the fragmentation of 
the compound 268 to give dye 269, and then spontaneous 1,6 elimination to create 
azaquinonemethide 270 and the fluorescent compound 271, to observe an off/on 
system.  
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Scheme 82 The biocatalyzed transformation to release fluorescent compound 271. 
 
3.1.1. Choice of the self-immolative linker 
There have been many examples during the last decade in which numerous self-
immolative linker approaches have been advanced as the strategy of efficient prodrug 
designs of various pharmaceuticals which will be acceptable for the synthesis of 
organic compounds through many methods.7,8 This concept of a self-cleavable linker 
which plays the role of a spacer unit between the peptidyl substrate and a fluorescent 
label is showing a potentially additional advantage as it increases the enzymatic 
reactivity as well as spectral properties. Moreover, this self-immolative spacer strategy  
causes the reduction of the background noise associated with nonspecific hydrolysis of 
the resulting pro-fluorophore compared to “standard” two-component fluorogenic 
protease substrates. The self-decomposition of the spacer through a protease-initiated 
domino reaction can lead to releaseof fluorophores which contain an aniline, a phenol, 
or a thiophenol derivative.9 The requirement for such fluorophores to deliver a high 
off/on signal for this type reaction is a fluorescence modification once the aniline / 
phenol / thiophenol is involved in an electron withdrawing bond, of which cleavage is 
induced by the self immolative reaction. Among the fluorophores displaying such 
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properties, fluorescent amines such as 7-amino-4-methylcoumarin (AMC), rhodamine 
110, or cresyl violet can be expected to give protease-activated optical probes with 
excellent analytical properties.  
Pr. Renard’s group in Rouen has a good experience in such kind of bioprobes. For 
instance, in 2008, his group described the synthesis of a novel self-immolative spacer 
system 272 which will be able to release phenol-containing compounds (Scheme 83).10 
 
 
Scheme 83 Representation of novel self-immolative spacer 272 upon biotransformation. 
These novel compounds for this application proved to be precisely stable under 
physiological conditions and activated through spontaneous decomposition of the 
intermediate under neutral aqueous conditions. The advantage of this dye was proved 
by the preparation of a fluorogenic substrate aimed at the detection of the activity of 
penicillin amidase whose strong fluorescence is unmasked through enzyme-domino 
reactions. Moreover, they could be potentially a good guide for the design of 
profluorophore or prodrug delivery systems appropriate for cancer imaging or 
chemotheraphy.10 
In the same year, Renard’s group prepared a new class of far-red Emitting fluorogenic 
dye 274, Figure 47. In their strategies, they introduced the beneficial use of a PABA 
derivative as a linker between peptidyl substrate and the fluorophore. This self-
immolative spacer when present shows higher stability in physiological media and 
even better enzymatic recognition and cleavage kinetics.11  
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Figure 47 Representation of novel Far-Red Emitting Fluorogenic Dye 274. 
Additionally, the designed fluorogenic derivatives were projected in precise manner:  
1) as 7-alkoxycoumarins emit more weakly when compared with 7-hydroxycoumarins 
they can give the pro-fluorescence properties, 
2) the phenol group of the 7-hydroxycoumarin and an hemicyanine dye should work as 
a push-pull device, 
3) the presence of one or two double bonds in the 3-position of the coumarin aims at 
producing the red-shift of the emission wavelength (extension of the π-conjugation of 
the dye), 
4) to achieve water solubility, a sulfonate group was introduced on the hemicyanine 
derivative.  
Furthermore they proved that self-immolative linkers based on PABA derivatives (the 
stabilising spacer is N,N’-dimethylethylendiamine) disassemble faster than ones with a 
hemithioaminal core. As a result, the PABA dyes are suitable to use to get fast-
responsive probes and the hemithioaminal linker will be more useful for the 
preparation of tunable (bio)functionalised probes.11  
Noticeably Pr. Renard’s group were using the commercially available para-aminobenzyl 
alcohol (PABA) as the self-immolative spacer. PABA is one of the most popular self-
immolative linkers applicable in prodrug design. The pioneer in this field is 
Katzenellenbogen whose group described in 1981 that 4-aminobenzyl alcohol can be 
useful as an efficient self-immolative linker in prodrug design. In Scheme 84 is shown 
the design of this approach in which the linker is used as a connector between a drug 
and an enzymatic substrate. Noticeably, the prodrug is stable and non toxic until the 
enzymatic substrate is connected followed by the cleavage of substrate’s bond by the 
enzyme to release a free active drug.12 
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Scheme 84 The design of prodrug probe in which the linker is used as a connector between a drug and 
an enzymatic substrate. 
 
The utility of this self-immolative spacer was examined as well by Shabat et al.,13 they 
used 4-nitroaniline as a model drug and lysine as an enzymatic substrate for trypsin. In 
Scheme 85 is shown the reaction of trypsin with designed prodrug 275, and as a result 
the release of aniline derivatives 277 was observed, which spontaneously provides 
azaquinonemethide 270 and free 4-nitroaniline 278.13 
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Scheme 85 The model drug 275 and lysine as an enzymatic substrate for trypsin. 
Taking all these points into account, the immolative spacer PABA was chosen as it 
offered the right levels of reactivity, was well-precedented in biological applications, 
and was commercially available. 
 
3.1.2. Choice of the enzyme and fluorophore 
After choosing the suitable spacer, confirmation of the self-immolative methodology in 
the context of new protease-sensitive pro-fluorescent probes was needed. It was 
decided to develop assays with penicillin amidase (PGA), a commercially available and 
widely used biocatalyst which is used in the enzymatic synthesis of β-lactam 
antibiotics; since it allows the deprotection of phenacetyl protected amines. This type 
of enzyme is not expensive, and is readily manageable in an immobilized form. 
Moreover, it is stable even if using reasonable amount of organic solvents (acetone or 
methanol, up to 40-50% in water) and can be widely used to react (either in solution or 
on solid phase) as a suitable reagent or catalyst in organic synthesis.14 Most known 
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examples include the selective deprotection of amino groups within complex 
molecular architectures (i.e. dendrimers15).16 
Remarkably, the studies for in vitro detection of PGA activity are based on the use of 
phenylacetamide derivatives of fluorescent amines (e.g. AMC) as fluorogenic 
substrates. The focus of this project is to design a novel class of PGA-sensitive pro-
fluorescent probes which will check how the PABA moiety, introduced between the 
fluorophore and the protease-reactive group of the latent fluorophores, is fulfilling the 
requirements for biomolecular imaging applications:  
1) The changes of the fluorescence intensity should be significantly increased upon 
reaction with the enzyme,  
2) The bioprobe needs to be stable under physiological conditions,  
3) The enzyme-domino reaction has to be efficient due to release the fluorophore.  
The choice of the fluorophore used in the project was influenced by many factors and 
as in vitro and in vivo applications involve the use of fluorescent compounds exhibiting 
a significant emission in the range 450−750 nm (650−750 nm for in vivo). It was 
decided to work with  7-amino-4-methylcoumarin (AMC), since this fluorescent 
compound shows large decrease in  fluorescence intensity once attached to an 
electron withdrawing group, is soluble in water as well as in organic media, is 
commercially available, and easy to handle in organic chemical reactions.16  
 
3.2. Results and discussion 
The methodology towards a preparation of the target molecule is presented as a 
retrosynthetic route in Scheme 86. The first step will involve the synthesis of starting 
materials which are 7-amino-4-methylcoumarin itself 102, the tricarbonyliron complex 
derivative, and finally the introduction of the self-immolative spacer PABA. Afterwards 
the simple nucleophilic addition to get fluorescent derivative 271 followed by 
incorporation of carbonyl group in the molecule 279 which can possibly react with 
PABA derivative to reach a target bioprobe 268 (Scheme 86). 
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Scheme 86 Retrosynthetic route towards the preparation of desired bioprobe 268. 
 
3.2.1. Preparation of 7-amino-4-methylcoumarin 
Synthesis of the fluorescence reporting group 268 was investigated starting from the 
commercially available 3-aminophenol 101 by Pechmann condensation17 at reflux with 
ethyl acetoacetate in the presence of BiCl3 as depicted in Scheme 87. Under these 
reaction conditions, the desired fluorophore 102 was obtained in 26% yield. The work 
up gave much trouble as the crude product was sticky and insoluble in most organic 
solvents and multicomplex products were formed.  
 
 
Scheme 87 Pechmann condensation to obtain fluorophore 102. 
In order to improve the yield and overcome the difficulties with the work up to isolate 
fluorophore 102, after further literature investigation,18 it was decided to protect the 
amino group on the 3-aminophenol 101 by reaction with ethyl chloroformate in diethyl 
ether to obtain 3-hydroxyphenylurethane 281 (54%), Scheme 88. The reaction mixture 
was stirred for 2 hours at room temperature before being quenched.  
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Scheme 88 Protection of 3-aminophenol 101. 
Afterwards, the addition of ethyl acetoacetate in sulphuric acid to get the protected 
coumarin derivative 282 in good yield (76%) was followed by the acidic deprotection of 
282 which was performed by using the mixture of sulphuric acid and acetic acid at 
reflux for 4 hours to afford the target molecule 102 in 99% yield, Scheme 89. 
 
Scheme 89 Improved synthetic route to obtain fluorophore 102. 
 
3.2.2. Preparation of tricarbonyl complex and its cation 
The target tricarbonyliron complexes were prepared based on the procedures 
reported by Birch19 and improved by Pearson et al.20  The synthesis of tricarbonyl(ɳ4-
cyclohexa-1,3-dienecarboxylic acid methyl ester)iron 283 was isolated in good yield 
(65%) after reaction with diironnonacarbonyl in dry THF at reflux as shown in Scheme 
90.   
 
 
Scheme 90 Preparation of tricarbonyl iron complex 283. 
To evaluate the possibility of improved procedures, the complexation of the simple 
1,3-cyclohexadiene 19 with various iron reagents using the typical reaction conditions 
found in the literature  was also examined, Table 11. The 1,3-cyclohexadiene 19 and 
143 
 
iron pentacarbonyl (FeCO5) and diironnonacarbonyl (Fe2CO9) in various solvents were 
heated at reflux for different amounts of time. Unfortunately, it was not possible to 
synthesise tricarbonyl(ɳ4-cyclohexa-1,3-diene)iron 21 in better yield than 30%. The 
results are reported in Table 11. 
 
 
Scheme 91 Complexation of 1,3-cycloheadiene 19 with various iron reagents to get desired 21. 
 
Table 11 Yields and different reaction conditions applied to Scheme 91. 
 
 
In order to improve the reaction conditions for the iron complexation to occur in 
synthetically useful yields, the application of ligand exchange reagents 287a and 287b 
was investigated. Following chemistry of Pearson group,21 the first attempt was made 
using an equimolar mixture of trans-cinnamaldehyde 284 and suitable amine 285a or 
285b in the presence of molecular sieves in dry DCM. The reaction was carried out 
overnight before solvent was removed and the products were isolated in excellent 
yields (Table 12, Scheme 92). 
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Scheme 92 Preparation of compounds 286a-b. 
 
Table 12 Yields applied for Scheme 92. 
 
 
Furthermore, these compounds 286a and 286b can be converted into ligands 
exchange reagents by iron complexation by using sonication of diirononacarbonyl in 
dry THF. This transformation also occurs in high yield as reported in Table 13, Scheme 
93.21 
 
 
Scheme 93 Preparation of ligands exchange 287a-b. 
 
Table 13 Yields applied for Scheme 93. 
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These two ligand exchange complexes 287a and 287b were used in the next step by 
addition of 1,3-cyclohexadiene 19 and at reflux in dry THF. The reaction mixture was 
refluxed for 1.5 hours before being quenched. The advantage of this reaction is that 
the azabuta-1,3-diene 286a or 286b, Scheme 94 can be recovered and reused to 
prepare new batches of the ligand exchange complexes. The results for this reaction 
are shown in Table 14. 
 
 
Scheme 94 Reaction with ligands exchange 287a-b affording compound 21. 
 
Table 14 Yields applied for Scheme 94. 
 
As was reported by Pearson group,21 the yield was increasingly improved in 
comparison with previous methods but it was not possible to obtain the same yield as 
in the literature. 
Next, inspired by the Pauson group’s example,22 which describes the preparation of 
the iron complex derivatives by using silica and without any solvent, we developed 
access to tricarbonyliron complexes. The desired tricarbonyl(ɳ4-cyclohexa-1,3-
diene)iron complex 21 was obtained in the best 78% yield through the reaction of the 
starting 1,3-cyclohexadiene 19 with silica gel in the presence of diironnonacarbonyl by 
gentle heating in a sonic bath, Scheme 95. 
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Scheme 95 Preparation of tricarbonyliron complex 21. 
 
For the next step, following the classic23 method, the desired tricarbonyl(ɳ5-cyclohexa-
1,3-dienylium)iron hexafluorophosphate product 48 was obtained in a good 97% yield 
by hydride abstraction from the starting tricarbonyliron complex 21 with 
triphenylcarbenium hexafluorophosphate in dry DCM. The reaction mixture was stirred 
for 1 hour before being quenched to obtain product 48 (Scheme 96) as yellow crystals.  
 
 
Scheme 96 Preparation of salt 48. 
 
3.2.3. Preparation of the core of the molecule 
The new fluorescent compound (±)-271 was prepared by reaction of electrophilic 
cation 48 with 7-amino-4-methylcoumarin 102 in dry DCM in the presence of 
dimethylaminomethyl-polystyrene in modest 46% yield (Scheme 97).  
 
Scheme 97 Preparation of fluorescent compound (±)-271. 
The fluorescence properties of the new tricarbonyliron complex (±)-271 were studied. 
The absorption spectrum in DMSO at 25°C indicates the absorbance maximum at 350 
nm and emission at 446 nm (Figure 48) and, from a series of measurements at 
different concentrations, a quantum yield of 58% was calculated for compound  
(±)-271. 
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Figure 48 The excitation (350 nm) and emission (446 nm) spectra for compound (±)-271. 
 
Satisfyingly, although most of the fluorophores can display fluorescence quenching in 
the presence of organometallic species24, it was noted that (±)-271 showed almost the 
same fluorescent properties as the 7-aminocoumarin itself. In order to further exploit 
this methodology, the scope and limitation of this reaction was investigated. The same 
reaction conditions were used for different types of aminocoumarins (commercially 
available). The results of this reaction are shown in Table 15. 
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Table 15 Yields for fluorescent dyes (±)-288-292 by using different substrates. 
 
The preparation of compound (±)-288 was of particular importance because it should 
have an enhanced quantum yield and red shift in the emission spectrum. For 
compound (±)-289, an increase in solubility was expected once the ester has been 
cleaved to a carboxylic acid. Furthermore, (±)-291 can potentially be used as a scaffold 
for the extension of conjugation through the amine in the position 3. All of these 
expectations are under current investigations within our group. 
Noteworthy, as for the nitro compound (±)-290, the application of this methodology to 
7-hydroxy-4-methylcoumarine 293 failed to give the expected compound (±)-294, 
Scheme 98. 
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Scheme 98 Unsuccessful application of previous methodology to 7-hydroxy-4-methylcoumarine 293. 
 
This failure was assigned to the greater fragility of the 7-hydroxycoumarin moiety 293 
(as compared to 7-aminocoumarin moiety 102) in presence of amines (both through 
base-mediated lactone ring opening, and 1-4 addition on the alpha-beta unsaturated 
ester moiety). In order to modify this methodology for the synthesis of 7-hydroxy-4-
methylcoumarin derivatives, the effects of changing the supported base was 
evaluated. For this purpose, 7-hydroxy-4-methylcoumarin 293 was reacted with cation 
48 by using potassium carbonate in dry DCM to achieve the target molecule (±)-294 in 
great yield (81%) (Scheme 99). 
 
 
Scheme 99 Preparation of fluorescent compound (±)-294. 
 
The further exploitations of these reaction conditions were investigated. As previously, 
using different types of 7-hydroxycoumarin (which were commercially available) under 
the same reaction conditions, gave the results shown in Table 16.  
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Table 16 Yields for fluorescent dyes (±)-295-297 by using different substrates. 
 
 
Although the reaction gave (±)-295 in satisfactory yield, this reaction fate seems to be 
very sensitive as far as the substrate is concerned since (±)-297 and (±)-294 only differ 
by a single additional methyl group.  
Finally the investigation of an alternative synthesis towards the series of 7-
aminocoumarine derivative 299 which will contain the tricarbonyliron moiety in 
position 4, since these “carbon-linked” structures might be more robust in 
physiological conditions that the heteroatom-linked alternatives described above, 
where, particularly in the oxygen-linked series the C-O bond next to the diene complex 
would be labile under acidic conditions. For this purpose, the construction of the 
aminocoumarin moiety directly starting from already obtained iron complex  283 was 
envisaged, and then using a Claisen condensation to give the beta keto ester 298, 
required for the Pechmann condensation, which would be followed by addition of 3-
aminophenol as depicted Scheme 100.  
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Scheme 100 Synthetic route towards new fluorescent compound 299. 
However, starting from the previously prepared cyclohexa-1,3-dienecarboxylic acid 
methyl ester 233, problems were encountered with the proposed Claisen step25 when 
addition of ethyl acetate in the presence of different bases was investigated. The 
different bases were assayed for this reaction. The base was added at 0°C to the ethyl 
acetate/233 reaction mixture in dry THF. The reaction was stirred at room 
temperature for three hours before being quenched. Under these reaction conditions 
the desired compound 300 was not obtained, whichever base was used (Table 17, 
Scheme 101). 
 
Scheme 101 Preparation of compound 300. 
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Table 17 Yields applied for Scheme 89. 
 
 
After these unsuccessful attempts, the previously prepared tricarbonyl(cyclohexa-1,3-
dienecarboxylic acid methyl ester)iron complex 283 was used under the same reaction 
conditions. Again, the desired product 298 was not formed under the conditions listed 
in Table 18, Scheme 102. 
 
Scheme 102 Unsuccessful attempt to obtain compound 298. 
 
Table 18 Yields applied for Scheme 102. 
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At this stage in the project, with the oxygen-linked and nitrogen-linked structures 
available, the preparation of the linker and fluorophore building blocks were 
performed. This allowed time to make an initial study of the assembly of the first 
generation of tricarbonyliron-containing self-immolative linker-based biosensors, to 
permit their initial evaluation with their target enzyme systems. Successful results in 
that part of the project would then justify renewed efforts with the more stable 
carbon-linked structures, which, because of improved stability, might prove more 
practical in real applications. 
 
3.2.4. Preparation of PABA linker 
In order to prepare the self-immolative spacer phenylacetamide 304, firstly the 
phenylacetyl chloride 303 was synthesised, by treatment of phenyl acetic acid 301 with 
oxalyl chloride in dry DCM with catalytic DMF, at 0o C.26 The reaction mixture was 
stirred for 3 hours before being quenched. The phenylacetyl chloride 303 was used 
directly in the next step of the synthesis in a reaction with p-aminobenzyl alcohol 
(PABA) 302 in the presence of pyridine in a mixture of dry DCM and DMF to obtain in 
good yield (90%) the expected product 304 (Scheme 103). 
 
 
Scheme 103 Preparation of PABA derivative 304. 
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3.2.5. Preparation of target molecule (±)-268 
Despite the unsolved difficulties with the Claisen route to the carbon-linked 4-
substituted series of regioisomers, with the nitrogen- and oxygen-linked 
tricarbonyliron-containing coumarins in hand (see Tables 15 and 16), and with all the 
other main parts needed to construct the target molecule now available, the 
investigation of the synthesis of the proposed novel pro-fluorescent bioprobes was 
performed. Two routes were investigated for this purpose. As a first attempt, it was 
decided to use the N,N'-carbonyldiimidazole - CDI27 305 with previously prepared  
(±)-tricarbonyl[7-(cyclohexa-2,4-dien-1-ylamino)-4-methyl-2H-chromen-2-one]iron 271 
in dry DCM, in the presence of 5% of DMAP and pyridine, or triethylamine, but this 
failed to give compound (±)-268. The replacement of CDI 305 by N,N’-disuccinimidyl  
carbonate - DSC28 307 shown in Scheme 104 also did not allow to synthesise the 
carbamate (±)-268. This failure was assigned to the low nucleophile character of the 
aniline combined with the further electronic effect of the iron tricarbonyl complex. 
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Scheme 104 Synthetic route towards target compound (±)-268. 
 
 
It was decided to use a more electrophilic counterpart, namely phosgene, although 
this reactant displays high toxicity. The last attempt for this route included the use of 
(±)-tricarbonyl[7-(cyclohexa-2,4-dien-1-ylamino)-4-methyl-2H-chromen-2-one]iron 271 
in dry toluene followed by addition of phosgene solution (20%) in the presence of 
triethylamine as a supporting base.29 The reaction mixture was stirred for 3 hours at 
room temperature. Afterwards, phenylacetamide 304 in dry toluene was added to the 
reaction mixture. Unfortunately this methodology, as in the previous attempts, failed 
to give desired target molecule (±)-268, Scheme 105. This procedure, when applied to 
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the substrate, led to mixture of compounds, which could not be identified. Similarly, 
the reaction failed to proceed when using reflux or longer reaction times.  
 
 
Scheme 105 Unsuccessful route towards the preparation of target molecule (±)-268 using phosgene. 
 
It was therefore decided to investigate an alternative route, featuring the reaction of 
PABA derivatives with different reagents as a first step. Utilisation of the N,N'-
carbonyldiimidazole - CDI 305 in dry DCM, in the presence of 5% of DMAP and 
pyridine, or triethylamine failed to give compound 310. Afterwards, the use of CDI 305 
by N,N’-disuccinimidyl carbonate - DSC 307 was checked but this also did not allow the 
synthesis of the carbamate (±)-268 (Scheme 106). 
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Scheme 106 Unsuccessful route towards the preparation of target molecule (±)-268 using CDI 305 and 
DSC 307. 
 
In the last attempt, phenylacetamide 304 was used in the presence of triethylamine as 
a base follow by addition of 20% phosgene solution in dry toluene at 0 oC, Scheme 107. 
The reaction mixture was stirred for 4 hours before being quenched. Afterwards, the  
(±)-tricarbonyl[7-(cyclohexa-2,4-dien-1-ylamino)-4-methyl-2H-chromen-2-one]iron 271 
in dry toluene was added and the reaction mixture was stirred additional 3 hours at 
room temperature. As previously, the reaction failed to proceed when varying the 
supporting bases or upon reflux or even longer reaction time. 
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Scheme 107 Alternative attempted route towards the preparation of target molecule (±)-268. 
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3.3. Conclusion 
Despite the fact that it was not possible to achieve, in the time available, the synthesis 
of the final target molecules, the work described in this section of the thesis has 
further extended the definition of the scope and limitations of the commonly used 
tricarbonyliron chemistry when challenged by the demands of real target molecule 
synthesis. The novel intended applications of the target molecules as bioprobes mean 
that previously unexplored functionality (boronates in project 1, and now coumarins in 
project 2) are included in the targets, which in earlier typical cases where the 
tricarbonyliron methodology has been employed, have focused on natural product 
targets (e.g. terpenes30, alkaloids31 in the cyclohexadienyliron series, and HETEs32 in 
the case of acyclic complexes). Despite the difficulties described above, in the early 
stage of the organoiron route, successful development of an alternative method of 
preparation of these complexes was achieved, which can now be applied in future 
synthetic work. Turning to coumarin chemistry, the reactivity of the well-known 
electrophilic cyclohexadienyliron complexes was checked by the reaction with 7-
amino-4-methylcoumarin 102 to obtain a new fluorescent compound (±)-271. The 
methodology has been successfully applied to the preparation of novel series of 
fluorescent compounds (±)-288, (±)-291, (±)-292, (±)-294, (±)-295, which could be 
regarded as valuable precursors in prodrug applications. The confirmation of the 
retained fluorescent properties of one of these novel organometallic derivatives is 
itself an important achievement, providing the information needed to plan their 
application in further examples of bioprobe-based procedures. 
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CHAPTER 4: 
Experimental Part 
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4.1. General Methods 
Chemicals of reagent grade were used as purchased unless stated otherwise. When 
mentioned as distilled, THF, Et2O, and DME were freshly distilled from sodium 
benzophenone ketyl. DCM and acetonitrile were distilled from calcium hydride. 
Toluene was distilled from sodium. All non-aqueous reactions were carried out under 
oxygen-free nitrogen or argon using flame-dried glassware. Flash column 
chromatography was carried out using Davisil LC60A 40-63 micron silica (amorphous 
silicon dioxide). Thin layer chromatography was carried out using commercially 
available Macherey-Nagel pre-coated TLCsheets (ALUGRAM® SIL G/UV254 silica 
plates). Proton and carbon NMR spectra were recorded on a Varian UNITYplus 400 
MHz spectrometer with a 5 mm Inverse detect broad band z-gradient probe, a Bruker 
Avance III nanobay 400 MHz spectrometer with a 5 mm broad band observe BBFOplus 
probe fitted with an actively shielded z-gradient coil and Bruker Avance III 500 MHz 
spectrometer with a 5 mm broad band observe BBFOplus smart probeTM fitted with 
an actively shielded z-gradient coil (500 MHz). NMR signals were measured using the 
residual non-deuteriated NMR solvent signal as a reference (for 1H NMR, CDCl3 at 7.27 
ppm DMSO-d6 at 2.50 ppm, CD3CN at 1.94 ppm, and CD3OD at 3.31 ppm). For 
13C NMR, 
the signals of CDCl3 at 77.0 ppm, DMSO-d6 at 39.51 ppm, CD3CN at 118.26 ppm, and 
CD3OD at 49.00 ppm were used. Melting points were measured on a Buchi melting 
point B-545 apparatus. Infra-red spectra were recorded on a Perkin Elmer Spectrum 
100 FT-IR spectrometer. The specific rotations were measured on an ADP 440 
polarimeter from Bellingham + Stanley, and were measured in DCM at 15 mg mL–1 
unless otherwise stated. Chemical ionisation and high resolution mass spectra were 
measured at the EPSRC Mass Spectrometry Centre at the University of Wales, 
Swansea. 
Protocol for handling and storage of Diironnonacarbonyl and Pentacarbonyliron: 
• Diironnonacarbonyl and pentacarbonyliron  must be stored under inert gas at -
4°C in the freezer at all times. Incorrect storage results in decomposition to produce 
finely divided black particles of pyrophoric iron. 
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• Before use, the diironnonacarbonyl  or pentacarbonyliron should be left in the 
fume hood for about 15-20 minutes before opening the container it is stored in, to 
allow the contents to come to room temperature. 
• All handling of diironnonacarbonyl or pentacarbonyliron must take place in the 
fume hood. It must be weighed out on a balance under a blanket of argon in the fume 
hood. (Use an inverted funnel attached to an argon line) 
• All glassware etc. that will come in contact with the diironnonacarbonyl or 
pentacarbonyliron should be pre-dried in an oven and then cooled in a dessicator. 
• All spillages must immediately be cleaned up using acetone and all utensils 
used must be rinsed with acetone also. If pyrophoric iron develops and it starts to 
produce smoke, 1 M aqueous HCl should be used to quench the reacting iron. 
• Once opened, the diironnonacarbonyl or  pentacarbonyliron must be sealed 
under nitrogen or argon before being returned to the freezer. 
Protocol for Removal and Treatment of Pyrophoric Iron, Iron Pentacarbonyl and 
Triirondodecarbonyl, Side Products Formed During Reaction: 
• A short silica gel gravity column is performed to remove any pyrophoric iron 
from the reaction mixture. The silica used should then be quenched using dilute HCl 
and water. When safe to do so (when sufficiently diluted with water), the dilute acid 
solution that elutes from the column can be disposed of down the sink in the fume 
hood.  
• Any iron pentacarbonyl formed at the end of reaction (isolated as yellow liquid 
in rotary evaporator trap) should be treated with the utmost care. The iron 
pentacarbonyl is quenched using household bleach or bromine water (prepared by 
shaking bromine (3g) with water (100 cm3) until a homogeneous solution is obtained) 
and is also disposed of down the sink when safe to do so (when sufficiently diluted 
with water). All glassware used is rinsed with household bleach. 
• The triiron dodecarbonyl formed is a green coloured material, which is 
separated from the product on the second silica (flash chromatography) column. This 
is treated with a dilute basic solution (e.g. sodium hydroxide solution) to adjust the pH 
of the triiron dodecacarbonyl to pH 10-11 and is then treated with bleach. This is done 
slowly in order to control the temperature. The resulting solution is left to stand 
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overnight. The solution is then adjusted to pH 7 by slow addition of dilute HCl and 
disposed of down the sink in the fume hood. 
 
(3-Methoxycarbonylallyl)-triphenylphosphonium bromide (232)1 
 
 
Chemical Formula: C23H22BrO2P 
Molecular Weight: 441.2973 g/mol 
 
Methyl-4-bromocrotonate (2.24 mL, 19.1 mmol) was added dropwise to a solution of 
triphenylphosphine (5.01 g, 19.1 mmol) in dry toluene (20 mL). After stirring for 2 days 
at room temperature, the precipitate was removed by filtration, washed with toluene 
and finally with petroleum ether to give the expected compound as white crystals 
(8.05 g, 96%). 
1H NMR (200 MHz, CDCl3) δ 8.15 – 7.57 (Ar-H, m, 15H), 6.94 – 6.64 (3-H, m, 1H), 6.52 
(2-H, dd, J = 15.5, 4.8 Hz, 1H), 5.29 (1-H, dd, J = 16.3, 1.2 Hz, 2H), 3.73 (4-H, s, 3H). 
Data in agreement with those previously reported.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
166 
 
Cyclohexa-1,3-dienecarboxylic acid methyl ester (233)1  
 
 
Chemical Formula: C8H10O2 
Molecular Weight: 138.1638 g/mol 
 
Saturated sodium hydrogen carbonate (108 mL) followed by acrolein (0.81 mL, 17.2 
mmol) were added to a mixture of (3-methoxycarbonyl-allyl)-triphenylphosphonium 
bromide (7.62 g, 17.2 mmol) in DCM. The two phase reaction mixture was stirred at 
room temperature for 3 days. After separation of the phases, the organic phase was 
dried over MgSO4, and then concentrated in vacuo. Purification by flash 
chromatography (DCM, Rf = 0.75) gave a colourless oil (1.25 g, 52 %). 
IR (NaCl) v = 1721 (COOMe). 
1H NMR (500 MHz, CDCl3) δ 6.99 (1-H, d, J = 5.4 Hz, 1H), 6.17 – 6.11 (2-H, m, 1H), 6.05 
(3-H, ddt, J = 9.3, 5.4, 1.8 Hz, 1H), 3.75 (6-H, br. s, 3H), 2.50 – 2.40 (5-H,m, 2H), 2.31 – 
2.22 (4-H, m, 2H). 
13C NMR (126 MHz, CDCl3) δ 168.06, 133.62, 133.36, 127.23, 124.07, 51.70, 22.97, 
20.88. 
Data in agreement with those previously reported.1 
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Cyclohexa-1,3-dienecarboxylic  Acid (234)1  
 
 
Chemical Formula: C7H8O2 
Molecular Weight: 124.1372 g/mol 
 
To a solution of cyclohexa-1,3-dienecarboxylic acid methyl ester (2.04 g, 14.5 mmol) in 
MeOH (20 mL), NaOH(aq) was added in two portions (1M, 2x20 mL). After stirring for 3 
h, the aqueous phase was washed once with petroleum ether (25 mL), acidified with 
concentrated aqueous HCl, and extracted with DCM (5 x 50 mL). The organic phase 
was dried over MgSO4, filtered and concentrated by rotary evaporation. The residue 
was purified by flash chromatography (petroleum ether/ EtOAc/AcOH [79:20:1]) to 
afford the expected compound as white crystals (1.05 g, 59 %). 
1H NMR (500 MHz, CDCl3) δ 7.14 (1-H, d, J = 5.4 Hz, 1H), 6.27 – 6.16 (2-H, m, 1H), 6.09 
(3-H, ddt, J = 9.3, 5.4, 1.9 Hz, 1H), 2.52 – 2.40 (5-H, m, 2H), 2.37 – 2.25 (4-H, m, 2H). 
13C NMR (126 MHz, CDCl3) δ 172.96, 135.66, 134.92, 126.52, 124.10, 23.01, 20.39. 
Data in agreement with those previously reported.1 
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Tricarbonyl(ɳ4-cyclohexa-1,3-dienecarboxylic acid)iron(235)1  
 
 
Chemical Formula: C10H8FeO5 
Molecular Weight: 264.0125 g/mol 
 
To a slurry of diironnonacarbonyl (10.0 g, 27.5 mmol) in dry THF (15 mL) was added a 
solution of cyclohexa-1,3-dienecarboxylic  acid (1.51 g, 11.9 mmol) in dry THF (5 mL). 
The reaction mixture was flushed with argon and stirred at reflux under argon for 5 h. 
After filtration of the mixture through a short pad of Celite, the solvent was removed 
in vacuo. (Caution! Pentacarbonyliron is extremely toxic by inhalation). Gradient 
chromatography column using a stepwise gradient of petroleum ether/EtOAc [80:20], 
and petroleum ether/ EtOAc/AcOH [79:20:1] afforded 1.81 g of yellow crystals (59 %).  
IR (NaCl) ν =2055 (C≡O symmetric), 1980 (C≡O asymmetric), 1660 (C=O). 
1H NMR (500 MHz, CDCl3) δ 6.07 (1-H, br. s, 1H), 5.39 (2-H, br. s, 1H), 3.42 (3-H, br. s, 
1H), 2.33 – 2.07 (4-H, m, 1H), 2.06 – 1.86 (4-H, m, 1H), 1.80 – 1.55 (5-H, m, 1H), 1.52 – 
1.32 (5-H, m, 1H). 
Data in agreement with those previously reported.1 
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General procedures for the preparation of tricarbonyliron complexes of amide 
derivatives 
Method A (reaction with Et3N)
2  
The appropriate carboxylic acid (0.31 g, 1.14 mmol) was dissolved in dry DCM (15 mL) 
under argon. Two equivalents of oxalyl chloride (0.20 ml, 2.27 mmol) followed by a 
catalytic amount of DMF were added and reaction mixture was stirred for 2h at room 
temperature. The solvent was removed in vacuo with a rotary evaporator (bath 
temperature 30 °C). The yellow oil was dried under high vacuum (6 mmHg) for 10 
minutes, and then was dissolved in dry DCM (15 mL). Triethylamine (0.40 mL, 2.84 
mmol, 2.5 equiv.) and the appropriate amine (2.47 mmol, 2.2 equiv.) were added and 
the reaction mixture was stirred at room temperature for 3-6 h (reaction monitored by 
TLC) to give the desired amides after flash chromatography on silica gel (Et2O/hexane 
[3:1]). 
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Tricarbonyl[ɳ4-cyclohexa-1,3-dien-1-yl(pyrrolidin-1-yl)methanone]iron (241a) 
 
 
Chemical Formula: C14H15FeNO4 
Molecular Weight: 317.1182 g/mol 
 
Flash chromatography (Et2O/hexane [3:1], Rf = 0.27) gave 0.30 g, 81% of a yellowish 
powder.  
M.p. 100-103 °C. 
IR (NaCl) v = 2043 (C≡O symmetric), 1964 (C≡O asymmetric), 1606 (C=O).  
1H NMR (500 MHz, CDCl3) δ 6.16 (1-H, d, J = 4.0 Hz), 5.39 – 5.34 (2-H, dist. dd, J = 6.7, 
4.0 Hz 1H), 3.82 (3-H, br. s, 1H), 3.63 – 3.35 (6-H, 7-H, m, 4H), 2.03 – 1.85 (8-H, 9-H, 4-
H, m, 4H), 1.81 – 1.69 (5-H, m, 2H), 1.54 – 1.38 (4-H, m, 1H). 
13C NMR (126 MHz, CDCl3) δ 171.53, 85.91, 85.87, 71.79, 64.33, 48.20 (br.), 47.39, 
27.06, 25.94, 23.89, 23.13.  
HRMS [APCI] for [M-] C14H14FeNO4 requires 316.0474, found 316.0470.  
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Tricarbonyl[ɳ4-(R)-methyl-1-(cyclohexa-1,3-dienecarbonyl)pyrrolidine-2-carboxylate] 
iron (241b) 
 
 
 
Chemical Formula: C16H17FeNO6 
Molecular Weight: 375.1543 g/mol 
 
Flash chromatography (Et2O/hexane [3:1], Rf = 0.2) gave 0.29 g, 67% of a brown oil,  
[α] D
24 = + 89 (0.0012, DCM) consisting of two diastereoisomers, as evidenced by peak 
doubling in the 1H- and 13C- NMR spectra below. 
IR (NaCl) v = 2045 (C≡O symmetric), 1966 (C≡O asymmetric), 1744 (ester C=O ), 1610 
(amide C=O ). 
1H NMR (500 MHz, CDCl3) δ 6.13 (1-H, d, J = 4.5 Hz, 1H), 6.12 (1-H, d, J = 4.5 Hz, 1H), 
5.37 (2-H, dd, J = 5.9, 4.5 Hz, 1H), 5.32 (2-H, dd, J = 5.9, 4.5 Hz, 1H), 4.51 (7-H, t, J = 7.8 
Hz, 1H), 4.45 – 4.34 (7-H, br. m, 1H), 3.99 – 3.87 (9-H, 2 overlapping m, 1H), 3.71 (10-H, 
s, 3H), 3.64 (10-H, s, 3H), 3.68 – 3.57 (9-H, 2 overlapping m, 1H), 3.44 (3-H, d, J = 5.9 Hz, 
1H), 3.38 (3-H, d, J = 5.9Hz, 1H), 2.33 – 1.69 (4-H, 5-H, 6-H, 8-H, m, 7H), 1.56 – 1.48 (4-
H, 5-H, m, 1H), 1.49 – 1.39 (4-H, 5-H, m, 1H). 
13C NMR (126 MHz, CDCl3) δ 173.04, 172.97, 171.92, 171.83, 86.37, 86.15, 85.66, 
85.44, 70.18, 69.80, 64.70, 63.75, 60.69, 60.14, 52.26, 52.09, 48.73, 48.43, 28.85, 
28.72, 26.33, 26.00, 25.40, 25.38, 23.02, 22.92. 
HRMS [ASAP oil] for [M+] C16H17FeNO6 requires 376.0478, found 376.0479. 
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Tricarbonyl[ɳ4-(cyclohexa-1,3-dienyl)-morpholin-4-yl-methanone]iron (241c)3 
 
 
Chemical Formula: C14H15FeNO5 
Molecular Weight: 333.1176 g/mol 
 
Flash chromatography (Et2O/hexane, [3:1], Rf = 0.14) gave 0.36 g, 92% of a yellow solid.  
M.p. 139-141 °C. 
 IR (NaCl) v = 2043 (C≡O symmetric), 1964 (C≡O asymmetric), 1606 (C=O), 1409 (C=C), 
1113 (C-N).  
1H NMR (500 MHz, CDCl3) δ 6.13 (1-H, d, J = 4.0 Hz, 1H), 5.33 (2-H, dist. dd, J = 6.8, 4.0 
Hz 1H), 3.84 - 3.51 (6-H, 7-H, 8-H, 9-H, m, 8H), 3.50 – 3.44 (3-H, m, 1H), 1.99  
(4-H, dddd, J = 15.5, 11.5, 5.3, 3.0 Hz, 1H), 1.83 (5-H, dd, J = 13.7, 8.0 Hz, 1H), 1.76 (5-H, 
dd, J = 13.7, 11.5 Hz, 1H), 1.45 (4-H, dddd, J = 15.5, 8.0, 5.3, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 171.99, 86.20, 85.54, 68.96, 66.85, 65.15, 45.32 (br.), 
27.13, 23.56.  
HRMS [+pNSI] for [M+] C14H15FeNO5 requires 334.0372, found 334.0372.  
Data in agreement with those previously reported.3 
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Tricarbonyl[ɳ4-cyclohexa-1,3-dien-1-yl(piperidin-1-yl)methanone]iron (241d) 
 
 
Chemical Formula: C15H17FeNO4 
Molecular Weight: 331.1448 g/mol 
 
Flash chromatography (Et2O/hexane [3:1], Rf =0.43) gave 0.29 g, 75 % of yellow solid. 
M.p. 89-91 °C.  
IR (NaCl) ν =2044 (C≡O symmetric), 1965 (C≡O asymmetric), 1614 (C=O), 1429 (C=C), 
1258 (C-N). 
1H NMR (500 MHz, CDCl3) δ  6.11 (1-H, d, J = 4.2 Hz, 1H), 5.29 (2-H, dist. dd, J = 6.4, 4.2 
Hz, 1H), 3.78 – 3.46 (6-H, 7-H, m, 4H), 3.46 – 3.39 (3-H, m, 1H), 1.99 (4-H, dddd, J = 
15.6, 11.2, 5.6, 3.1 Hz, 1H), 1.83 (5-H, dd, J = 14.0, 8.0 Hz, 1H), 1.81 – 1.76 (5-H, br. m, 
1H), 1.73 – 1.50 (8-H, 9-H, 10-H, m, 7H), 1.43 (4-H, dddd, J = 15.6, 8.0, 5.5, 4.0 Hz, 1H). 
13CNMR (126MHz, CDCl3) δ 171.51, 85.74, 85.58, 70.44, 64.78, 46.23 (br.), 27.14, 
26.00, 24.68, 23.77. 
 HRMS [ASAP] for [M+] C15H17FeNO4 requires 332.0580, found 332.0582.  
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Tricarbonyl[ɳ4-cyclohexa-1,3-dien-1-yl(4-methylpiperazin-1-yl)methanone]iron 
(241e) 
 
 
Chemical Formula: C15H18FeN2O4 
Molecular Weight: 346.1594 g/mol 
 
Flash chromatography (Et2O/hexane 3:1, Rf = 0.43) gave 0.51 g, 74 % of yellow solid, 
 M.p. 101-103 °C.  
IR (NaCl) ν =2050 (C≡O symmetric), 1971 (C≡O asymmetric), 1624 (C=O), 1461, 1421 
(C=C), 1263 (C-N).  
1H NMR (500 MHz, CDCl3) δ 6.12 (1-H, d, J = 4.1 Hz, 1H), 5.30 (2-H, dist. dd, J = 6.2, 4.1 
Hz, 1H), 3.97 – 3.49 (6-H, 7-H, m, 4H), 3.47 – 3.44 (3-H, m, 1H), 2.42 (8-H, 9-H, br. s, 
4H), 2.31 (10-H, s, 3H), 1.99 (4-H, dddd, J = 15.0, 11.4, 5.5, 3.0 Hz, 1H), 1.82 – 1.81 (5-H, 
dd, J = 13.7, 8.0 Hz, 1H), 1.79 (5-H, dd, J = 13.7, 11.4 Hz, 1H), 1.47 – 1.42 (4-H, m, 1H). 
13C NMR (126 MHz, CDCl3) δ 171.71, 85.98, 85.61, 69.52, 64.98, 54.94, 46.18, 30.45, 
27.19, 23.64.  
HRMS [+pNSI] for [M+] C15H18FeN2O4 requires 347.0689, found 347.0687.  
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Tricarbonyl[ɳ4-cyclohexa-1,3-dien-1-yl(thiazolidin-3-yl)methanone]iron (241f) 
 
 
Chemical Formula: C13H13FeNO4S 
Molecular Weight: 335.1566 g/mol 
 
Flash chromatography (Et2O: hexane [3:1], Rf = 0.1) gave 0.21 g, 55 % of yellow solid. 
M.p. 93-95 °C. 
IR (NaCl) ν = 2050 (C≡O symmetric), 1979 (C≡O asymmetric), 1624 (C=O), 1404, 1369 
(C=C), 1263 (C-N).  
1H NMR (500 MHz, CDCl3) δ 6.11 (1-H, d, J = 4.2 Hz, 1H), 5.34 (2-H, dist. dd, J = 6.5, 4.2 
Hz, 1H), 4.18 (7-H, s, 2H), 3.54 – 3.39 (3-H, m, 1H), 3.13 (8-H or 6-H, t, J = 6.4 Hz, 2H), 
2.81 (8-H or 6-H, t, J = 6.4 Hz, 2H), 1.98 (4-H, dddd, J = 15.1, 11.0, 5.8, 3.1 Hz, 1H), 1.83 
(5-H, dd, J = 14.0, 11.0 Hz, 1H), 1.79 (5-H, dd, J = 14.1, 8.0 Hz, 1H), 1.54 – 1.35 (4-H, m, 
1H). 
13C NMR (126 MHz, CDCl3) δ 171.86, 86.29, 85.37, 71.28, 64.88, 58.67, 55.94, 30.07, 
26.62, 23.26. 
HRMS [+pNSI] for [M+] C13H13FeNO4S: requires 335.9991, found 335.9987.  
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Method B (Reaction with NaH)4 
The appropriate carboxylic acid (0.31 g, 1.17 mmol) was dissolved in dry DCM (15 mL) 
under argon. Two equivalents of oxalyl chloride (0.20 mL, 2.35 mmol) were added and 
reaction mixture was stirred for 2 h at room temperature. The solvent was removed 
under vacuum (bath temperature 30°C). The resultant yellow oil was dried under high 
vacuum (6 mmHg) for 10 minutes, and then was dissolved in dry THF. The mixture was 
added to a suspension of sodium hydride (0.07 g, 2.94 mmol, 2.5 equiv.) and the amine 
(0.26 g, 2.68 mmol, 2.2 equiv.) in dry THF. The mixture was stirred at room 
temperature for 3h (reaction was monitored by TLC) to give the desired amide after 
extraction with diethyl ether (3 x 15 mL), followed by flash chromatography on silica 
gel. 
Tricarbonyl[ɳ4-1-(cyclohexa-1,3-dienecarbonyl)pyrrolidine-2,5-dione]iron (241j) 
 
Chemical Formula: C14H11FeNO6 
Molecular Weight: 345.0852 g/mol 
 
Flash chromatography (Et2O: hexane, 3:1, Rf = 0.32) gave 0.37 g, 95 % of yellow solid. 
M.p. 165-167 °C. 
IR (NaCl) v = 2064 (C≡O), 1989 (C≡O), 1725 (C=O), 1696 (C=O), 1335 (C=C), 1257 (C-N).  
1H NMR (500 MHz, CDCl3) δ 6.19 (1-H, d, J = 3.9 Hz, 1H), 5.46 (2-H, dd, J = 6.6, 3.9 Hz, 
1H), 3.51 (3-H, s, 1H), 2.78 (6-H, 7-H, s, 4H), 1.95 (4-H, dddd, J = 15.1, 11.0, 5.7, 3.5 Hz, 
1H), 1.79 (5-H, dd, J = 14.2, 8.5 Hz, 1H), 1.71 (5-H, ddd, J = 14.2, 11.0, 2.5 Hz, 1H), 1.54 
(4-H, dddd, J = 15.1, 8.5, 5.5, 3.3 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 174.55, 173.44, 88.67, 86.94, 66.87, 63.83, 29.16, 26.25, 
22.21.  
HRMS [APCI] for [M+] C14H11FeNO6 requires 346.0009, found 346.0008.  
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Tricarbonyl[ɳ5-5-(morpholine-4-carbonyl)cyclohexa-2,4-dien-1-ylium]iron 
hexafluorophosphate (242c) 
 
 
Chemical Formula: C14H19F6FeNO5P 
Molecular Weight: 482.1135 g/mol 
 
Following the procedure reported by Birch et al.,5 to  a solution of tricarbonyl-
[(cyclohexa-1,3-dienyl)-morpholin-4-yl-methanone]iron (0.54 g, 1.62 mmol) in dry 
DCM (15 mL) was added to a solution of triphenylcarbenium hexafluorophosphate 
(0.75 g, 1.95 mmol, 1.2 equiv.) in dry DCM (15 mL). The reaction mixture was stirred 
for 40 minutes at room temperature and poured into wet Et2O. The resulting yellow 
precipitate was washed twice with Et2O (15 mL) and dried in vacuo to provide 0.35 g of 
yellow crystals in 70 % yield.  
IR (NaCl) v = 2118 (C≡O symmetric), 2063 (C≡O asymmetric), 1634 (C=O), 839 (P-F). 
1H NMR (500 MHz, CD3CN) δ 6.98 (2-H, t, J = 5.2 Hz, 1H), 6.12 (1-H, d, J = 5.2 Hz, 1H) 
5.78 (3-H, dist. dd, J = 5.2, 7.0 Hz, 1H), 4.40 (4-H, dist dd, J = 6.3, 7.0 Hz, 1H), 3.71 – 
3.49 (6-H, 7-H, 8-H or 9-H, m, 6H), 3.24-(8-H or 9-H, m, 2H), 2.22 (5-H, br. s, 1H), 2.18 
(5-H, br. s, 1H). 
13C NMR (126 MHz, CD3CN) δ (C-N inside the morpholine ring is not observed), 165.47, 
102.76, 101.73, 85.96, 81.64, 66.91, 64.28, 27.78. 
HRMS [+pNSI] for [M+] C14H14FeNO5 requires 332.0216, found 332.0217.  
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9-Bromomethylanthracene (249)6 
 
 
Chemical Formula: C15H11Br 
 Molecular Weight: 271.1518 g/mol  
 
Phosphorus tribromide (2.30 g, 8.49 mmol) was added dropwise to the suspension of 
9-hydroxymethylanthracene (1.52 g, 7.29 mmol) in toluene (50 mL). The mixture was 
stirred at room temperature for 1 h until it becomes homogeneous  
and then saturated sodium carbonate solution (15 mL) was added slowly. The organic  
phase was separated and washed with water, brine and dried over magnesium 
sulphate. After filtration, the solvent was removed  in  vacuo and  
compound was purified by flash chromatography column (ether/hexane 1:1) to  
give the title compound as a yellow powder (1.71 g, 88 %);  
M.p.  143-144 °C (lit.6 : 143-146°C). 
1H NMR (500 MHz, CDCl3) δ 8.48 (9-H, s, 1H), 8.30 (8-H, 1-H, d, J = 8.2 Hz, 2H), 8.04 (5-
H, 4-H, d, J = 8.5 Hz, 2H), 7.65 (7-H, 2-H, ddd, J = 8.9, 6.5, 1.3 Hz, 2H), 7.51 (6-H, 3-H, 
ddd, J = 8.2, 6.6, 0.8 Hz, 2H), 5.53 (2-H, s, 2H).  
13C NMR (126 MHz, CDCl3) δ 131.70, 129.83, 129.39, 129.30, 127.98, 126.90, 125.49, 
123.62, 27.09. 
Data in agreement with those previously reported.6 
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9-Azidomethylanthracene (250)6  
 
 
Chemical Formula: C15H11N3 
Molecular Weight: 233.2679 g/mol 
 
To a solution of 9-bromomethylanthracene (1.59 g, 5.86 mmol) in DMSO (62 mL) was 
added in one portion, sodium azide (0.39 g, 5.98 mmol). The reaction mixture was 
stirred for 3.5 h at 65 °C. The mixture was then cooled to room temperature and 
poured into H2O (50 mL) and extracted with EtOAc (3 x 30 mL). The organic phase was 
washed with brine and dried over MgSO4. After filtration, the solvent was evaporated 
in  vacuo to give the expected product (1.02 g, 78 %). 
M.p. 82-83 °C (lit.6 : 80-83°C). 
1H NMR (500 MHz, CDCl3) δ 8.49 (9-H, s, 1H), 8.29 (8-H, 1-H, d, J = 8.9 Hz, 2H), 8.04 (5-
H, 4-H, d, J = 8.4 Hz, 2H), 7.60 (7-H, 2-H, dd, J = 8.3, 6.2 Hz, 1H), 7.51 (6-H, 3-H, dd, J = 
16.6, 9.3 Hz, 1H), 5.30 (10-H, s, 1H). 
13C NMR (126 MHz, CDCl3) δ 131.5, 130.8, 129.4, 129.1, 127.0, 125.9, 125.3, 123.6, 
46.4. 
Data in agreement with those previously reported.6 
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9-aminomethylanthracene (107) 
 
 
Chemical Formula: C15H13N 
Molecular Weight: 207.2704 g/mol 
 
Method A (Staudinger reaction)6  
 
Under a nitrogen atmosphere, 9-azidomethylanthracene (1.01 g, 4.57 mmol) was 
dissolved in anhydrous THF (15 mL). Triphenylphosphine (1.26 g, 4.79 mmol, 1.05 
equiv.) was added at 0 oC. The reaction was removed from the ice bath and stirred at 
room temperature for 2 h before H2O (1.21 g, 14.7 equiv., 67.1 mmol) was added and 
stirred for an additional 2.5 h. The reaction was monitored by TLC, eluting with ethyl 
acetate: hexane (5:1). When the starting material was completely converted into 
product, Et2O (60 mL) was added. The mixture was cooled to  
0 °C, followed by addition of 10% aq. HCl (30 mL). The salt was collected by vacuum 
filtration and dissolved in EtOAc (50 mL), and the solution was cooled to 0 °C. 
Concentrated aqueous ammonia solution NH4OH (40 mL) was added until the pH 
became 12, followed by addition of H2O (50 mL). The organic layer was separated. The 
aqueous layer was again extracted with EtOAc (2 × 30 mL). The combined organic 
phase was washed with brine and dried over MgSO4. After filtration the solvent was 
evaporated in vacuo to afford the crude product as yellow powder which was 
recrystallised from chloroform/hexane to give the title compound as yellow needles 
(0.62 g, 67%). 
 
Method B (reductive amination reaction)7 
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To a solution of 9-anthracenealdehyde (1.01 g, 4.89 mmol, 1 equiv.) in dry DCE (50 ml) 
under nitrogen, was added ammonium chloride (0.65 g, 12.2 mmol, 2.5 equiv.). The 
resulting solution was stirred for 2 h at room temperature, after which, the reducing 
agent (19.6 mmol, 4 equiv.)was added. The reaction mixture was stirred overnight. The 
aqueous layer was extracted with DCM (2 x 30 ml) and the combined organic layers 
were dried over MgSO4 filtered and evaporated. Crude material was then purified by 
silica gel column chromatography (diethyl ether/ hexane [1:1]) affording the desired 
amine. (for yields, See Tables 4, 5, 6 Chapter 2) 
 
Method C (reductive amination with different reagents)  
 
9-Anthracenealdehyde (0.36 g, 1.74 mmol) was dissolved in dry DCE (20 mL), then 3-
aminophenylboronic acid hemisulfate salt (0.32 g, 1.74 mmol) was added and the 
mixture was stirred for 2 h. After that time NaBH4 (0.26 g, 6.96 mmol) was added in 
portions. After stirring overnight at room temperature, the solution was acidified with 
1M HCl, followed by extraction with DCM (3 x 10 mL). The organic phase was dried 
over MgSO4, filtered, and concentrated by rotary evaporation. The residue was 
purified by flash chromatography column (diethyl ether/ hexane [1:1]) to give the 
expected compound as a yellow powder (0.14 g, 25 %).  
M.p. 102-103 °C (lit.6: 101-102°C). 
1H NMR (400 MHz, CDCl3) δ 8.31 (9-H, s, 1H), 8.24 (8-H, 1-H, d, J = 8.7, 2H), 7.95 (5-H, 
4-H, d, J = 8.4,  2H), 7.47 (7-H, 2-H, J = 8.7, 7.9, 1.3, ddd, 2H), 7.39 (6-H, 3-H, ddd, J = 
8.4, 7.9, 1.1, 2H), 4.74 (10-H, s, 2H). 
13C NMR (100 MHz, CDCl3) δ 131.5, 129.5, 129.2, 128.1, 128.0, 127.0, 125.4, 123.7, 
46.5. 
Data in agreement with those previously reported.6 
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(±)-Tricarbonyl{ ɳ4-5-[(anthracen-9-ylmethyl)amino] cyclohexa-1,3-dien-1-
yl)(morpholino)metha-none }iron (260) 
 
 
 
Chemical Formula: C29H26FeN2O5 
Molecular Weight: 538.3721 g/mol 
 
A solution of 9-aminomethylanthracene (0.36 g, 1.74 mmol, 2.2 equiv.) in dry THF (15 
mL) was added dropwise to a mixture of tricarbonyl[5-(morpholine-4-
carbonyl)cyclohexa-2,4-dien-1-ylium}iron hexafluorophosphate (0.19 g, 0.79 mmol) 
and DMAM-PS (0.58 g, loading 3 mmol of base/g) in dry THF (15 mL). The reaction was 
stirred overnight at room temperature and was monitored by FT-IR and TLC. The 
reaction mixture was filtered and the solvent was evaporated under vacuum. The 
yellow solid was purified by column chromatography on silica (eluent Et2O/Hexane 
[1:1]) and the title compound was obtained as a light yellow powder (0.07 g, 15 %, 
Rf = 0.17 for Et2O/Hexane [3:1]). (for yields, See Table 7 Chapter 2) 
M.p. 196-198 °C. 
IR (NaCl) v = 2052 (C≡O symmetric), 1977 (C≡O asymmetric), 1725 (C=O). 
1H NMR (500 MHz, CDCl3) δ 8.46 (15-H, s, 1H), 8.27 (11-H, 19-H,d, J = 8.8 Hz, 2H), 8.01 
(14-H, 16-H, d, J = 8.3 Hz, 2H), 7.54 (18-H, 12-H, ddd, J = 8.8, 6.6, 1.1 Hz, 2H), 7.48 (13-
H, 17-H, dist. dd, J = 8.3, 6.6 Hz, 2H), 6.24 (1-H, d, J = 4.2 Hz, 1H), 5.48 (2-H, dd, J = 6.8, 
4.2 Hz, 1H), 5.45 (diastereotopic 10-H, d, J = 11.1 Hz, 1H), 5.37 (diastereotopic 10-H, d, 
J = 11.1 Hz, 1H), 4.41 (4-H, dm, J = 9.3 Hz, 1H),  3.74 – 3.59 (6-H, 7-H, 8-H, 9-H, m, 6H), 
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3.51 – 3.43 (6-H, 7-H, 3-H, m, 3H), 2.27 (5-H, dd, J = 14.7, 9.3 Hz, 1H), 1.65 (N-H, br. s), 
1.49 (5-H, dd, J = 14.7, 4.4 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 171.43, 131.56, 130.95, 129.26, 128.75, 128.30, 126.51, 
125.14, 124.06, 86.98, 85.76, 66.79, 63.75, 62.59, 61.81, 45.43 (br.), 30.50. 
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General procedure for the synthesis of protected boronic acid derivatives 8 
The appropriate (bromo)- or (amino) phenyl boronic acid derivative (2.33 mmol, 1 
equiv.) and 2,2-dimethyl-1,3-propanediol (2.56 mmol, 1.1 equiv.) in dry toluene (5 mL) 
were stirred overnight. The solvent was removed under reduced pressure and the 
residue was taken up with DCM (30 mL) and extracted with water (3x 10 mL). The 
organic layer was dried over MgSO4 and evaporated to obtain the expected 
compound. 
 
2,2-Dimethylpropane-1,3-diyl (o-(bromomethyl)phenyl)boronate (246)9 
 
 
Chemical Formula: C12H16BBrO2 
Molecular Weight: 282.9692 g/mol 
 
Light yellow oil, 0.47 g 72%,  
IR (NaCl) v = 1599 (aromatic).   
1H NMR (500 MHz, CDCl3) δ 7.72 (4-H, d, J = 7.5 Hz, 1H), 7.31 – 7.25 (2-H, 3-H, m, 2H), 
7.21 – 7.16 (1-H, m, 1H), 4.84 (5-H, s, 2H), 3.72 (6-H, 7-H, s, 4H), 0.98 (8-H, 9-H, s, 6H). 
13C NMR (126 MHz, CDCl3) δ (
13C resonance for aromatic C bonded to B not observed), 
143.69, 135.73, 130.69, 130.35, 127.74, 72.56, 34.65, 31.93, 22.09.  
Data in agreement with those previously reported.9 
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2-[3-(Bromomethyl)phenyl]-5,5-dimethyl-1,3,2-dioxaborinane (247)9  
 
 
Chemical Formula: C12H16BBrO2 
Molecular Weight: 282.9692 g/mol 
 
White solid 0.63 g, 95 %, 
 M.p. 105-108°C  
IR (NaCl) v = 1477 (aromatic)  
1H NMR (500 MHz, CDCl3) δ 7.83 (4-H, s, 1H), 7.74 (3-H, d, J = 7.4 Hz, 1H), 7.49 – 7.45 
(2-H, m, 1H), 7.34 (1-H, t, J = 7.5 Hz, 1H), 4.52 (5-H, s, 2H), 3.78 (6-H, 7-H, s, 4H), 1.03 
(8-H, 9-H, s, 6H). 
13C NMR (126 MHz, CDCl3) δ (
13C resonance for aromatic C bonded to B not observed), 
137.04, 134.55, 134.07, 131.50, 128.24, 72.47, 34.01, 32.03, 22.04.  
Data in agreement with those previously reported.9 
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3-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)aniline (245)10 
 
 
Chemical Formula: C11H16BNO2 
Molecular Weight: 205.0612 g/mol 
 
Grey powder, 0.34 g 72 %,  
IR (NaCl) v = 3443 (-NH2), 3360 (B-O)  
1H NMR (500 MHz, CDCl3) δ 7.25 – 7.20 (1-H, m, 1H), 7.20 – 7.12 (2-H, 3-H, m, 2H), 6.80 
– 6.73 (4-H, m, 1H), 3.76 (5-H, 6-H, s, 4H), 3.62 (bs, 2H), 1.02 (7-H, 8-H, s, 6H). 
 13C NMR (126 MHz, CDCl3) δ (
13C resonance for aromatic C bonded to B not observed), 
145.79, 128.66, 124.24, 120.48, 117.63, 72.37, 31.93, 21.98.  
Data in agreement with those previously reported.10 
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 (R)-2-phenyl-2-(anthracen-9-ylmethylamino)-ethanol (265)11 
 
 
Chemical Formula: C23H21NO 
Molecular Weight: 327.4189 g/mol 
 
To a solution of 9-anthracenecarboxylaldehyde (1.60 g, 7.76 mmol) in dichloroethane 
was added the (R)-2-amino-2-phenyl-ethanol (1.00 g, 7.29 mmol) in dry DCE (10 mL). 
The mixture was refluxed for 6 h. After the mixture had cooled to room temperature, 
NaBH4 (0.51 g, 13.5 mmol) was added slowly, followed by stirring for 4 h at room 
temperature. The solvent was removed under vacuum and the residue taken up with 
DCM and then washed with saturated NaCl solution (3 × 50 mL). The organic phase 
was dried over anhydrous MgSO4, filtered, and evaporated to dryness. The crude 
product was purified by flash column chromatography (silica gel, DCM/MeOH [50/1]). 
1.84 g of yellowish foam was obtained with 74 % yield. 
M.p. 89-92°C. 
IR (NaCl) v = 3058 (O-H, N-H),1673 (aromatic C=C). 
1H NMR (500 MHz, CDCl3) δ 8.40 (5-H, s, 1H), 8.12 (1-H, 9-H, d, J = 8.5 Hz, 2H), 8.02 – 
7.96 (4-H, 6-H, m, 2H), 7.50 – 7.38 (m, 9H), 4.66 (17-H, d, J = 12.4 Hz, 1H), 4.59 (17-H, d, 
J = 12.4 Hz, 1H), 4.06 (16-H, dd, J = 9.1, 4.5 Hz, 1H), 3.73 (15-H, dd, J = 11.0, 4.5 Hz, 1H), 
3.56 (15-H, dd, J = 10.9, 9.2 Hz, 1H), 2.26 (bs, 2H). 
 13C NMR (126 MHz, CDCl3) δ 140.39, 131.66, 130.66, 130.48, 129.29, 129.00, 128.22, 
127.71, 127.65, 126.34, 125.12, 124.17, 66.61, 65.40, 43.55.  
Data in agreement with those previously reported.11 
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(2-(((anthracen-9-ylmethyl)(2-hydroxy-1-phenylethyl)amino)methyl)phenyl)boronic 
acid (268)11  
 
 
Chemical Formula: C30H28BNO3 
Molecular Weight: 461.3592 g/mol 
 
To a mixture of 2-phenyl-2-(anthracen-9-ylmethylamino)-ethanol (0.30 g, 0.88 mmol) 
in dry MeCN (10 mL) was added K2CO3 (0.49 g, 3.51 mmol) and 2-(2-
bromomethylphenyl)-1, 3, 2-dioxaborinane (0.36 g, 1.41 mmol) and the mixture was 
refluxed for 8 h. The reaction mixture was cooled to room temperature and the 
solvent was removed under vacuum and the residue was taken up with H2O (10 mL). 
The aqueous phase was extracted with DCM (3 × 30 mL), and the combined organic 
extracts were washed with brine (2 × 20 mL) and dried over anhydrous MgSO4. The 
solvent was removed under vacuum and the residue purified by column 
chromatography (silica gel, DCM/MeOH [20:1]) to give 0.11 g of the expected 
compound (27%).  
IR (NaCl) v = 3207 (B-OH), 3063 (-OH).  
1H NMR (500 MHz, CDCl3) δ 8.41 (5-H, s, 1H), 8.24 (1-H, 9-H, d, J = 8.0 Hz, 2H), 7.95 (4-
H, 6-H, d, J = 8.0 Hz, 2H), 7.55 – 7.32 (2-H, 3-H, 7-H, 8-H, 10-H, m, 5H), 7.24 – 7.21 (22-
H, m, 1H), 7.17 -7.05 (11-H, 12-H, 13-H, 14-H, m, 4H), 6.67 (19-H, 20-H, 21-H, d, J = 7.5 
Hz, 3H), 5.22 (15-H, d, J = 14.2 Hz, 1H), 5.01 (15-H, d, J = 14.2 Hz, 1H), 4.59(17-H, d, J = 
6.5 Hz, 1H), 4.56 (17-H, d, J = 6.5 Hz, 1H), 4.04 (dd, J = 10.8, 6.0 Hz, 1H), 3.99 – 3.94 (18- 
H, m, 1H), 3.92 – 3.82 (18-H, m, 1H). 
 Data in agreement with those previously reported.11 
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Tricarbonyl(ɳ4-cyclohexa-1,3-dienecarboxylic acid methyl ester)iron (283)5  
 
 
Chemical Formula: C11H10FeO5 
Molecular Weight: 278.0391 g/mol 
 
To a slurry of diironnonacarbonyl (3.05 g, 8.38 mmol) in dry THF (2 mL) was added the 
solution of cyclohexa-1,3-dienecarboxylic acid methyl ester (0.50 g, 3.64 mmol) in dry 
THF (3 mL). The reaction mixture was flushed with argon and stirred at reflux under 
argon for 5 h. (Caution! Pentacarbonyliron is extremely toxic by inhalation). After 
filtration of the mixture through a short pad of Celite, the solvent was removed  in  
vacuo. Gradient column chromatography using a stepwise gradient of petroleum 
ether/EtOAc [80:20], and petroleum ether/ EtOAc/AcOH [79:20:1] afforded 0.65 g of 
yellow crystals (65 %).  
IR (NaCl) v = 2056 (C≡O symmetric), 1982 (C≡O asymmetric), 1715 (COOMe). 
1H NMR (500 MHz, CDCl3) δ 6.04 (1-H, bs, 1H), 5.36 (2-H, s, 1H), 3.70 (6-H, bs, 3H), 3.37 
(3-H, bs, 1H), 2.29 – 1.33 (4-H, 5-H, m, 4H).  
13C NMR (126 MHz, CDCl3) δ 210.34, 172.72, 88.60, 85.30, 64.81, 63.32, 51.67, 25.25, 
23.00. 
Data in agreement with those previously reported.5 
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General procedure for the preparation of 1-azabuta-1,3-diene derivatives12 
Trans-cinnaldehyde (82.8 mmol, 1 equiv.) and suitable amine (82.8 mmol, 1 equiv.) 
were dissolved in dry DCM (120 mL) containing molecules sieves. The reaction mixture 
was left overnight. The solvent was removed by vacuum and solid was dried over high 
vacuum for few hours. 
 
1,4-Diphenyl-1-azabuta-1,3-diene (286a)12  
 
 
Chemical Formula: C15H13N 
Molecular Weight: 207.2704 g/mol 
 
Pale yellow needles, 15.3 g, 89 %  
1H NMR (500 MHz, CDCl3) δ 8.19 (3-H, dd, J = 7.1, 1.2 Hz, 1H), 7.52 – 7.43 (1-H, 2-H, m, 
2H), 7.40 – 7.26 (Ar-H, m, 5H), 7.20 – 7.03 (Ar-H, 13-H, m, 5H). 
13C NMR (126 MHz, CDCl3) δ 161.78, 151.83, 144.17, 135.71, 129.73, 129.30, 129.05, 
128.71, 127.63, 126.25, 121.05. 
Data in agreement with those previously reported.12 
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1-(4-Methoxyphenyl)-4-phenyl-1-azabuta-1,3-diene (286b)12 
 
 
 
 
Chemical Formula: C16H15NO 
Molecular Weight: 237.2964 g/mol 
 
17.8 g, 91 % yellowish crystals.  
M.p. 121-122 °C (lit.12 : 122°C). 
1H NMR (500 MHz, CDCl3) δ 8.31 – 8.28 (3-H, m, 1H), 7.57 – 7.50 (7-H, 9-H, m, 2H), 7.42 
– 7.32 (5-H, 6-H, 8-H, m, 3H), 7.23 – 7.19 (10-H, 12-H, m, 2H), 7.12 (1-H, 2-H, d, J = 4.6 
Hz, 2H), 6.94 – 6.91 (11-H, 13-H, m, 2H), 3.83 (4-H, s, 3H). 
13C NMR (126 MHz, CDCl3) δ 159.65, 158.54, 144.67, 143.16, 135.90, 129.51, 129.02, 
128.90, 127.52, 122.35, 114.55, 55.60. 
Data in agreement with those previously reported.12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
192 
 
General procedure for the preparation of ɳ4-1-azabuta-1,3-diene)tricarbonyliron 
complexes12 
A mixture of 1-azabuta-1,3-dienes (69.6 mmol, 1 equiv.) and diironnonacarbonyl 
(104.4 mmol, 1.5 equiv.) in dry THF (120 mL) was sonicated at room temperature for 
24 h. (Caution! Pentacarbonyliron is extremely toxic by inhalation). The mixture was 
concentrated by rotary evaporation followed by flash chromatography (Et2O/pentane 
[1:10]) of the residue on silica gel. 
 
Tricarbonyl[(1-4-η)-1,4-diphenyl-1-azabuta-1,3-diene]iron (287a)12  
 
 
Chemical Formula: C18H13FeNO3 
Molecular Weight: 347.1457 g/mol 
 
Red crystals, 22.3 g, 92 %.  
IR (NaCl) v = 2051 (C≡O symmetric), 1980 (C≡O asymmetric). 
1H NMR (500 MHz, CDCl3) δ 7.58 – 6.70 (3-H, 4-H, 5-H, 5-H, 7-H, 8-H, 9-H, 10-H, 11-H, 
12-H, 13-H, m, 11H), 5.80 (2-H, s, 1H), 3.47 (1-H, s, 1H). 
Data in agreement with those previously reported.12 
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Tricarbonyl[(1-4-η)-1-(4-methoxyphenyl)-4-phenyl-1-azabuta-1,3-diene]iron (287b)12  
 
 
 
Chemical Formula: C19H15FeNO4 
Molecular Weight: 377.1717 g/mol 
 
Red crystals, 22.9 g, 94 %.  
M.p. 139 °C (dec). 
IR (NaCl) v = 2051 (C≡O symmetric), 1985 (C≡O asymmetric). 
1H NMR (500 MHz, CDCl3) δ 7.49 – 6.59 (3-H, 4-H, 5-H, 7-H, 8-H, 9-H, 10-H, 11-H, 12-H, 
13-H, bm, 10H), 5.61 (2-H, s, 1H), 3.69 (6-H, s, 3H), 3.32 (1-H, s, 1H). 
13C NMR (126 MHz, CDCl3) δ 155.54, 146.70, 139.13, 129.05, 128.91, 127.54, 126.98, 
126.74, 122.69, 122.38, 114.57, 114.44, 104.43, 74.08, 62.04, 55.57. 
Data in agreement with those previously reported.12 
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Tricarbonyl(ɳ4-cyclohexa-1,3-diene)iron (21)13 
 
 
Chemical Formula: C9H8FeO3 
Molecular Weight: 220.0030 g/mol 
 
Method A (reaction with Fe2CO9 in different solvent)
12  
To the suspension of diironnonacarbonyl (5.01 g, 16.5 mmol) in dry THF (7 mL) was 
added 1,3-cyclohexadiene (0.57 g, 7.17 mmol) and the mixture refluxed for 6 h. 
(Caution! Pentacarbonyliron is extremely toxic by inhalation). The reaction mixture 
was filtered through a short pad of Celite and solvent was removed. The residue was 
dissolved in petroleum ether for purification on flash chromatography on neutral 
aluminium oxide to afford the product as yellow oil. (For yields, see Table 12, Chapter 
3) 
 
Method B (reaction with FeCO5)
13,14  
 
Following the procedure reported by Birch13 and improved by Pearson et al.,14 1,3-
cyclohexadiene (0.57 g, 7.17 mmol) was dissolved in dry n-Bu2O (24 mL) and iron 
pentacarbonyl was added (3.9 g, 19.9 mmol). The reaction mixture was refluxed for 43 
h and then filtered through Celite. (Caution! Pentacarbonyliron is extremely toxic by 
inhalation). The filter pad was rinsed with n-Bu2O. The solvent was removed by rotary 
evaporation, followed by flash chromatography (petroleum ether/EtOAc [80:20]). (For 
yields, see Table 12, Chapter 3) 
 
Method C (reaction with ligand exchange 287a and 287b) general method12 
 
1,3-Cyclohexadiene (1.20 ml, 12.5 mmol) was dissolved in dry THF (25 mL). The 
solution was transferred into a solution of the azadiene complex (3.22 mmol) in dry 
THF (100 mL). The reaction mixture was refluxed for 1.5 h, and then cooled to room 
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temperature. The solvent was evaporated in vacuo to a volume of 1 mL. The residue 
was purified by flash chromatography (pentane) on silica gel to afforded expected 
compound as yellow oil. (For yields, see Table 16, Chapter 3) 
 
Method D (modified reaction with Fe2CO9 and silica on sonic bath based on procedure 
reported by Pauson et al.15) 
 
1,3-Cyclohexadiene (0.57 g, 7.17 mmol) was mixed with diironnonacarbonyl and silica 
(5 g per g of Fe2CO9) and placed in the sonic bath at 50 °C for 24 h. (Caution! 
Pentacarbonyliron is extremely toxic by inhalation). After cooling, the mixture was 
separated by flash chromatography (hexane:diethyl ether [1:1]) to give 1.22 g, 78 % of 
yellow liquid. 
IR (ATR) v= 2059 (C≡O symmetric) ,1981 (C≡O asymmetric). 
1H NMR (200 MHz, CDCl3) δ 5.33 – 5.23 (2-H, 3-H, m, 2H), 3.34 – 3.08 (1-H, 4-H, m, 2H), 
1.90 – 1.43 (5-H, 6-H, m, 4H). 
13C NMR (50 MHz, CDCl3) δ 212.36, 85.47, 62.57, 23.99. 
Data in agreement with those previously reported.12,13  
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Tricarbonyl(ɳ5-cyclohexa-1,3-dienylium)iron hexafluorophosphate (48)13  
 
 
Chemical Formula: C9H7F6FeO3P 
Molecular Weight: 363.9593 g/mol 
 
To a solution of triphenylcarbenium hexafluorophosphate (10.9 g, 2.82 mmol) in dry 
DCM (30 mL) was added dropwise a solution of tricarbonyl(ɳ4-cyclohexa-1,3-diene)iron 
(5.16 g, 2.35 mmol) in dry DCM (30 ml). The reaction mixture was stirred for 1 hour at 
ambient temperature and wet diethyl ether (700 ml) was added. The yellow 
precipitate was filtered and washed three times with diethyl ether (150 ml) to give 
pure tricarbonyl (ɳ5-cyclohexadienylium)iron hexafluorophosphate as yellow crystals 
(8.27 g, 97 %). 
IR (NaCl) v = 2125 (C≡O symmetric), 2084 (C≡O asymmetric). 
1H NMR (500 MHz, CD3CN) δ 7.14 (2-H, t, J = 5.5 Hz, 1H), 5.82 (1-H, 3-H, t, J = 6.3 Hz, 
2H), 4.23 (4H, 6-H, t, J = 6.8 Hz, 2H), 2.92 (5-H, dt, J = 15.8, 6.2 Hz, 1H), 1.89 (5-H, br. s, 
1H). 
13C NMR (126 MHz, CD3CN) δ 102.49, 90.00, 65.42, 24.03. 
Data in agreement with those previously reported.12,13  
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3-Hydroxyphenylurethane (281)16 
 
 
Chemical Formula: C9H11NO3 
Molecular Weight: 181.1885 g/mol 
 
Ethyl chloroformate (5.00 g, 46.1 mmol) was added to a mixture of 3-aminophenol 
(5.00 g, 46.1 mmol) in dry diethyl ether (200 mL). The reaction mixture was stirred for 
2 h at room temperature. The grey mixture was crystallized from toluene/cyclohexane 
(100 mL/200 mL) to give colourless crystals (4.24 g, 54 %).  
M.p. 93-94 °C (lit.16 : 94-95°C) 
1H NMR (300 MHz, CDCl3) δ 7.36 (1-H, s, 1H), 7.13 (3-H, t, J = 8.1 Hz, 1H), 6.73 – 6.52 
(2-H, 4-H, m, 2H), 6.47 (N-H, O-H,  br. s, 2H), 4.23 (5-H, q, J = 7.1 Hz, 2H), 1.31 (6-H, t, J 
= 7.1 Hz, 3H)  
13C NMR (50 MHz, CDCl3) δ 157.04, 154.14, 139.06, 130.10, 110.83, 110.61, 106.08, 
61.78, 14.62. 
Data in agreement with those previously reported.16 
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7-Carbethoxyamino-4-methylcoumarin (282)16  
 
 
Chemical Formula: C13H13NO4 
Molecular Weight: 247.2466 g/mol 
 
Ethyl acetoacetate (3.80 mL, 29.8 mmol) was added to the suspension of 3-
hydroxyphenylurethane (4.21 g, 25.1 mmol) in 70% H2SO4 (58 mL) and stirred for 4 h at 
room temperature. The mixture was poured into water/ice giving white crystals. 
Recrystallization from absolute ethanol yielded colourless needles (4.75 g, 77%). 
M.p. 185-186 °C (lit.16 : 186-188°C). 
1H NMR (200 MHz, DMSO-d6) δ 8.62 (1-H, s, 1H), 7.64 (2-H, d, J = 8.7 Hz, 1H), 7.51 (N-
H, s, 1H), 7.36 (3-H, d, J = 8.7 Hz, 1H), 6.18 (4-H, s, 1H), 4.15 (6-H, q, J = 7.1 Hz, 2H), 2.35 
(5-H, s, 3H), 1.24 (7-H, t, J = 7.1 Hz, 3H). 
13C NMR (50 MHz, DMSO-d6) δ 160.10, 153.86 (2C), 153.37, 153.21, 142.90, 125.96, 
114.27, 111.85, 104.40, 60.74, 18.03, 14.47. 
Data in agreement with those previously reported.16  
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7-Amino-4-methylcoumarin (102) 
 
 
Chemical Formula: C10H9NO2 
Molecular Weight: 175.1840 g/mol 
 
Method A (deprotection of 7-carbethoxyamino-4-methylcoumarin)16  
 
7-Carbethoxyamino-4-methylcoumarin (6.89 g, 27.9 mmol) in conc. H2S04 (25 g) and 
glacial acetic acid (25 g) was heated at reflux. After 4 h, the mixture was poured into 
ice/water (100 mL) and left overnight. To the resulting suspension was added 50% aq. 
NaOH (50 mL) with cooling by addition of ice chips, until pH~10. The yellow precipitate 
was filtered and washed with ice water (3 x 50 mL) and purified by crystallization from 
ethanol to give yellow needles (4.89 g, 99 %). 
 
Method B (without a solvent)17 
 
To a mixture of p-aminophenol (0.49 g, 4.58 mmol), ethyl acetoacetate (0.39 mL, 3.05 
mmol) was added, followed by a catalytic amount of BiCl3. The reaction mixture was 
stirred at reflux for 4 h. The purification by gradient chromatography EtOAc/DCM [7:3] 
to provide expected compound (0.21 g, 26 %). 
M.p. 222-223 °C (lit. M.p.16 : 223°C)  
1H NMR (500 MHz, DMSO-d6) δ 7.40 (3-H, d, J = 8.6 Hz, 1H), 6.56 (2-H, dd, J = 8.6, 2.2 
Hz, 1H), 6.40 (1-H, d, J = 2.2 Hz, 1H), 6.09 (N-H2, s, 2H), 5.90 (4-H, J = 1.1 Hz, 1H), 2.29 
(5-H, d, J = 1.1 Hz, 3H).  
13C NMR (126 MHz, DMSO-d6) δ 160.70, 155.43, 153.72, 153.05, 126.18, 111.14, 
108.81, 107.45, 98.49, 18.00. 
Data in agreement with those previously reported.16,17  
 
200 
 
 
Phenylacetyl chloride (303)18 
 
 
 
Chemical Formula: C8H7ClO 
Molecular Weight: 154.5936 g/mol 
 
At 0°C, to a mixture of phenylacetic acid (2.01 g, 14.7 mmol) in dry DCM (10 mL) oxalyl 
chloride (1.27 mL, 14.7 mmol) was slowly added, followed by a few drops of DMF. The 
reaction mixture was stirred at room temperature for 3 h and evaporated to give the 
expected acid chloride which was used in the following reaction. The yield was 
assumed to be quantitative. 
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N-(4-(hydroxymethyl)phenyl)-2-phenylacetamide(304)18  
 
 
Chemical Formula: C15H15NO2 
Molecular Weight: 241.2851 g/mol 
 
Phenylacetyl chloride (0.53 mL, 4.01 mmol) was added dropwise to a solution of  
p-aminobenzyl alcohol (0.52 g, 4.21 mmol). At 0 °C, dry pyridine (0.68 mL, 8.4 mmol) 
was added to the reaction mixture. The reaction was stirred under argon for 1.5 h and 
checked by TLC, and then purified by chromatography column (DCM/EtOAc, 7:3) to 
give white solid (0.87 g, 90 %).  
1H NMR (200 MHz, CD3OD δ 7.54 (3-H, 4-H, d, J = 8.5 Hz, 2H), 7.39 – 7.24 (1-H, 2-H, 5-
H, 6-H, 7-H, 8-H, 9-H, m, 7H), 4.56 (10-H, s, 2H), 3.68 (11-H, s, 2H).  
13C NMR (50 MHz, CD3OD δ 172.28, 138.97, 138.65, 136.84, 130.13, 129.58, 128.58, 
127.94, 121.23, 64.84, 44.68. 
Data in agreement with those previously reported.18  
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General procedure for the synthesis of substitued 7-aminocoumarin derivatives  
To a solution of the appropriate 7-amino-4-methyl-chromen-2-one (2.86 mmol, 1 
equiv.) in dry THF (22 ml) was added dimethylaminomethyl-polystyrene (3-4 mmol/g 
base loading, 1.15 equiv.) followed by tricarbonyl(ɳ5-cyclohexadienylium)iron 
hexafluorophosphate (3.29 mmol, 1.15 equiv.). The reaction mixture was stirred 
overnight and progress was monitored by TLC. The solvent was removed by rotary 
evaporation, and the obtained residue was purified by column chromatography 
(Et2O/hexane [1:1]) followed by preparative TLC. 
(±)-Tricarbonyl[ɳ4-7-(cyclohexa-2,4-dien-1-ylamino)-4-methyl-2H-chromen-2-
one]iron (271) 
 
 
Chemical Formula: C19H15FeNO5 
Molecular Weight: 393.1711 g/mol 
 
Yellow solid (0.51 g, 46 %).  
M.p. 196-198 °C. 
IR (NaCl) v = 2047 (C≡O symmetric), 1967 (C≡O asymmetric), 1708 (C=O), 1606 (C=C). 
1H NMR (500 MHz, CDCl3) δ 7.32 (9-H, d, J = 8.6 Hz, 1H), 6.39 (8-H, dd, J = 8.6, 2.3 Hz, 
1H), 6.35 (7-H, d, J = 2.3 Hz, 1H), 5.97 (10-H, d, J = 1.0 Hz, 1H), 5.58 (2-H, dist. dd, J = 
6.0, 4.4 Hz, 1H), 5.41 (3-H, dist. dd, J = 6.0, 4.4 Hz, 1H), 4.11 (N-H, d, J = 7.6 Hz, 1H), 
4.02 (6-H, ddd, J = 10.1, 7.6, 3.6 Hz,  1H), 3.17 (1-H, ddd, J = 6.0, 3.6, 1.2 Hz, 1H), 3.04 
(4-H, ddd, J = 6.0, 3.8, 1.8 Hz, 1H), 2.47 (5-H, ddd, J = 15.1, 10.1, 3.8 Hz,  1H), 2.32 (11-
H, d, J = 1.0 Hz, 3H), 1.44 (5-H, d, J = 15.1 Hz, 1H).   
13C NMR (126 MHz, CDCl3) δ 211.03, 161.92, 155.99, 152.95, 150.57, 125.74, 110.93, 
110.46, 109.81, 98.87, 87.63, 84.03, 60.66, 56.97, 51.45, 32.68, 18.65. 
HRMS [ASAP] for [M+] C19H15FeNO5 requires 394.0372, found 394.0370. 
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(±)-Tricarbonyl[ɳ4-7-(cyclohexa-2,4-dien-1-ylamino)-4-(trifluoromethyl)-2H-chromen-
2-one]iron (288) 
 
 
Chemical Formula: C19H12F3FeNO5 
Molecular Weight: 447.1425 g/mol 
 
Bright yellow powder (0.95 g, 74%). 
M.p.  183-185 °C. 
IR (NaCl) v = 2050 (C≡O), 1970 (C≡O), 1718 (C=O), 1606 (C=C). 
1H NMR (500 MHz, CDCl3) δ 7.43 (9-H, d, J = 8.3 Hz, 1H), 6.43 (7-H, 8-H, overlapping s 
and d, J = 8.2 Hz, 2H), 6.37 (10-H, s, 1H), 5.64 (2-H, t, J = 5.0 Hz, 1H), 5.55 (3-H, t, J = 5.0 
Hz, 1H), 4.32 (N-H, d, J = 6.7 Hz, 1H), 4.07 – 3.94 (6-H, m, 1H), 3.18 – 3.10 (1-H or 4-H, 
m, 1H), 3.08 – 3.01 (1-H or 4-H, m, 1H), 2.48 (5-H, ddd, J = 15.0, 10.5, 4.0 Hz, 1H), 1.45 
(5-H, partially obscured d, J = 15.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 210.97, 160.37, 157.22, 151.36, 142.02 (q, JC-F = 32.6 Hz) 
126.54 (q, JC-F = 1.9 Hz), 122.06 (q, JC-F = 275.4 Hz) 111.55, 109.18 (q, JC-F = 5.9 Hz), 
104.30, 98.84, 87.85, 84.05, 60.20, 56.92, 51.46, 32.81. 
HRMS [ASAP] for [M+] C19H12F3FeNO5 requires 448.0090, found 448.0080. 
 
 
 
 
 
 
 
 
 
 
 
204 
 
(±)-Tricarbonyl[ɳ4-7-(cyclohexa-2,4-dien-1-ylamino)-2-methyl-4H-chromen-4-
one]iron (292). 
 
 
Chemical Formula: C19H15FeNO5 
Molecular Weight: 393.1711 g/mol 
 
Pale yellow  powder (0.96 g, 86 %). 
M.p. 211-213 °C. 
IR (NaCl) v = 2047 (C≡O), 1966 (C≡O), 1645 (C=O), 1593 (C=C). 
1H NMR (500 MHz, DMSO) δ 7.62 (9-H,  d, J = 8.8 Hz, 1H), 6.78 (N-H, d, J = 7.4 Hz, 1H), 
6.61 (8-H, dd, J = 8.8, 2.0 Hz, 1H), 6.35 (7-H, br. d, J = 2.0 Hz, 1H), 5.96 (10-H, bs, 1H), 
5.82 (2-H, dist. dd, J = 5.7, 4.5 Hz, 1H), 5.63 (3-H, dist. dd, J = 6.1, 4.5 Hz, 1H), 3.94 (6-H, 
ddd, J = 10.1, 7.4, 3.7 Hz, 1H), 3.29 (1-H or 4-H, ddd, J = 6.1, 3.7, 1.2 Hz, 1H), 3.17 (4-H, 
ddd, J = 5.7, 3.9, 1.7, 1H), 2.39 (5-H, ddd, J = 15.0, 10.1, 3.9 Hz, 1H), 2.29 (11-H, s, 3H), 
1.43 (5-H, br. d, J = 15.0 Hz, 1H).  
13C NMR (126 MHz, DMSO) δ 211.83, 175.72, 164.63, 158.42, 152.45, 125.60, 112.55, 
109.28, 95.56, 87.53, 85.20, 61.98, 58.28, 50.05, 31.42, 30.67, 19.76. 
HRMS [ASAP] for [M+] C19H15FeNO5 requires 394.0372, found 394.0370. 
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General procedure for the synthesis of substitued hydroxyl coumarin derivatives  
To a solution of the appropriate 7-hydroxy-4-methyl-chromen-2-one (4.12 mmol, 1 
equiv.) in dry DCM (10 mL) was added potassium carbonate (8.24 mmol, 2 equiv.) 
followed by tricarbonyl(ɳ5-cyclohexadienylium)iron hexafluorophosphate (4.74 mmol, 
1.15 equiv.). The reaction mixture was stirred overnight and progress was monitored 
by TLC. The salt was collected by filtration purified by column chromatography (Et2O: 
hexane, 3:1). 
 
(±)-Tricarbonyl[ɳ4-7-(cyclohexa-2,4-dien-1-yloxy)-4-methyl-2H-chromen-2-one]iron 
(294) 
 
 
Chemical Formula: C19H14FeO6 
Molecular Weight: 394.1559 g/mol 
 
Rf = 0.3, a brown solid (1.31 g, 81 %). 
M.p. 103-105 °C. 
IR (NaCl) v = 2046 (C≡O), 1966 (C≡O), 1694 (C=O), 1604 (C=C). 
1H NMR (500 MHz, CDCl3) δ 7.45 (9-H, d, J = 8.8 Hz, 1H), 6.71 (8-H, dd, J = 8.8, 2.3 Hz, 
1H), 6.66 (7-H, d, J = 2.3 Hz, 1H), 6.12 (10-H, s, 1H), 5.64 (2-H, dist. dd, J = 5.2, 5.0 Hz, 
1H), 5.55 (3-H, dist. dd, J = 5.4, 5.2 Hz, 1H), 4.82 (6-H, ddd, J = 10.1, 3.1, 2.8 Hz, 1H), 
3.12 (1-H, ddd, J = 5.0, 3.1, 1.5 Hz 1H), 3.01 (4-H, ddd, J = 5.4, 3.8, 1.7 Hz, 1H), 2.51 (5-
H, ddd, J = 15.3, 10.0, 3.8 Hz, 1H), 2.37 (11-H, s, 3H), 1.68 (5-H, d, J = 15.3 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 210.79, 161.37, 161.35, 155.35, 152.62, 125.71, 113.66, 
113.16, 112.07, 102.52, 87.90, 85.03, 75.80, 57.52, 55.30, 31.56, 18.77. 
HRMS [ASAP] for [M-] C19H14FeO6 requires 393.0056, found 393.0053. 
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(±)-Tricarbonyl[ɳ4-7-(cyclohexa-2,4-dien-1-yloxy)-4-(trifluoromethyl)-2H-chromen-2-
one]iron (295). 
 
 
Chemical Formula: C19H11F3FeO6 
Molecular Weight: 448.1272 g/mol 
 
Brown solid (1.44 g, 78 %). 
M.p. 182-185 °C. 
IR (NaCl: v = 2052 (C≡O), 1974 (C≡O), 1738 (C=O), 1610 (C=C). 
1H NMR (500 MHz, CDCl3) δ 7.58 (9-H, dq, J = 9.0 Hz, JH-F = 1.5 Hz, 1H), 6.77 (8-H, dd, J = 
9.0, 2.4 Hz, 1H), 6.72 (7-H, d, J = 2.4 Hz, 1H), 6.60 (10-H, br. s, 1H), 5.65 (2-H, dist. dd,  
J = 5.5, 5.0 Hz, 1H), 5.56 (3-H, dist. dd, J = 5.4, 5.0 Hz, 1H), 4.85 (6-H, ddd, J = 9.5, 3.1, 
2.8, 1H), 3.18 (1-H, ddd, J = 5.5, 3.1, 1.3 Hz, 1H), 3.02 (4-H, ddd, J = 5.4, 3.8, 1.7, 1H), 
2.52 (5-H, ddd, J = 15.4, 9.5, 3.8 Hz, 1H), 1.69 (5-H, d, J = 15.4 Hz, 1H).   
13C NMR (126 MHz, CDCl3) δ 210.66, 162.28, 159.50, 156.42, 141.71 (q, JC-F = 32.8 Hz) 
126.54 (q, JC-F = 2.1 Hz), 121.73 (q, JC-F = 275.5 Hz), 114.21, 112.27 (q, JC-F = 5.6 Hz), 
107.06, 102.90, 87.97, 85.01, 76.11, 57.06, 55.13, 31.58. 
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